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Abstract 
 
Monocytes comprise a key component of the innate immune system. Their excessive 
and/or prolonged recruitment and/or activation can however be harmful and has been 
associated with the pathogenesis of numerous inflammatory disorders, most notably 
atherosclerosis. Consequently there is much interest in deciphering the mechanisms by 
which monocytes migrate into sites of inflammation. In this context, whilst many 
studies have investigated the roles of adhesion molecules and chemokine receptors, very 
little attention has been placed on the potential involvement of proteases. To help 
address this point, and considering cigarette smoke-induced recruitment of monocytes 
to the lung is impaired in mice deficient in neutrophil elastase (NE
-/-
), we sought to 
further investigate the role of NE, a serine protease, in monocyte migration. 
To achieve this we successfully crossed CX3CR1-eGFP-knock-in mice, which exhibit 
fluorescently labelled monocytes, with NE
-/-
 mice. By comparing NE
-/-
 and NE
+/+
 
littermates we demonstrated, for the first time, NE expression in murine monocytes. 
Peritonitis, ear, and cremaster muscle models of inflammation were subsequently 
employed to assess the involvement of NE in monocyte recruitment. In CCL2-induced 
peritonitis, a predominantly monocyte-driven inflammatory model, monocyte 
infiltration was significantly reduced after 16 hours in NE
-/-
 mice compared to NE
+/+
 
controls. Monocyte transmigration was also defective in the ears (though interestingly 
not the cremaster muscles) of NE
-/-
 mice stimulated with CCL2, with the majority of 
monocytes seemingly unable to penetrate the venular endothelium. Furthermore, 
immunostaining revealed transmigrating monocytes were depleted of their intracellular 
NE stores. Taken together, it appears the release of NE by monocytes promotes their 
transmigration in response to CCL2, identifying NE as a potential therapeutic target for 
monocyte-driven pathologies.  
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CHAPTER 1: General introduction 
 
1.1 Inflammation 
All animals possess some form of immune system that serves to maintain good health 
by eliminating invading pathogens (e.g. viruses and bacteria) and other harmful 
substances. The immune system of humans and other higher vertebrates can be divided 
into two interdependent branches: innate and adaptive. The innate immune system 
provides general protection against all foreign agents, while the adaptive immune 
system initiates a more potent response, specific to each pathogen. Both systems operate 
by utilising a cellular component, represented mainly by specialised immune cells 
called leukocytes, and a humoral component, mediated by soluble macromolecules that 
reside in extracellular fluids. In addition, the innate immune system features anatomical 
barriers, including the skin and mucous membranes, which physically and chemically 
resist pathogens and ultimately represent the first line of defence against infection.  
If these barriers are penetrated, or the host incurs some other form of tissue damage (e.g. 
burn or blunt trauma injuries), inflammation is triggered. Inflammation is a 
physiological response mediated in large by the innate immune system and is 
characterised by the accumulation of blood plasma and leukocytes at the site of damage. 
It functions to contain, if not remove the inciting stimulus as well as any damaged or 
necrotic cells resulting from the insult, and initiate tissue repair. Furthermore, as innate 
immune cells are integral to the priming of T and B lymphocytes, the inflammatory 
response contributes to activating the adaptive immune system, the ultimate weapon 
against most infections and capable of generating immunological memory. 
Inflammation is therefore essential to resolving injury and restoring tissue homeostasis 
and typically promotes a healthy state.    
 
a) Acute inflammation: 
Inflammation can be classified as acute or chronic. Acute inflammation is triggered 
immediately at a site of injury by resident cells, predominantly those belonging to the 
innate immune system, such as macrophages, mast cells, and dendritic cells (DCs) 
(Newton and Dixit, 2012). These cells express a variety of germline encoded intra- and 
extracellular pattern recognition receptors (PRRs) that detect pathogen-associated 
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molecular patterns (PAMPs) during infection and damage-associated molecular patterns 
(DAMPs) released from injured host cells. Collectively termed inflammatory inducers, 
the recognition of these molecules by PRRs activates intracellular signalling pathways 
stimulating the release of chemical molecules that cause and regulate local 
inflammation (Figure 1.1). 
Several families of PRRs exist including the cytoplasmic nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs) and the membrane-bound Toll-
like receptors (TLRs), which have been most expansively characterised. Having an 
extensive repertoire of PRRs, many of which can recognise several inducer molecules, 
ensures a rapid and effective immune response is elicited upon exposure to a variety of 
stimuli. PAMPs are molecules exclusively expressed by microbial pathogens. They are 
evolutionarily highly conserved and typically play an essential role in pathogen 
survival. They include fungal β-glucans and lipopolysaccharide (LPS), the major cell 
wall component of Gram-negative bacteria and one of the most potent PAMPs known 
(Mogensen, 2009). Certain pathogens also release toxins and other virulence factors that 
are not sensed directly by PRRs but rather induce an inflammatory response through 
their adverse effects on the host tissue (Medzhitov, 2008). This process is mediated in 
part by DAMPs, endogenous host-derived molecules with defined intracellular 
functions under basal conditions. During stress however, DAMPs are actively secreted 
or released from cells and subsequently bound by PRRs. Among the best characterised 
human DAMPs are the cytoplasmic proteins S100A8 and S100A9 and the nuclear 
protein HMGB1, all of which can induce inflammation by engaging TLRs (Medzhitov, 
2008).  
PRRs promote two main functions upon ligand binding: they activate resident 
macrophages and DCs to remove microbes and host debris by phagocytosis and they 
initiate intracellular signal transduction cascades. Different inducer molecules activate 
distinct sets of PRRs, triggering distinct signalling pathways that allow for a more 
tailored stimulus-dependent immune response (Akira et al., 2006). Common to all PRR 
signalling however is the activation of transcription factors. Nuclear factor κB (NF-κB) 
and activator protein 1 (AP-1) are two major, ubiquitously expressed transcription 
factors that respond to the vast majority of inflammatory stimuli and lie downstream of 
all TLR signalling (Akira et al., 2006). They work in synergy with other inducible 
transcription factors to regulate the expression and release of many different 
19 
 
inflammatory mediators. These include antimicrobial peptides capable of killing 
microorganisms directly, as well as small intercellular signalling proteins called 
cytokines, which ultimately co-ordinate the development of the inflammatory response. 
The release of inflammatory mediators results in three major and interrelated responses 
that occur locally at the site of tissue damage: vascular dilation, increased vascular 
permeability, and leukocyte infiltration and activation. This collective effect clinically 
manifests as redness, heat, swelling, and pain, the cardinal signs of acute inflammation. 
Vascular dilation is initiated by mediators such as histamine and nitric oxide. Their 
release relaxes vascular smooth muscle cells, widening the lumen of precapillary 
arterioles and engorging the tissue with blood. Histamine also increases vascular 
permeability, along with bradykinin and leukotrienes. These mediators trigger 
contraction of endothelial cells of postcapillary venules, which separates intercellular 
junctions forming small pores (Kumar et al., 2010). An increase in blood flow and 
vascular permeability results in the net movement of plasma from the blood into the 
tissue. This fluid exudate is rich in proteins such as fibrinogen, kinins, complement, and 
immunoglobulins that activate coagulation, promote pathogen killing, and generally 
contribute to the inflammatory response. Moreover, fluid loss concentrates erythrocytes 
in the vasculature and reduces the local blood flow. This condition is called stasis and 
facilitates the rolling of leukocytes along the endothelium and their subsequent 
migration into the tissue.  
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Polymorphonuclear neutrophils (PMNs) are the earliest and most abundantly recruited 
leukocyte cell type during acute inflammation, typically reaching the site of damage 
after the first 6-24 hours. This is followed by a second wave of monocyte infiltration 
after 24-48 hours (Kumar et al., 2010). Upon recruitment to damaged tissue, leukocytes 
undergo activation by interacting with local inducer molecules and inflammatory 
mediators, resulting in the enhancement of their defensive functions. Monocytes 
generally differentiate into more specialised macrophages and DCs which, along with 
activated neutrophils, constitute potent phagocytes, engulfing microbes and dead cells 
and incorporating them into phagocytic vacuoles. Internalisation triggers an oxidative 
burst in which the multisubunit enzyme NADPH oxidase is assembled in the vacuole 
membrane prior to generating reactive oxygen species (ROS), potent microbicidal 
agents considered to be the major killing mechanism for most invading pathogens (Dale 
et al., 2008). The fusion of lysosomal granules with phagocytic vacuoles introduces a 
range of digestive and hydrolytic enzymes which further contribute to pathogen killing 
before catalysing their degradation. Activated leukocytes can also kill pathogens 
extracellularly independent of phagocytic uptake by secreting antimicrobial molecules 
and releasing the contents of their granules. Moreover, neutrophils have been shown to 
release extracellular traps (NETs), a sticky network of chromatin DNA and granule 
proteins that ensnare pathogens and promote their killing. In addition to exerting 
Figure 1.1: Phases of acute inflammation. Acute inflammation is a local response to tissue 
damage (e.g. getting a splinter) and comprises three main steps: detection of the insult (A), 
recruitment of effector molecules and cells (B) and restoration of tissue homeostasis (C). 
Inflammation is triggered immediately at the site of injury by resident cells of the innate 
immune system, mainly macrophages (MФ) and DCs. These cells present on their surfaces 
pattern recognition receptors (PRRs) that recognise inflammatory inducer molecules associated 
with microbial pathogens and cellular damage. Engagement of PRRs induces cell activation and 
the release of cytokines and chemokines, which orchestrate the inflammatory response. Local 
blood vessels dilate and become more permeable, promoting the influx of blood plasma and 
leukocytes. Neutrophils (PMN) are typically recruited first and, along with tissue macrophages, 
constitute potent phagocytes. In addition, neutrophils release their own mediators and granule 
contents, directly mediating the recruitment of classical monocytes (mono.). These cells are 
highly plastic, capable of differentiating into both macrophages and DCs with both pro- and 
anti-inflammatory characteristics. Once neutrophils have successfully cleared the inciting 
stimulus, they undergo apoptosis (faded cells). This not only promotes continued monocyte 
influx but prevents further infiltration of neutrophils. The clearance of apoptotic neutrophils by 
macrophages prompts an anti-inflammatory programme, which includes the secretion of growth 
factors that helps to restore tissue homeostasis. Resolution of inflammation is marked by the 
emigration of monocyte-derived cells out of the inflamed site via the lymphatics.  
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antimicrobial effects, activated leukocytes also release a plethora of inflammatory 
mediators that amplify the inflammatory response and perpetuate leukocyte recruitment. 
Extravasated neutrophils for example release preformed granule proteins, which 
promote monocyte recruitment both directly by activating receptors on their surfaces 
and indirectly by stimulating the secretion of monocyte-specific chemokines by resident 
macrophages and endothelial cells (Soehnlein and Lindbom, 2010). 
Once the offending stimulus has been successfully removed, the inflammatory response 
begins to resolve. Vessel permeability and calibre returns to a normal status and the 
local production of pro-inflammatory cytokines is suppressed, abating further neutrophil 
recruitment. This is supported by the active secretion of mediators possessing pro-
resolution and anti-inflammatory properties. These include interleukin (IL)-10, an 
inhibitor of the pro-inflammatory transcription factor NF-κB, and members of the 
lipoxin, protectin and resolvin families, which selectively block neutrophil chemotaxis 
and more generally contribute to the resolution phase by promoting the nonphlogistic 
(i.e. non-inflammatory) recruitment of monocytes and activating macrophages to engulf 
apoptotic neutrophils and cellular debris (Serhan et al., 2008). As inflammation subsides 
other secreted mediators orchestrate wound healing, ideally by initiating tissue 
regeneration. In this context, residual cells are stimulated to deposit extracellular matrix 
(ECM) proteins and undergo proliferation, thereby re-filling the wound area and 
restoring tissue homeostasis, integrity and function (Kumar et al., 2010). This is 
supported by local angiogenesis, which functions to re-establish the vasculature and 
provide nutrients and oxygen crucial for anabolic processes. Macrophages eventually 
leave the site of injury, predominantly by draining into the lymph nodes, marking the 
end of the resolution phase (Serhan and Savill, 2005).  
 
b) Chronic inflammation:  
Acute inflammation typically lasts for hours or days. If however the noxious stimulus is 
not quickly removed or the regulation of the inflammatory or healing response becomes 
impaired, inflammation can persist for weeks, months or even years. During such 
prolonged, or chronic, inflammation continuing leukocyte infiltration and attempted 
tissue healing occur at the site of injury simultaneously. Chronic inflammation can be 
caused by persistent infections by microorganisms that are difficult to eliminate (e.g. 
Mycobacterium tuberculosis, the causative pathogen of Tuberculosis), prolonged 
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exposure to toxic agents (e.g. silica particles), or self-antigens that induce an 
autoimmune response. In addition to succeeding single or repeated bouts of acute 
inflammation, chronic inflammation can also develop insidiously as a low-grade, 
smouldering, often asymptomatic response.  
While acute inflammation is mediated by abundant neutrophil recruitment, during 
chronic inflammation there is a shift in type of leukocyte to mononuclear cells, 
predominantly monocytes/macrophages and lymphocytes. As these cells accumulate 
and proliferate at the site of injury they produce a range of chemical mediators that 
induce the hallmarks of chronic inflammation. Proteolytic enzymes and ROS are 
secreted in an attempt to clear the inciting agent, however, acting largely non-
specifically, their continuous release during chronic inflammation often results in 
collateral damage to otherwise healthy tissue. Subsequent healing can often not be 
accomplished by regeneration and instead occurs by fibrosis, a hardening or scarring of 
the tissue resulting from the excess deposition of collagens and other ECM proteins. 
Stimulated by macrophage-derived growth factors, fibrosis can severely impair tissue 
architecture and function, potentially culminating in organ failure. Other mediators, 
such as bradykinin and histamine, excite local nociceptive neurons causing persistent 
pain, while extensive systemic effects are also associated with chronic inflammation 
including fever, fatigue, weight loss and wasting (Kumar & Wakefield, 2010). 
In this context, inflammation may no longer benefit the host but instead be detrimental. 
Indeed, chronic inflammation underlies the pathology of many common and clinically 
important diseases including rheumatoid arthritis, asthma, Alzheimer’s disease, and 
atherosclerosis. Moreover, persistent inflammation promotes carcinogenesis by causing 
DNA damage and generating proliferative and anti-apoptotic signals, thereby enhancing 
the risk of developing cancer (Fitzpatrick, 2001). Responsible globally for over 35 
million deaths a year, these chronic disorders now represent the leading cause of 
morbidity and mortality worldwide, affecting the young and the old, the rich and the 
poor, and different ethnicities alike. In addition, they have a substantial economic 
impact both on patients' families and society as a whole. In the United States for 
example, healthcare spending and lost business productivity due to chronic disease 
totals over $250 billion and $1 trillion per year, respectively (DeVol & Bedroussian, 
2007). With current treatments proving largely ineffective and the burden of chronic 
diseases projected to increase there is a great emphasis on further understanding the 
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mechanisms of chronic inflammation in the hope that this will catalyse the development 
of novel therapeutic strategies (Mackay, 2008). This particular study focusses on 
monocytes, whose continuous recruitment, activation and differentiation into tissue 
macrophages and DCs is a typical hallmark of chronic inflammation.  
 
1.2 Monocytes 
a) Monocyte heterogeneity:  
Monocytes are generally the largest leukocyte cell type in the blood, morphologically 
characterised by an abundant and moderately granular cytoplasm and a kidney-shaped 
nucleus. There are two major subsets of monocytes in humans, originally distinguished 
by size, function and differential expression of the surface markers CD14 (a co-receptor 
for LPS) and CD16 (a low affinity Fc receptor) (Grage-Griebenow et al., 2001). 
Described first and accounting for ~90% of the total monocyte population in healthy 
individuals, classical monocytes were large cells with relatively high phagocytic 
activity, superoxide release, and CD14 expression but absent for CD16 (CD14
++
 CD16). 
Conversely, non-classical monocytes, comprising only ~10% of monocytes, were 
smaller in size, had low peroxidase activity, and were CD14 low, CD16 high (CD14
+
 
CD16
++
). Numerous other phenotypic differences have since been elucidated, including 
distinct chemokine receptor expression profiles. Classical monocytes are CCR2
+
, 
CCR5
–
 and CX3CR1
low
, while non-classical monocytes are CCR2
–
, CCR5
+
 and 
CX3CR1
hi 
(Ingersoll et al., 2010). 
Two major monocyte subsets have been reported in other mammals including pigs, rats 
and mice. Murine monocytes have been particularly well characterised and are 
collectively identified as CD115
+
, CD11b
+
, F4/80
int
 blood cells (Sunderkötter et al., 
2004). Represented in roughly equal proportion in the circulation, the two murine 
monocyte subsets are typically distinguished by the marker lymphocyte antigen 6C 
(Ly6C), a protein with unknown function. Ly6C
+
 monocytes are also CCR2
hi
 and 
CX3CR1
med
, resembling human classical monocytes. Likewise, Ly6C
–
 monocytes are 
CCR2
low
, CX3CR1
hi
 and CD16
+
 similar to human non-classical monocytes. It was 
consequently proposed that homologous monocyte subsets exist in humans and mice. 
Indeed, similar morphological features, comparable gene expression profiles and the 
identification of other common surface markers reveal both subsets (herein collectively 
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referred to as classical and non-classical monocytes) are broadly conserved between the 
two species (Figure 1.2) (Ingersoll et al., 2010). Accordingly, mouse models have been 
and continue to be routinely used to characterise monocyte biology.   
 
 
 
 
 
b) The mononuclear phagocyte system: 
Monocytes, like all other leukocytes develop from pluripotent haematopoietic stem cells 
(HSCs) that reside in the bone marrow. Changes in gene expression enable HSCs to 
commit to alternative differentiation pathways culminating in the production of distinct 
leukocyte subsets. For monocytes, maturation occurs via several intermediate 
progenitors, namely the common myeloid progenitor (CMP), the 
granulocyte/macrophage progenitor (GMP), and the macrophage/DC progenitor (MDP). 
These progenitor cells, along with mature monocytes and their macrophage and DC 
derivatives comprise the mononuclear phagocyte system (MPS) (Figure 1.3). 
Commitment to the mononuclear phagocyte lineage is critically dependent on the 
transcription factor PU.1. When sufficiently activated by the cytokine macrophage 
colony-stimulating factor (M-CSF), PU.1 functions to antagonise the transcription 
factor C/EBP-α, imperative for the development of neutrophils, while also promoting 
monocyte maturation more directly by inducing secondary transcription factors and 
Figure 1.2: Phenotype of murine monocyte subsets: Classical and non-classical monocytes 
possess characteristic expression profiles of adhesion molecules and chemokine receptors, 
which govern distinct recruitment mechanisms. These profiles are largely conserved in humans 
and mice. 
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other genes characteristic of monocytes, such as CD14, scavenger receptors, and the 
adhesion molecules CD11b and CD18 (Valledor et al., 1998). Classical monocytes are 
reportedly the first subset to develop in the bone marrow, differentiating directly from 
MDPs. Classical monocytes in turn give rise to non-classical monocytes. This appears 
to occur via a distinct ‘intermediate’ subset, which, in addition to acting as a transitional 
population, also possesses discrete biological functions (Wong et al., 2011).  
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Upon maturation, monocytes emigrate out of the bone marrow and enter the 
bloodstream. For classical monocytes, this process is dependent on the activation of C-
C chemokine receptor 2 (CCR2) by its ligands CCL2 and CCL7 (Tsou et al., 2007). 
This differs for non-classical monocytes which express considerably lower levels of 
CCR2, however an analogous mechanism has yet to be elucidated (Ingersoll et al., 
2011). Alternatively, it has been postulated that the conversion of classical monocytes 
to non-classical monocytes can occur directly in the bloodstream (Sunderkötter et al., 
2004). As well as circulating freely in the blood, a large proportion of mature 
monocytes have been shown to collect in the subcapsular red pulp of the spleen, in both 
humans and mice (van der Laan et al., 2014). These monocytes remain in an 
undifferentiated state and have an identical morphology and transcriptome compared to 
their blood counterparts (Swirski et al., 2009a).  
In the steady state monocytes constitute approximately 10% of total blood leukocytes in 
humans and 4% in mice. They typically circulate for several days, after which they die, 
return to the bone marrow, or move into tissues to replenish resident macrophages and 
DCs. Found throughout the body, these mononuclear phagocytes fulfil many important 
physiological functions during homeostasis, for example removing senescent cells and 
cellular debris, tissue remodelling, and serving as sentinels to invading microbes. While 
both monocyte subsets are capable of differentiating into both macrophages and DCs in 
vitro (Geissmann et al., 2003), it appears classical monocytes are the dominant 
precursors in the steady state in vivo. Indeed, classical murine monocytes have been 
Figure 1.3: The mononuclear phagocyte system. The mononuclear phagocyte system (MPS) 
comprises monocytes and their bone marrow (BM) progenitors, as well as tissue macrophages 
(MΦ) and dendritic cells (DC). Classical monocytes are developed directly in the BM, 
differentiating from several intermediate progenitors, including the common myeloid progenitor 
(CMP), the granulocyte/macrophage progenitor (GMP), and the macrophage/DC progenitor 
(MDP). Upon maturation, classical monocytes enter the bloodstream in a CCR2-dependent 
manner, wherein they may differentiate further into non-classical monocytes, seemingly via a 
distinct intermediate population. It has also been postulated that non-classical monocytes can 
develop directly in the BM, either from classical monocytes or other progenitor cells. In 
addition to circulating freely, a large proportion of mature monocytes home to the spleen. Under 
steady state conditions, classical monocytes maintain populations of resident macrophages and 
DCs in the peripheral tissues, while non-classical monocytes patrol blood vessels for damage. 
During inflammation, classical monocytes egress from the BM and spleen and are extensively 
recruited to the damaged tissue where they differentiate into pro-inflammatory TipDCs or M1-
like macrophages. Non-classical monocytes are also recruited to sites of inflammation and 
possibly contribute to wound healing by differentiating into M2-like macrophages.  
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shown to repopulate macrophages and DCs in the skin, lungs, and digestive tract, 
though other populations appear to be predominantly maintained by local proliferation 
(Auffray et al., 2009). While non-classical monocytes have for example been shown to 
reconstitute a subpopulation of pulmonary DCs (Jakubzick et al., 2008), it appears their 
primary function under homeostatic conditions is immunosurveillance. Non-classical 
murine monocytes are known to reside in resting tissues and have also been observed by 
intravital microscopy to constitutively crawl on the luminal side of the endothelium in 
blood vessels in the dermis and mesentery (Auffray et al., 2007). As such, they are 
ideally located to scavenge microparticles and cellular debris, as well as survey their 
surroundings for tissue damage (Carlin et al., 2013).  
 
c) Monocytes during inflammation: 
As part of the inflammatory response, circulating monocytes mobilise to damaged 
tissues where they play an essential role in clearing the inciting stimulus and restoring 
tissue homeostasis. The recruitment of monocytes during inflammation is supported by 
a transient increase in the total number of monocytes in the blood. Mature monocytes 
residing in the spleen and bone marrow enter the bloodstream en masse in an 
angiotensin II and CCL2-dependent manner, respectively (Shi and Pamer, 2011). In 
addition, monocyte production in the bone marrow is heightened (Robbins and Swirski, 
2010). The spleen and bone marrow therefore serve as monocyte reservoirs, which, 
when deployed into the circulation, promote rapid and abundant monocyte 
accumulation. Generally during both acute and chronic inflammation the classical 
monocyte subset predominantly accumulates in the circulation and is extensively 
recruited to the site of injury (Ingersoll et al., 2011). This is observed in murine models 
of bacterial, viral, fungal and parasitic infection, wherein they contribute to the control 
of pathogen growth by partaking in phagocytosis and producing a combination of pro-
inflammatory mediators including TNF-α, ROS, nitric oxide, and type 1 interferon 
(Robbins and Swirski, 2010). In addition, recruited classical monocytes and/or their 
DC-derivatives can enter draining lymph nodes and engage the adaptive immune system 
by priming T lymphocytes, as seen following infection with Leishmania major and 
Mycobacterium tuberculosis (Serbina et al., 2008).  
Using a model of peritoneal infection with the bacterium Listeria monocytogenes (so 
called because it induces a strong monocyte response), Auffray et al. also report 
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abundant classical monocyte infiltration, however this was preceded by an influx of 
non-classical monocytes, entering the peritoneal cavity after just 1 hour. These cells 
initiated an early inflammatory response by releasing the potent inflammatory mediators 
TNF-α and interleukin-1 beta (IL-1β) and upregulating genes encoding chemokines, 
TLRs, defensins, and complement proteins (Auffray et al., 2007). A direct result of this 
response was the recruitment of classical monocytes, which were shown to release large 
quantities of their own inflammatory mediators before differentiating into inflammatory 
cells resembling TIP (TNF-α/ inducible nitric oxide synthase (iNOS)-producing) DCs. 
This coincided with a shift in gene expression in the non-classical monocytes: pro-
inflammatory genes were turned off and instead an M2-like macrophage differentiation 
programme was initiated. M2-like, or alternatively activated macrophages are involved 
in tissue remodelling, wound repair, and immunomodulation.  
This latter study describes distinct biological functions for classical and non-classical 
monocytes in response to bacterial infection: classical monocytes were recruited more 
extensively and initiated pro-inflammatory activities, while non-classical monocytes, 
despite developing an early pro-inflammatory response, ultimately adopted an anti-
inflammatory phenotype. Comparable observations have been made in several models 
of sterile injury. Using a mouse model of myocardial infarction, Nahrendorf et al. 
observed a biphasic recruitment of monocytes to the healing myocardium (Nahrendorf 
et al., 2007). Large numbers of classical monocytes were initially recruited in a CCR2-
dependent manner and exhibited phagocytic, proteolytic and pro-inflammatory activity. 
This was followed by a less pronounced CX3CR1-dependent influx of non-classical 
monocytes, which displayed anti-inflammatory properties and promoted tissue healing 
via myofibroblast accumulation, angiogenesis, and collagen deposition. Similarly, using 
a model of notexin-mediated skeletal muscle injury, Arnold et al. revealed an early 
recruitment of classical monocytes which expressed the inflammatory mediators TNF-α 
and IL-1β (Arnold et al., 2007). After several days however the proportion of non-
classical monocytes increased and began to exhibit features of anti-inflammatory 
macrophages. This phenomenon was not attributed to a secondary wave of non-classical 
monocyte recruitment, but instead resulted from the local differentiation of classical 
monocytes into non-classical monocytes. These and other studies suggest classical and 
non-classical monocytes have divergent and complementary functions during 
inflammation. Classical monocytes are more extensively recruited to damaged tissues, 
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acquire a pro-inflammatory profile resembling TIP-DCs or inflammatory M1-like 
macrophages, and promote pathogen clearance. Conversely, non-classical monocytes 
are recruited in smaller numbers, acquire an anti-inflammatory profile resembling M2-
like macrophages, and promote wound healing. 
It is emerging that while monocytes do contribute directly to inflammation by 
performing phagocytosis and releasing inflammatory cytokines, their most significant 
attribute is their mobility. By circulating in the blood, monocytes can undergo 
extravasation and enter tissues throughout the body. This is facilitated through the 
expression of a broad array of chemotactic receptors, enabling monocytes to respond to 
a variety of chemoattractants including chemokines, chemotactic lipids, and 
complement fragments (Bachelerie et al., 2013). The two monocyte subsets 
differentially express these receptors and hence exhibit distinct migration patterns. In 
general however, the receptors CCR2 and CX3CR1 appear to be commonly and 
critically employed in the migration of classical and non-classical monocytes, 
respectively (Domínguez and Ardavín, 2010). Once they infiltrate the site of 
inflammation, monocytes inevitably differentiate into macrophages and dendritic cells. 
These cells, though harbouring a limited migration potential, are longer living with 
more specialised immune functions. Macrophages are larger than monocytes with more 
lysosomal granules and consequently have a greater capacity for phagocytosis. They 
also display great plasticity, adopting a range of activation states, both pro- and anti-
inflammatory, depending on the environmental signals they receive. DCs are the 
premier antigen-presenting cells, although macrophages and certain B-lymphocytes 
share this capability. DCs engulf foreign matter and pathogens by phagocytosis, migrate 
to regional lymph nodes, and activate lymphocytes by displaying digested protein 
fragments, or antigens, on their surfaces. DCs therefore play a key role in activating and 
regulating the adaptive immune system and by extension contribute to establishing 
immunologic memory. 
It is clear that monocytes and their derivatives are key players in the inflammatory 
response. They not only directly promote the killing and clearance of a diverse range of 
bacterial, fungal and protozoal pathogens, but also activate adaptive immunity and 
participate in tissue healing (Shi and Pamer, 2011). Like a double-edged sword 
however, their excessive and/or prolonged recruitment and/or activation can be harmful 
and is known to contribute to the pathogenesis of various infections, cancers, 
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neurodegenerative diseases and inflammatory diseases. In particular, as 
monocytes/macrophages are recognised as the dominant cells during chronic 
inflammation, they have been strongly implicated in the development of many chronic 
inflammatory diseases. These include rheumatoid arthritis, during which synovial 
infiltration of monocytic cells damages cartilage and propagates inflammation through 
the release of pro-inflammatory mediators, proteases and ROS (Kawanaka et al., 2002), 
and asthma, where recruited monocytes and macrophages promote destruction of the 
alveolar walls and induce mucus hypersecretion (Rivier et al., 1995). Most importantly, 
monocytes contribute greatly to the pathogenesis of atherosclerosis, a chronic 
inflammatory condition of the arterial wall (Figure 1.4). As the most common cause of 
cardiovascular disease, atherosclerosis underlies the leading cause of morbidity and 
mortality in the developed world and is threatening to attain this status worldwide 
(Lloyd-Jones et al., 2010).  
 
d) Monocytes and atherosclerosis: 
Atherosclerosis usually develops slowly over many years and is characterised by the 
deposition of fatty deposits in the walls of large arteries, typically at sites of disturbed 
laminar flow. It is initiated by the activation and dysfunction of the arterial endothelium. 
Alterations in its cellular structure and composition, as well as an increased 
permeability enables low-density lipoprotein (LDL), the major cholesterol-carrying 
lipoprotein in the blood, to accumulate in the subendothelial intima (Weber and Noels, 
2011). As LDL is retained it becomes susceptible to oxidation, cleavage and 
aggregation. These modifications turn LDL toxic to the endothelial cells, thereby further 
increasing their immune activity and promoting inflammation. This involves up-
regulating the expression of adhesion molecules and secreting chemokines, which 
together promote the recruitment of blood leukocytes, particularly monocytes, to the 
arterial wall (Weber and Noels, 2011). Here monocytes engulf modified LDL through 
scavenger receptors and differentiate into macrophages and/or DC-like cells. These cells 
continue to take-up LDL and other lipids, soon transforming into lipid-laden foam cells. 
Unable to migrate out of the intima, foam cells accumulate in the evolving lesion and 
form early plaques. Foam cells secrete chemokines and other mediators, thereby 
perpetuating the inflammatory response, and stimulate local cell proliferation. This 
collectively causes the plaque to grow in size, narrowing the artery lumen and 
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restricting the flow of blood. The secretion of matrix-degrading proteases and the 
formation of a necrotic core, driven largely by the death of resident foam cells, render 
the atherosclerotic plaque unstable. Ultimately the plaque may rupture with the ensuing 
release of debris often resulting in occlusive luminal thrombosis, culminating in heart 
attack, stroke, and sudden cardiac death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Stages in the development of atherosclerotic plaques. Atherosclerotic plaques 
typically develop in the walls of large arteries and are initiated by the accumulation of 
circulating low-density lipoprotein (LDL) within the subendothelial intima. This is promoted by 
local endothelial dysfunction or injury, as well as excess levels of LDL in the blood. Trapped 
LDL is subjected to chemical modifications, which promote its retention in the tissue and incite 
a local inflammatory response characterised by cytokine and chemokine secretion and the up-
regulation of luminal adhesion molecules by overlying endothelial cells. These collectively 
promote the recruitment of circulating monocytes to the intima, which undergo subsequent 
differentiation into macrophages. Highly phagocytic, macrophages become laden with engulfed 
LDL and other lipids, resulting in foam cell formation. These cells constitute potent secretors of 
inflammatory cytokines that perpetuate the infiltration of monocytes and other cell types, 
including circulating T-cells and underlying smooth muscle cells. They are unable however to 
process the excess lipids and eventually undergo cell death, generating a lipid-rich necrotic 
core. As the plaque grows, the artery lumen narrows, restricting blood flow. More severely, 
weakening of the plaque cap by proteases can cause the plaque to rupture, spilling 
thrombogenic material into the circulation, potentially culminating in a heart attack or stroke. 
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Work on mice has provided an insight into the mechanisms that underlie the 
development of atherosclerosis. Using apolipoprotein E–deficient (ApoE-/-) mice, which 
exhibit high levels of circulating cholesterol and spontaneously develop atherosclerosis 
on a high-fat diet, the classical monocyte subset was shown to be proportionally 
elevated in the blood. This was attributed to an increase in the survival and proliferation 
of these cells, as well as impaired conversion to the non-classical subset (Swirski et al., 
2007). Classical monocytes were also shown to be predominantly and continually 
recruited to atherosclerotic plaques in a CCR2, CCR5 and CX3CR1-dependent manner, 
with their accumulation increasing proportionally with lesion size (Tacke et al., 2007). 
Upon infiltration, classical monocytes secrete inflammatory mediators, ROS, and 
proteases prior to undergoing differentiation into macrophages and eventually foam 
cells (Robbins et al., 2012). Non-classical monocytes also infiltrate plaques, albeit less 
frequently. Their recruitment relies on CCR5 but surprisingly not on CX3CR1. While 
their precise role in disease progression remains largely unknown, non-classical 
monocytes do exhibit phagocytic and proangiogenic functions upon recruitment 
(Swirski et al., 2009b). Moreover, they selectively upregulate CD11c, a marker for DCs, 
and have therefore been postulated to mediate local adaptive immune responses (Tacke 
et al., 2007).    
The majority of currently available therapeutics against atherosclerosis serve to alleviate 
hypertension (e.g. β-blockers) and hyperlipidemia (e.g. statins) (Weber and Noels, 
2011). While these drugs do reduce the risk of atherosclerosis, they do not fully inhibit 
the formation of atherosclerotic plaques. Moreover, they do not adequately protect 
patients with pre-existing coronary artery disease from secondary cardiovascular events. 
This is thought to be due, in part, to the fact that existing therapeutics do not directly 
address the inflammatory mechanisms that underlie atherosclerosis (Charo and Taub, 
2011). In this context, and considering the critical role played by monocytes in the 
initiation, propagation, and progression of atherosclerosis, broadening our 
understanding of the mechanisms that govern monocyte migration could uncover novel 
therapeutic targets. In support of this, inhibiting monocyte-associated chemokine 
pathways almost abolishes atherosclerosis in ApoE
-/-
 mice (Combadière et al., 2008). 
Moreover, several anti-inflammatory drugs have now entered late phase clinical trials, 
some of which are directed at blocking monocyte trafficking into atherosclerotic 
plaques (Charo and Taub, 2011). Manipulating monocyte infiltration could also offer 
33 
 
new paradigms for the treatment of other monocyte-driven inflammatory disorders. 
Indeed, selectively disrupting leukocyte migration appears to represent a particularly 
promising therapeutic avenue for a variety of inflammatory conditions, both in animal 
models and more importantly in clinical trials (Mackay, 2008). Further still, when 
regarding the essential role played by monocytes in host defence, delineating the 
mechanisms underlying monocyte migration could inspire new ways to enhance their 
activities, thereby improving the treatment of various cancers and infectious diseases 
(Nourshargh et al., 2010).    
 
1.3 Leukocyte adhesion cascade 
In order to enter peripheral tissues, both in the steady state and during inflammation, 
circulating monocytes partake in a multi-step process in which they adhere to and 
subsequently traverse the walls of endothelial-lined blood vessels. This process has 
been similarly described for many kinds of leukocytes and is generally termed the 
leukocyte adhesion cascade. Originally encompassing three steps of leukocyte rolling, 
activation and firm adhesion, the leukocyte adhesion cascade has since been updated to 
include additional steps of leukocyte tethering, slow rolling, adhesion strengthening, 
intraluminal crawling, transcellular and paracellular transendothelial migration, and 
migration through the basement membrane and pericyte sheath (Ley et al., 2007) 
(Figure 1.5). Both the leukocyte and the endothelium play an active role during the 
leukocyte adhesion cascade by engaging complex signalling pathways and undergoing 
distinct molecular and structural changes.  
 
a) Leukocyte adhesion to the endothelium: 
Leukocyte extravasation in vivo occurs primarily at post-capillary venules. These blood 
vessels support TEM by exhibiting relative low haemodynamic shear forces, which are 
reduced further still during inflammation with the onset of stasis. Under these 
conditions, leukocytes are displaced to the inner endothelial lining of the venule wall by 
faster circulating erythrocytes, predisposing them to chemokines and adhesion 
molecules actively upregulated by post-capillary venules in inflamed tissues (Springer, 
1994). These include adhesion molecules of the selectin family, which mediate 
leukocyte tethering and rolling on the endothelium, the initial steps in the adhesion 
cascade. In response to inflammatory cytokines such as TNF-α and IL-1β, endothelial 
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cells (ECs) specifically and sequentially mobilise P-selectin and E-selectin to their 
luminal surfaces where, through use of an amino terminal carbohydrate recognition 
domain, they bind glycosylated ligands displayed on the surface of circulating 
leukocytes. P-selectin glycoprotein ligand 1 (PSGL1) is a major ligand for all selectins 
and is constitutively expressed by the majority of leukocytes (Laszik et al., 1996). Some 
ECs also express mature PSGL1 which, along with other inducible glycoproteins (e.g. 
CD34), serve as ligands for L-selectin, the third member of the selectin family and 
constitutively expressed by most leukocyte subtypes.  
Selectins bind their ligands with high tensile strength, enabling bonds to be formed even 
under the shear stress exerted by blood flow (Alon et al., 1995). In addition, selectin-
ligand bonds have characteristically fast association and dissociation rates. As the 
leukocytes repeatedly tether to and detach from the endothelium they slow down and 
begin to ‘roll’ along the inner surface of the vessel wall. While this process is reversible 
and does not commit the leukocyte to transmigration – rolling leukocytes often 
dissociate entirely from the endothelium and re-enter the circulation – selectin-binding 
is a pivotal step for normal leukocyte trafficking. Indeed, mice deficient in the selectins 
show drastic reductions in leukocyte rolling and extravasation and develop spontaneous 
skin infections culminating in death (Jung and Ley, 1999). Specifically regarding 
monocytes,  L-selectin appears to play a prominent role in the migration of classical 
monocytes as their recruitment following thioglycollate-induced peritonitis is reduced 
by more than 70% in L-selectin-deficient mice compared to wild-type controls (Tedder 
et al., 1995). Moreover, ApoE
-/-
 mice also deficient for P-selectin develop delayed 
onset, smaller atherosclerotic plaques containing fewer monocytes when fed a high-fat 
diet, emphasising its role in monocyte recruitment and suggesting similar mechanisms 
govern leukocyte transmigration through both venular and arterial vessel walls (Dong et 
al., 2000). 
While selectins constitute the most important rolling molecules, members of the integrin 
family of alpha/beta heterodimeric adhesion molecules are also involved. The integrin 
very late antigen-4 (VLA-4) for example is located on the surface of monocytes and 
mediates cell rolling by binding its receptor vascular cell adhesion molecule-1 (VCAM-
1) expressed on ECs (Gerszten et al., 1998). In addition, some integrins, including 
lymphocyte function-associated antigen-1 (LFA-1) and macrophage receptor 1 (Mac-1), 
appear to work in synergy with selectins to mediate slow rolling, a separate step in 
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which the speed of the rolling leukocyte is further reduced (Dunne et al., 2002). This 
serves to facilitate the subsequent firm arrest of leukocytes on the endothelium, which is 
nearly exclusively mediated by the integrins and constitutes their primary function 
during the adhesion cascade.  
 
 
 
 
 
 
 
During inflammation, leukocyte arrest is triggered by the binding of chemokines and 
lipid chemoattractants to corresponding G protein-coupled receptors (GPCRs) located 
on the surface of rolling leukocytes. Such chemokine receptors are differentially 
expressed by leukocyte subtypes and ultimately dictate their responsiveness to specific 
chemotactic molecules produced at the site of injury, predominantly by activated ECs 
and resident immune cells. Upon secretion, chemokines have been shown to interact 
with glycosaminoglycan chains of endothelial proteoglycans, which is thought to 
facilitate their retention on the vessel wall, even under shear stress, and promote 
leukocyte engagement (Proudfoot et al., 2003). Chemokine binding to leukocyte 
receptors elicits a rapid integrin-activation signal in the leukocyte, inducing dramatic 
conformational changes in their integrin ectodomains that results in an increased affinity 
Figure 1.5: The leukocyte adhesion cascade.  The leukocyte adhesion cascade is employed by 
monocytes and other leukocyte subsets to egress out of the bloodstream and enter tissues. This 
process is mediated by a series of interactions formed between the migrating leukocyte and the 
vessel wall. Originally encompassing steps of rolling, activation and firm adhesion, advances in 
real-time imaging have enabled additional steps to be defined which are collectively and 
sequentially described as follows: leukocyte capture, slow rolling, adhesion strengthening, 
intraluminal crawling, paracellular or transcellular transendothelial migration (TEM) and 
migration into the interstitial space through the pericyte layer and basement membrane. Image 
is adapted from Nourshargh et al., 2010. 
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for counter-ligands expressed by ECs (Calderwood, 2004). This can be similarly and 
cooperatively triggered by certain selectin interactions and in monocytes is transduced 
by phospholipase C and changes in intracellular calcium stores (Ley et al., 2007). Upon 
ligand recognition, integrins typically cluster together in the leukocyte membrane. This 
reinforces the existing adhesive interactions via cooperative binding and promotes the 
tight attachment of leukocytes to the inflamed endothelium.  
Integrins belonging to the β1- and β2-subfamilies are most relevant to leukocyte arrest. 
β2-integrins may however be less involved on monocytes as blockade of LFA-1 (αLβ2) 
and Mac-1 (αMβ2), as well as their ligands ICAM-1 and ICAM-2, did not prevent 
monocyte arrest (Schenkel et al., 2004). Instead, monocyte firm adhesion appears to be 
more substantially mediated by the β1-integrins, in particular VLA-4 (α4β1). Inhibition 
of VCAM-1, the principal ligand of VLA-4, but not ICAM-1 reduced both monocyte 
adhesion and early lesion formation in the arteries of ApoE
-/-
 mice (Cybulsky et al., 
2001). Similarly, the recruitment of classical monocytes in response to thioglycollate in 
a mouse peritonitis model was shown not to depend on LFA-1 or Mac-1 but on VLA-4, 
as well as CCL2 (Henderson et al., 2003). Indeed, CCR2-CCL2 signalling in classical 
monocytes has been reported to elicit activating conformational changes in VLA-4 
(Yang et al., 2014). 
 
b) Transendothelial migration: 
Leukocyte firm adhesion is a prerequisite for transendothelial migration (TEM), the 
subsequent step in the leukocyte adhesion cascade in which leukocytes penetrate the 
endothelial cell monolayer, or endothelium, that lines the vessel lumen. For this to be 
achieved, arrested leukocytes initially undergo cell spreading and polarisation, whereby 
they change from a spherical to a flattened morphology and form invading membrane 
protrusions, or pseudopodia, at their leading edge and a contractile uropod at the rear. In 
this state, leukocytes are able to travel laterally over the surface of the endothelium by 
establishing transient and sequential contacts with endothelial substrates. This process is 
termed intraluminal crawling and is mediated by integrin binding and the active 
reorganisation of the cytoskeleton (Phillipson et al., 2006). Guided by an intravascular 
chemokine gradient sequestered on the endothelium, leukocytes crawl towards the site 
of inflammation while scanning for optimal sites of TEM (Massena et al., 2010). 
Leukocytes typically crawl to and then along the cell-cell borders of adjacent ECs 
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through which they can subsequently squeeze towards the basal side of the endothelium 
(paracellular TEM). When crawling is inhibited however, leukocyte TEM is delayed 
and instead occurs primarily by passing directly through the body of an individual EC 
(transcellular TEM) (Phillipson et al., 2006). While both migration pathways are used 
by leukocytes under normal circumstances in vivo, the paracellular pathway seems to 
represent the most common route of emigration (Ley et al., 2007). 
The endothelium does not merely represent a barrier to migrating leukocytes but 
actively contributes to and regulates the transmigration process. Adherent leukocytes 
can induce the formation of endothelial-cell projections rich in the integrin ligands 
ICAM-1 and VCAM-1 and various cytoskeletal components. Termed transmigratory 
cups, these structures partially embrace the leukocyte and facilitate TEM, through both 
migration pathways, by providing a physical scaffold that is aligned parallel to the 
direction of extravasation (Carman and Springer, 2004). In addition, ICAM-1 and 
VCAM-1 clustering triggers endothelial signalling pathways, leading to an increase in 
cytosolic calcium and phosphorylation of vascular endothelial (VE)-cadherin and 
myosin light chain (MLC). Constituting the major adhesion molecule of endothelial 
adherens junctions, VE-cadherin does not support leukocyte TEM but rather acts as an 
obstacle to emigrating cells. Upon phosphorylation however, VE-cadherin interactions 
are destabilised, loosening EC junctions. This is supported by phosphorylated MLC, 
which triggers actin–myosin fibre contractions causing neighbouring ECs to pull apart. 
Collectively, these events induce small gaps at endothelial junctions and promote the 
paracellular transit of leukocytes through the endothelium (Muller, 2011). 
Numerous other endothelial molecules are functionally active during leukocyte TEM. 
The majority of these molecules localise to EC junctions and were originally implicated 
in paracellular migration, though it appears they may be similarly involved in 
transcellular migration. Platelet endothelial cell adhesion molecule-1 (PECAM-1, also 
known as CD31) was the first molecule reported to play a role exclusively at the point 
of leukocyte TEM both in vitro and in vivo (Muller, 2013). The extracellular domain of 
PECAM-1 engages in homophilic interactions. While this typically occurs between 
adjacent cells along the endothelial border, during TEM endothelial PECAM-1 can 
similarly interact with PECAM-1 expressed on the surface of leukocytes. This is crucial 
to the process of monocyte extravasation as blocking PECAM-1 reduces monocyte 
TEM by 70-90% (Muller et al., 1993). A similar phenotype is observed upon inhibition 
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of CD99 (Schenkel et al., 2002). As with PECAM-1, CD99 is expressed on ECs and 
leukocytes and undergoes homophilic binding during TEM. It appears endothelial 
PECAM-1 and CD99 sequentially engage their leukocyte counterparts, effectively 
guiding the leukocyte to the basal side of the endothelium (Schenkel et al., 2002). 
In a similar fashion, junctional adhesion molecules (JAM)-A and -C promote 
transmigration by binding the leukocyte integrins LFA-1 and Mac-1, respectively, while 
putative functions have also been described for endothelial cell-selective adhesion 
molecule (ESAM), CD99L2, vascular adhesion protein 1 (VAP1), and poliovirus 
receptor (Ley et al., 2007). Considering the broad array of molecules implicated in 
leukocyte TEM (Table 1.1), it was hypothesised that they may operate synergistically as 
a large “transmigration complex” that collectively constitutes a platform for migrating 
leukocytes (Muller, 2013). Indeed, a reticulum of interconnected vesicles rich in EC 
junctional molecules including PECAM-1, CD99 and JAM-A has been described in 
ECs, residing under the plasma membrane at the endothelial border. This lateral border 
recycling compartment (LBRC) is recruited to and exteriorised at the site of leukocyte 
transmigration. This serves to push endothelial cell-cell interactions and other 
obstructive structural components of the junction aside, as well as present unligated 
endothelial molecules to their corresponding molecules on the leukocyte cell surface. As 
the LBRC surrounds the leukocyte, it provides a passageway through which it can 
migrate. In this same manner, the LBRC, in accordance with other vesicular 
compartments such as vesiculo-vacuolar organelles (VVOs), has also been shown to 
facilitate the movement of leukocytes through the body of individual ECs via the 
transcellular pathway. It appears the LBRC is governed by a different set of molecules, 
depending on the inflammatory stimulus or the leukocyte subtype. For example, unlike 
monocytes, lymphocytes do not seem to require PECAM-1 for transmigration in vitro 
(Muller, 2001), while PECAM-1, ICAM-2 and JAM-A are involved in the migration of 
neutrophils in the cremaster muscle in response to IL-1β but not TNF-α (Woodfin et al., 
2009). 
Leukocytes typically travel to the abluminal side of the endothelium without pause. 
Under some circumstances however the transmigration process is disrupted. Leukocytes 
may move back and forth in the EC junction numerous times prior to entering the sub-
endothelial space (hesitant TEM), and have even been shown to migrate back through 
the junction in an abluminal-to-luminal direction and re-enter the blood (reverse TEM). 
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These phenomena have been best characterised in vivo in neutrophils and appear to be 
regulated by the junctional adhesion molecule JAM-C – the pharmacological blockade 
or genetic deletion of JAM-C in ECs results in enhanced disrupted TEM (Woodfin et 
al., 2011). Blocking JAM-C also increases reverse transmigration of monocytes through 
cultured ECs in vitro, however this has yet to be thoroughly explored in vivo (Bradfield 
et al., 2007). 
 
Table 1.1: Key endothelial cell-leukocyte interactions during transmigration. 
Endothelial molecule Leukocyte ligand Transmigration step 
CD34 L-selectin Tethering, rolling 
P-selectin PSGL-1 Tethering, rolling 
E-selectin ESL-1, PSGL-1 Tethering, rolling 
VCAM-1 VLA-4 Rolling, arrest  
ICAM-1 LFA-1 Rolling, arrest, crawling 
MAdCAM-1 α4β7-integrin Arrest 
ICAM-2 MAC-1, LFA-1 Crawling 
PECAM-1 PECAM-1 Transendothelial migration 
CD99 CD99 Transendothelial migration 
CD99L2 CD99L2 Transendothelial migration 
JAM-A LFA-1, JAM-A Transendothelial migration 
JAM-B VLA-4 Transendothelial migration 
JAM-C MAC-1 Transendothelial migration 
ESAM unknown Transendothelial migration 
 
c) Transmigration beyond the endothelium: 
Upon successfully crossing the endothelium, migrating leukocytes need to subsequently 
bypass the endothelial basement membrane (EBM) and, in most venules, the pericyte 
sheath. The pericyte sheath consists of a discontinuous network of pericyte cells that 
wrap themselves around ECs and aid in regulating their development and maintenance. 
Both cell types contribute to the formation of the EBM, which provides structural 
stability to the vessel wall and provides adhesive support to neighbouring cells. The 
EBM constitutes a thick layer of tightly packed and interconnected proteins, including 
laminins and collagen type IV. As such, it represents a substantial physical barrier to 
emigrating leukocytes that takes considerably longer to breach (> 15 minutes) compared 
to the endothelium (~5 minutes) (Ley et al., 2007). To facilitate its penetration, 
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leukocytes use ventral membrane protrusions to identify areas of the EBM with reduced 
levels of matrix proteins. Such low expression regions (LERs) represent preferred sites 
of leukocyte transmigration as they are not only easier to breach but are also more likely 
to be permeated by chemoattractants produced by the inflamed tissue. Moreover, LERs 
are closely associated with gaps in the pericyte sheath, which become enlarged during 
inflammation, acting essentially as gates for migrating leukocytes (Proebstl et al., 2012). 
In contrast to neutrophils, which employ matrix-degrading proteases to widen the LERs 
and ease their passage, monocytes appear to squeeze directly through LERs by 
dramatically changing their cellular shape (Voisin et al., 2009). 
Several molecules have been implicated in regulating the movement of leukocytes 
through the pericyte sheath and venular EBM including Mac-1, LFA-1 and ICAM-1, 
which collectively support leukocyte crawling along pericyte processes (Proebstl et al., 
2012), and integrin α6β1, the main receptor for vascular laminins (Dangerfield et al., 
2002). Once the leukocyte has successfully detached from the EBM, it can subsequently 
traffic through the interstitial space to the site of tissue damage. Actin protrusions 
formed at the leading edge of the cell intercalate with the porous network of the 
extracellular matrix, propelling the leukocyte forward (Weninger et al., 2014). This is 
termed amoeboid movement and may be supported by the actomyosin-mediated 
retraction of the cell rear. In this manner, leukocytes travel along a gradient of 
chemotactic agents to the site of inflammation where they subsequently exert their 
effector functions. 
The multi-step adhesion cascade has proved to be remarkably robust and has been 
observed for all kinds of leukocytes in a variety of inflammatory scenarios. This has 
posed somewhat of a hurdle for developing effective anti-inflammatory treatments as 
many potential therapeutic targets have widespread functions that are central to 
maintaining the protective functions of the immune system. Natalizumab for example is 
a monoclonal antibody that binds to the α4-subunit of α4β1 and α4β7 integrins 
expressed on the surface of most leukocytes. While it has been used successfully for the 
treatment of multiple sclerosis and Crohn’s disease it also rendered patients more 
susceptible to severe viral and bacterial infections. To circumvent such issues, 
researchers are now beginning to delineate leukocyte-specific, and even tissue- and 
stimulus-specific molecules and mechanisms of transmigration. These can be 
therapeutically targeted to interfere only with the cellular subsets that possess disease 
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activity while leaving other immune cells largely undisturbed. This should keep 
unwanted side-effects to a minimum and ensure the immune system as a whole is not 
severely compromised.  
In this light there is an emphasis on furthering our understanding of the specific 
mechanisms that regulate monocyte transmigration in the hope this will identify novel 
therapeutic targets for monocyte-driven pathologies. Whilst the roles of adhesion 
molecules and chemokine receptors in monocyte trafficking have been extensively 
researched, very little attention has been placed on the potential roles of proteases, 
which have been implicated in virtually every step of the inflammatory response 
including leukocyte transmigration. To address this issue, we have initially focussed on 
neutrophil elastase, a protease which has been routinely studied in neutrophils but 
whose function in monocytes has received little attention.    
 
1.4 Neutrophil elastase 
a) Biochemical properties of NE: 
As its name may suggest, neutrophil elastase (NE) was initially identified in neutrophils 
as a protease that could cleave the extracellular matrix protein elastin (Janoff and 
Scherer, 1968). NE has since been detected in other leukocyte subtypes and been shown 
to cleave virtually every type of matrix protein, including fibronectin, laminin, 
proteoglycans, and several types of collagen (Chua and Laurent, 2006). Its broad 
substrate specificity extends to other groups of proteins with various cytokines (e.g. IL-
1β and TNF-α), adhesion molecules (e.g. ICAM-1 and VCAM-1), and other proteases 
(e.g. MMP-2 and MMP-9) also liable to cleavage. NE belongs to the chymotrypsin 
superfamily of serine proteases, which cleave peptide bonds by forming a charge relay 
system composed of a catalytic triad of conserved histidine, aspartate, and serine 
residues. The active site in NE is lined with a series of bulky hydrophobic residues 
which accounts for its preference in cleaving small hydrophobic residues within its 
substrate molecules (Korkmaz et al., 2010).    
In neutrophils, NE primarily localises to cytoplasmic azurophil granules but has also 
been detected in the nucleus and in association with the plasma and other subcellular 
membranes. Azurophil granules contain two other structurally related serine proteases, 
cathepsin G (CG) and proteinase 3 (PR3). The expression and storage of all three 
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proteases peaks during the promyelocytic stage of neutrophil differentiation in the bone 
marrow and switches off upon maturation. NE is initially synthesised in the 
endoplasmic reticulum as a zymogen of 267 amino-acid residues in humans and 265 in 
mice (Figure 1.6). NE activation and packaging into granules is dependent on two 
separate amino-terminal processing steps. The signal sequence is first removed by 
signal peptidase, exposing a two-residue pro-sequence that is subsequently cleaved by 
dipeptidyl peptidase I (DPPI), rendering the active site accessible to substrate. In 
addition, NE can undergo carboxy-terminal processing by an unknown enzyme, 
however this is not required for NE activation. It does however expose a docking site 
that is thought to mediate NE trafficking to azurophil granules, as retention of the C-
terminus re-routes NE to the plasma membrane (Horwitz et al., 2004). Fully processed 
active NE constitutes a 218 amino-acid monomeric protein in humans and 219 in mice. 
It is highly cationic and in azurophil granules associates with a matrix of negatively 
charged proteoglycans. This matrix, in combination with the low pH of the granule’s 
interior, sequesters NE, a neutral-acting protease, in an inactive state until it is 
functionally required.  
The gene encoding NE is found on chromosome 19 in humans and chromosome 10 in 
mice in a gene-cluster that includes PR3. It consists of 5 exons of identical size and 4 
introns which are collectively larger in humans. Exon IV encodes two potential N-
glycosylation sites resulting in an apparent protein mass of 29-33 kDa upon SDS-
polyacrylamide gel electrophoresis (Korkmaz et al., 2010).  
 
 
 
 
 
Figure 1.6: Structure of neutrophil elastase. The mature NE protein is formed following the 
proteolytic removal of a signal peptide (by signal peptidase) and pro-dipeptide (by DPPI) at the 
N-terminus and typically a pro-peptide at the C-terminus (enzyme unknown). It contains four 
disulphide bridges and two N-glycosylation sites. Its secondary structure consists of two 
homologous β-barrels and a C-terminal α-helix. The catalytic triad of histidine, aspartate, and 
serine residues converge at the junction of the two β-barrels (Korkmaz et al., 2010).  
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b) Physiological and pathological activities of NE: 
Mapping the NE gene locus has enabled its physiological functions to be studied more 
rigorously through the generation of NE deficient (NE
-/-
) mice. In brief, this was 
achieved by replacing exon II of the NE gene with the neomycin phosphotransferase 
cDNA, thereby terminating NE transcript expression  (Belaaouaj et al., 1998). While the 
NE
-/-
 mice were not immunocompromised, that is, they did not spontaneously develop 
infections, they did demonstrate a greater susceptibility to sepsis and death following 
intraperitoneal infection with Gram negative, though not Gram positive bacteria 
compared to wild-type littermates. This was attributed to an inability of NE
-/-
 
neutrophils to successfully degrade engulfed bacteria. Typically following 
phagocytosis, azurophil granules fuse with the phagosome with the ensuing generation 
of reactive oxygen species inducing an increase in local pH. This in turn activates NE 
and other degradative enzymes, culminating in the death and breakdown of the 
bacterium. This fate was avoided however upon infection of NE
-/- 
neutrophils, the 
bacteria instead being seen to remain intact in the phagosome and even divide. 
Subsequent studies have shed light on the mechanisms that underlie NE-mediated 
intracellular bactericidal activity. NE was shown to directly mediate the killing of 
Escherichia coli by degrading outer membrane protein A (OmpA), a structural 
membrane protein that is highly conserved in a wide range of Gram-negative bacteria. 
Moreover, NE can cleave virulence factors of enterobacteria, such as Shigella flexneri 
and Yersinia enterocolitica, preventing their escape from phagolysosomes and 
promoting their clearance (Weinrauch et al., 2002). As well as targeting Gram negative 
bacteria, NE has also been shown to display potent antimicrobial activity against 
spirochaetes (Garcia et al., 1998) and fungi (Tkalcevic et al., 2000). 
NE is stored in azurophil granules at extremely high concentrations (~5 mM) and is 
thought to contribute mainly to the intracellular degradation of phagocytosed 
microorganisms. That being said, the anti-microbial functions of NE can also be exerted 
extracellularly. NE and other serine proteases can escape azurophil granules, translocate 
to the nucleus and form neutrophil extracellular traps (NETs) by interacting with 
chromatin DNA. Once deployed by the cell, these sticky structures capture and kill 
bacteria, fungi, and parasites (Papayannopoulos et al., 2010). NE can also be released 
straight into the extracellular environment, either via the stimulated exocytosis of 
azurophil granules, or indirectly during frustrated phagocytosis or following neutrophil 
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apoptosis. In this state, NE has been shown to cleave the bacterial virulence factor 
flagellin, relinquishing its biological activity (López-Boado et al., 2004). Neutrophil 
degranulation freely releases only up to 25% of total NE stores into the extracellular 
space. A much greater proportion of NE instead associates with the neutrophil cell 
surface by binding to negatively charged sulphate groups of chondroitin sulphate- and 
heparan sulphate-containing proteoglycans (Campbell and Owen, 2007). Here it 
remains in an active state and, importantly, becomes inaccessible, and therefore 
resistant, to α1-antitrypsin (α1-AT), the major endogenous NE inhibitor, which is 
abundantly expressed in the plasma and interstitial fluid. Thus, membrane-bound NE is 
thought to represent the predominant and most active form of extracellular NE.  
While clearly involved in host defence, NE, particularly in its extracellular form, has 
also been implicated in other inflammatory processes. One such function involves 
modulating the activity of chemokines and cytokines by proteolysis. The removal of a 
C-terminal peptide from chemerin for example converts it into a potent agonist for its 
receptor ChemR23 expressed by DCs and macrophages (Wittamer et al., 2005). In 
contrast, the N-terminal processing of CXCL12 results in a loss of chemotactic activity, 
attenuating T-lymphocyte migration (Rao et al., 2004). The pro-inflammatory cytokines 
TNF-α, IL-1β and IL-6 are also inactivated by NE. As well as directly cleaving 
cytokines, released NE has also been shown to modulate cytokine expression. In a 
model of P. aeruginosa infection, TNF- α, MIP-2, and IL-6 were all induced by NE, 
possibly through the cleavage of TLR-4, and shown to actively contribute to host 
protection (Benabid et al., 2012). Young et al. also show an impaired generation of the 
pro-inflammatory mediators IL-1β, KC and MIP-1α in zymosan-stimulated tissues in 
NE
-/-
 mice, resulting in a reduction in neutrophil recruitment (Young et al., 2004). As 
neutrophils are typically the first cells to infiltrate sites of inflammation, their ability to 
regulate the activity and expression of cytokines through NE enables them to influence 
subsequent leukocyte recruitment. This may result in the dampening or enhancement of 
the inflammatory response as necessary. 
Neutrophil degranulation occurs during transmigration in response to numerous 
inflammatory mediators, particularly leukotriene B4 (LTB4) and formyl tripeptide 
(fMLP). Upon release, NE has been shown to mobilise to the migrating front of the cell 
(Cepinskas et al., 1999). This same study reported an 80% reduction in neutrophil 
migration when NE was pharmacologically blocked, implicating NE as a key regulator 
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of transmigration. As outlined earlier, the molecules PSGL-1, ICAM-1 and VCAM-1 
are important in several steps of the leukocyte adhesion cascade and are all liable to 
cleavage by NE. This may function to regulate the sequential movement of neutrophils 
through the vessel wall by removing existing cell-cell or cell–ECM interactions or by 
influencing EC signalling pathways (Pham, 2006). In addition, NE-mediated proteolysis 
may also help regulate integrin binding (Si-Tahar et al., 1997). Its ability to cleave 
virtually every type of matrix protein also identified NE as a potential mediator of 
migration through the dense endothelial basement membrane. Supporting this, NE 
inhibitors have been shown to reduce matrix-protein degradation (Heck et al., 1990), as 
well as neutrophil migration through EBM-like structures in vitro (Delacourt et al., 
2002). Inhibiting NE also arrested migrating neutrophils at the level of the venular EBM 
in vivo in the cremaster muscle, possibly owing to an inability to enlarge LERs (Young 
et al., 2007).  
Other putative functions of NE have also been reported. NE for example can release 
soluble complement receptor 1 (CR1) from the surface of erythrocytes, which can 
subsequently inhibit complement proteins (Sadallah et al., 1999). NE has also been 
shown to influence cell signalling through protease activated receptors (PARs), a 
subfamily of GPCRs that mediate a number of pathways involved in the inflammatory 
response. They are expressed by a variety of cells including ECs and leukocytes and are 
functionally regulated through proteolysis of their extracellular domains. In this manner, 
NE has been shown to inhibit canonical signalling pathways downstream of PAR-1 and 
PAR-2, triggering instead MAP kinase signalling, resulting in a decrease in vascular 
permeability (Mihara et al., 2013). NE may also contribute to wound healing by 
releasing growth factors, digesting cellular debris and remodelling components of the 
extracellular matrix (Barrick and Campbell, 1999).  
This same ability to cleave matrix proteins can however cause tissue damage if NE is 
excessively or inappropriately released. Furthermore, NE can activate the degradative 
matrix metalloproteinases MMP-2, MMP-3, and MMP-9, and disarm their inhibitor, 
TIMP-1. Accordingly, NE has been implicated in several human pathologies which 
feature neutrophil-mediated inflammation. Chronic obstructive pulmonary disease 
(COPD) constitutes the fourth leading cause of death worldwide and is characterised by 
a persistent blockage of airflow from the lungs. Disease progression is associated with 
NE-mediated pulmonary tissue destruction and mucus secretion, resulting from 
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neutrophil accumulation and activation. Tobacco smoking is the most common cause of 
COPD, though it can also be caused by a genetic deficiency in the NE inhibitor α1-
antitrypsin, which typically protects against unregulated proteolysis in the lung. NE has 
similarly been implicated in other lung conditions, including acute lung injury (ALI), 
cystic fibrosis and adult respiratory distress syndrome (ARDS). Administration of the 
synthetic NE inhibitor Sivelestat (ONO-5046) has been shown to attenuate pulmonary 
disorders and improve pulmonary function, however its clinical application is limited to 
the treatment of ALI and ARDS, and only in Japan (Lucas et al., 2013).          
Elevated levels of NE have likewise been found in the synovial fluid of rheumatoid 
arthritis patients, where it contributes to cartilage degradation (Elsaid et al., 2003). 
Moreover, NE has been implicated in the development and rupture of atherosclerotic 
plaques (Henriksen and Sallenave, 2008) and in the metastasis of some breast and lung 
cancers (Sato et al., 2006). Mutations in the NE gene have also attracted great interest 
due to their affiliation with neutropenia, a disorder characterised by an abnormally low 
number of neutrophils predisposing patients to recurrent bacterial infections. Though 
the precise mechanisms underpinning neutropenia remain to be clarified, it appears 
mutant NE proteins either misfold or are mislocalised, culminating in the diminished 
production of neutrophils from progenitor cells in the bone marrow (Horwitz et al., 
2007).        
 
c) NE and monocytes: 
The biochemical properties of NE, with regards to both its physiological and 
pathological functions, have almost entirely been studied in neutrophils. In contrast, 
very few studies have explored NE in the context of monocytes. A subpopulation of 
human monocytes have however been shown to store NE and other enzymes 
traditionally associated with neutrophils in cytoplasmic granules (Owen et al., 1994). 
This was corroborated by Dollery et al. who demonstrated NE mRNA and protein 
expression in human blood monocytes and their macrophage derivatives (Dollery et al., 
2003). Moreover, they show abundant NE in the macrophage-rich areas of vulnerable 
atherosclerotic plaques where it presumably promotes plaque rupture. As with 
neutrophils, NE has also been implicated in the migration of monocytes, though this too 
remains unclear. Supporting a role for NE in monocyte transmigration, it has been 
shown that monocytes deficient in NE exhibit reduced motility through matrix 
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structures in vitro and cigarette smoke-induced recruitment of monocytes to the lung is 
impaired in NE
-/-
 mice (Shapiro et al., 2003). Conversely, the presence of the NE-
specific inhibitor ONO-5046 had no effect on CCL2-induced monocyte migration in the 
mouse cremaster muscle in vivo (Voisin et al., 2009). Taken together, it is possible that 
NE is only functional in a stimulus- and/or tissue-specific manner.  
 
1.5 Hypothesis and aims of the study 
Confirming a role for NE in monocyte transmigration may uncover novel therapeutic 
avenues to treat monocyte-driven pathologies, such as atherosclerosis. In this light, and 
given the limited and contradicting results that currently exist, we sought to continue to 
explore NE as a potential regulator of monocyte transmigration in vivo in this study. 
The overriding objectives we want to address are as follows: 
 
(i)  Establishing a mouse model to facilitate the concurrent study of NE and 
monocyte biology. 
Transgenic CX3CR1-eGFP-knock-in mice exhibit eGFP-fluorescent monocytes 
enabling them to be accurately distinguished from other leukocyte subsets. 
Classical and non-classical monocytes can be further differentiated through 
differences in eGFP intensity and Ly6C expression. These mice will be crossed 
with NE
-/-
 mice in order to robustly study NE specifically in the context of 
monocytes.    
 
(ii)  Investigating the expression of NE in murine monocytes.  
While NE has been identified in human monocytes, this has yet to be confirmed 
in their murine counterparts. As such, we plan to harvest total leukocytes from 
CX3CR1-eGFP mice and extract pure populations of classical and non-classical 
monocytes. Quantitative real-time PCR and Western blot analysis will 
subsequently be employed to determine NE transcript and protein levels, 
respectively. 
 
(iii)  Investigating the functional role of NE in monocyte trafficking in vivo.  
To broadly determine if NE is involved in monocyte recruitment, monocyte 
infiltrates will be compared in a peritonitis model of inflammation between NE
-/-
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and NE
+/+
 mice. To elucidate a specific role for NE during monocyte TEM, 
immunofluorescent labelling and confocal microscopy will be employed to track 
CX3CR1-eGFP monocytes in the mouse cremaster muscle and ear dermis ex 
vivo. This will enable the mechanisms of monocyte extravasation to be explored, 
including how and where the monocytes interact with the vasculature. 
 
(iv)  Characterising the mode and dynamics of monocyte transmigration in vivo.  
Our lab has recently established a confocal intravital microscopy imaging 
platform to track leukocyte transmigration through cremasteric venules in real 
time. This technique offers outstanding spatial and temporal resolution, which 
should enable monocyte behaviour to be rigorously analysed during 
transmigration in vivo for the first time. Once optimised, we can subsequently 
investigate how NE, and indeed other molecules, may regulate monocyte 
transmigration over the course of an inflammatory insult.  
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CHAPTER 2: Materials and Methods 
 
2.1 Reagents 
a) Antibodies: 
Name Description Application 
(working conc.) 
Primary antibodies 
α-SMA  Monoclonal mouse anti-mouse α-SMA, clone 1A4, 
conjugated to Cy3, Sigma-Aldrich (St. Louis, 
USA) 
Confocal imaging 
(CI)  (6.5 μg/ml) 
β-actin  Monoclonal mouse anti-β-actin, clone AC-15, 
Sigma-Aldrich (St. Louis, USA) 
Western blot (WB) 
(1 μg/ml) 
CCR1 Monoclonal rat anti-mouse CCR1, clone 643854, 
conjugated to PE, R&D Systems (Abingdon, UK) 
Flow cytometry 
(FC) (1 μg/ml) 
CCR2 Monoclonal rat anti-mouse/rat CCR2, clone 
475301, conjugated to PE, R&D Systems 
(Abingdon, UK) 
FC (1 μg/ml) 
CCR5 
(CD195) 
Monoclonal hamster anti-mouse CD195, clone 
HM-CCR5, conjugated to PE, Biolegend (San 
Diego, USA) 
FC (1 μg/ml) 
CD115 Monoclonal rat anti-mouse CD115, clone AFS98, 
conjugated to PE or Alexa Fluor-488, eBioscience 
(Hatfield, UK) 
FC, CI (0.67 
μg/ml) 
CD45 Monoclonal rat anti-mouse CD45, clone 30-F11, 
conjugated to APC, Biolegend (San Diego, USA) 
FC, CI (0.5 μg/ml) 
F4/80 Monoclonal rat anti-mouse F4/80, clone BM8, 
conjugated to PE, eBioscience (Hatfield, UK) 
FC (0.67 μg/ml) 
Fc Block™ Monoclonal rat anti-mouse CD16/CD32, clone 
2.4.G2, Pharmingen (Oxford, UK) 
FC (1-5 μg/ml) 
GR1  Monoclonal rat anti-mouse Ly6G and Ly6C 
(GR1), clone RB6-8C5, conjugated to e660 or PE, 
BD Pharmingen (Oxford, UK) 
FC, CI (0.1 μg/ml) 
Integrin β2 
(CD18) 
Monoclonal rat anti-mouse CD18, clone C71/16, 
conjugated to PE, BD Pharmingen (Oxford, UK) 
FC (1 μg/ml) 
JAM-C Polyclonal rabbit anti-mouse JAM-C, Nr. 526, a 
kind gift from Prof. Beat Imhof (University of 
CI (1:100) 
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Geneva, Geneva, Switzerland) 
L-selectin 
(CD62L) 
Monoclonal rat anti-mouse CD62L, clone MEL-
14, conjugated to PE, BD Pharmingen (Oxford, 
UK) 
FC (0.5 μg/ml) 
Ly6G Monoclonal rat anti-mouse Ly6G, clone 1A8, 
conjugated to PE or Alexa Fluor-647, Biolegend 
(San Diego, USA) 
FC, CI (0.2 μg/ml) 
MRP-14 Monoclonal rat anti-mouse MRP-14, clone 2B10, 
conjugated in house to Alexa Fluor-647, a kind gift 
from Dr. Nancy Hogg (Cancer Research UK, 
London Research Institute, London, UK) 
CI (~7 μg/ml) 
NE Polyclonal rabbit anti-human NE, Abcam 
(Cambridge, UK) 
FC (1-5 μg/ml), CI 
(10 μg/ml), WB (1 
μg/ml) 
PECAM-1 
(CD31) 
Monoclonal rat anti-mouse CD31, clone 390, 
conjugated in house to Alexa Fluor-555 and 647, 
eBioscience (Hatfield, UK) 
CI (~5 μg/ml) 
VE-
cadherin 
(CD144) 
Monoclonal rat anti-mouse CD144, clone 
eBioBV13 (BV13), conjugated in house to Alexa 
Fluor-555 and 647, eBioscience (Hatfield, UK) 
CI (~5 μg/ml) 
Secondary antibodies 
Mouse IgG Polyclonal rabbit anti-mouse IgG, conjugated to 
HRP, Dako (Copenhagen, Denmark) 
WB (0.2 μg/ml) 
Rabbit IgG Goat anti-rabbit IgG, conjugated to Alexa Fluor-
488 or 555, Invitrogen (Paisley, UK) 
FC (0.8-4 μg/ml), 
CI (0.8 μg/ml) 
Rabbit IgG Goat anti-rabbit IgG, conjugated to HRP, 
Invitrogen (Paisley, UK) 
WB (0.2 μg/ml) 
Isotype controls 
Hamster 
IgG 
Monoclonal Armenian hamster anti-trinitrophenol 
-KLH IgG isotype control, clone HTK888, 
conjugated to PE, Biolegend (San Diego, USA) 
FC 
Rabbit IgG Polyclonal rabbit IgG isotype control, Abcam 
(Cambridge, UK) 
FC, CI 
Rat IgG2A Monoclonal rat anti-keyhole limpet hemocyanin 
(KLH) IgG2A isotype control, clone 54447, 
conjugated to PE, R&D Systems (Abingdon, UK)  
FC 
N.B. In house antibody conjugations were performed using Molecular Probes 
Antibody Labeling Kits (see below). 
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b) Inflammatory stimuli: 
Name Description 
CCL2 Recombinant Mouse CCL2/JE/MCP-1-CF, Cat. No.: 479-JE/CF, R&D 
Systems (Abingdon, UK) 
CCL2 Recombinant Human CCL2/MCP-1-CF, Cat. No.: 279-MC-010/CF, R&D 
Systems (Abingdon, UK) 
IFN-γ Recombinant Mouse IFN-gamma-CF, Cat. No.: 485-MI-100/CF, R&D 
Systems (Abingdon, UK) 
LPS LPS from Escherichia coli 0111:B4, Cat. No.: L4391, Sigma-Aldrich (St. 
Louis, USA) 
LTB4 LTB4, Cat. No.: 434625, Merck (Hoddeston Hets, UK) 
TNF-α Mouse TNF-α, Cat. No.: 401-ML-010/CF, R&D Systems (Abingdon, UK) 
 
c) Inhibitors: 
Name Description 
GW311616A NE inhibitor, Cat. No. sc-215120, Santa Cruz Biotechnology, Inc. 
(Santa Cruz, USA) 
H33 JAM-C blocking antibody, monoclonal rat anti-mouse JAM-C, 
clone H33, Millipore (Hoddeston Hets, UK) 
ONO-5046 NE inhibitor, kind gift from ONO Pharmaceuticals (Osaka, Japan) 
Protease 
inhibitors 
Halt™ Protease and Phosphatase Inhibitor Cocktail (100×), 
Thermo Scientific (Rockford, USA) 
 
d) Kits: 
Name Description 
BCA™ Protein Assay Kit   Cat. No.: 23227, Thermo Scientific (Rockford, USA) 
Leucoperm™ Fixation and 
Permeabilization Kit 
Cat. No.: BUF09C, AbD Serotec (Kidlingdon, UK) 
Molecular Probes® 
Antibody Labeling Kits 
Cat. No.: A2018-1/6/7, Invitrogen (Paisley, UK) 
Monocyte Isolation Kit 
(BM), mouse 
Cat. No.: 130-100-629, Miltenyi Biotec (Bergisch-
Gladbach, Germany) 
52 
 
RNeasy® Micro Kit Cat. No.: 74004, QIAGEN (Valencia, USA) 
iScript™ cDNA Synthesis 
Kit 
Cat. No.: 170-8890, Bio-Rad (Hemel Hempstead, UK) 
 
e) Miscellaneous: 
Name Description 
7-Aminoactinomycin D 
(7-AAD) 
~97% pure, reconstituted in PBS to 5 mg/ml, Sigma-
Aldrich (St. Louis, USA) 
Agarose UltraPure™ Agarose, Invitrogen (Paisley, UK) 
Bovine serum albumin (BSA) Cohn fraction V, 95% standard powder pH 7.0, New 
England Biolabs (Hitchin, UK) 
DAPI 4′,6-Diamidino-2-phenylindole dihydrochloride, 
Sigma-Aldrich (St. Louis, USA) 
Deoxynucleotide 
triphosphates (dNTPs) 
Bioline Reagents Ltd. (London, UK) 
DNA Ladder SmartLadder SF, Eurogentec (Southampton, UK) 
Draq5™ nuclear dye 5 mM, Biostatus Ltd. (Shepshed, UK) 
Dulbecco’s Modified Eagle’s 
Medium (DMEM) 
High glucose, Gibco (Paisley, UK) 
EZview™ Red Protein G 
Affinity Gel 
Sigma-Aldrich (St. Louis, USA) 
Foetal bovine serum (FBS) Gibco (Paisley, UK) 
Gelatin From bovine skin, Type B, Sigma-Aldrich (St. Louis, 
USA) 
GelRed
 TM
 nuclear dye 10,000×, Cambridge BioScience (Cambridge UK) 
Ham's F12 Nutrient Mixture Gibco (Paisley, UK) 
iQ™ SYBR® Green 
SuperMix 
Bio-Rad (Hemel Hempstead, UK) 
Ketamine Ketaset® solution, 100 mg/ml, Fort Dodge Animal 
Health Ltd. (Southampton, UK) 
L-Glutamine 200 mM, Gibco (Paisley, UK) 
MEM Non-Essential Amino 
Acids Solution  
100×, Gibco (Paisley, UK) 
Neutrophil Elastase Recombinant Mouse Neutrophil Elastase/ELA2, CF, 
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R&D Systems (Abingdon, UK) 
Neutrophil Elastase 680 
FAST™ 
Perkin-Elmer (Norwalk, USA) 
Normal goat serum (NGS) AbD Serotec (Kidlingdon, UK) 
Paraformaldehyde (PFA) 95%, VWR, (Soulbury, UK) 
Penicillin/Streptomycin 10 000 units of penicillin and 10 mg/ml 
streptomycin, Gibco (Paisley, UK) 
Phorbol 12-myristate 13-
acetate (PMA) 
≥ 99%, Sigma-Aldrich (St. Louis, USA) 
Polyacrylamide gels Mini-Protean® TGX™ precast polyacrylamide gels, 
Bio-Rad (Hemel Hempstead, UK) 
Poly-L-lysine solution 0.1% (w/v) in H2O, Sigma-Aldrich (St. Louis, USA) 
ProLong® Gold Antifade 
Mountant 
Invitrogen (Paisley, UK) 
Proteinase K 10 mg/ml, Bioline Reagents Ltd. (London, UK) 
Protein ladder SeeBlue® Plus2 Pre-stained Protein Standard, 
Invitrogen (Paisley, UK) 
RIPA buffer Sigma-Aldrich (St. Louis, USA) 
RPMI Media 1640 Gibco (Paisley, UK) 
Saline Sodium chloride, 0.9% w/v, Baxter Healthcare 
(Northampton, UK) 
Sodium dodecyl sulphate 
(SDS) 
10% SDS solution, Severn Biotech Ltd. 
(Kidderminister, UK) 
SuperSignal™ West Pico 
Chemiluminescent Substrate 
Thermo Scientific (Rockford, USA) 
TAQ polymerase Biotaq DNA polymerase, 5 U/μl, Bioline Reagents 
Ltd. (London, UK) 
Tetramethylbenzidine (TMB) Peroxidase substrate for ELISA, Sigma-Aldrich (St. 
Louis, USA) 
Tris-Acetate-EDTA (TAE) UltraPure 10× TAE buffer, Invitrogen (Paisley, UK) 
Tris-HCl 1 M Tris-HCl solution, pH 8.5, Severn Biotech Ltd. 
(Kidderminister, UK) 
Triton™ X-100 Sigma-Aldrich (St. Louis, USA) 
Trypan blue 0.4%, Gibco (Paisley, UK) 
Xylazine Rompun® 2% (w/v), 20 mg/ml, Bayer plc. 
(Newbury, UK) 
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2.2 Animals 
a) Maintenance of mice: 
All mice were housed in individually ventilated cages under conditions of controlled 
lighting (12 hour light, 12 hour dark) and temperature (20 – 23°C) and fed an ad libitum 
standard chow diet. Both male and female mice were used for experiments at an age 
between 6 and 15 weeks. All experiments were approved by the United Kingdom Home 
Office according to the Animals Scientific Procedures Act 1986. Mice were humanely 
culled by cervical dislocation at the completion of each study. 
 
b) Mouse strains: 
C57/BL6: Wild-type (WT) C57BL/6 mice were purchased from Charles River 
Laboratories (Margate, United Kingdom). All transgenic mouse strains used in this 
study were backcrossed onto the C57/BL6 genetic background.  
CX3CR1-eGFP-knock-in: These mice express the reporter gene enhanced green 
fluorescence protein (eGFP) under control of the endogenous CX3CR1 locus (Jung et 
al., 2000). CX3CR1-eGFP-ki mice exhibit fluorescently labelled classical and non-
classical monocytes, enabling their identification and tracking in vivo. The mice were 
initially obtained from the European Mutant Mouse Archive (Orleans, France). 
Neutrophil elastase knock-out: Homozygous KO mice are deficient for neutrophil 
elastase transcript and protein (Belaaouaj et al., 1998). The mice were initially received 
as a gift from Professor Steven Saphiro, MD (Department of Medicine, University of 
Pittsburgh, Pittsburgh, USA). NE KO mice were crossed with CX3CR1-eGFP-ki mice 
in order to study the role of NE in monocyte trafficking.  
LysM-eGFP-knock-in: These mice express eGFP under control of the endogenous 
lysozyme M (LysM) locus (Faust et al., 2000). LysM-eGFP-ki mice exhibit particularly 
bright neutrophils, enabling their identification and tracking in vivo. The mice were 
initially received as a gift from Professor Markus Sperandio (Walter Brendel Center of 
Experimental Medicine, Ludwig-Maximillians-Universität, Munich, Germany).   
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c) Genotyping transgenic mice: 
To determine the genotype of individual transgenic mice, a polymerase chain reaction 
(PCR)-based assay was performed on genomic DNA isolated from ear notches. The ear 
notches were initially digested overnight at 55°C in 250 µl lysis buffer containing 100 
mM Tris-HCl (pH 8.5), 5 mM EDTA, 200 mM NaCl, 0.2% SDS and 100 µg/ml 
Proteinase K. The cellular debris was pelleted by centrifugation at 17,000 relative 
centrifugal force (RCF) for 10 minutes at room temperature (RT) after which the 
supernatant was removed, added to 250 µl isopropanol in a fresh eppendorf tube and 
shaken to precipitate the DNA. The DNA was subsequently pelleted by centrifugation at 
17,000 RCF for 5 minutes at RT and washed in 70% ethanol. The ethanol was removed 
and the tubes left open for 5 minutes to air-dry, after which the DNA was resuspended 
in 50 µl DNAse free H2O. 
Two separate multiplex PCR assays were designed to distinguish WT and transgenic 
alleles of NE KO and CX3CR1-eGFP-ki mice. For each, PCR was performed on a 
DNAEngine® Peltier Thermal Cycler (Bio-Rad, Hemel Hempstead, UK) using a 
common forward primer and separate reverse primers specific for the WT and 
transgenic allele (Table 2.1). Details of the PCR reaction mixtures and cycling 
parameters are outlined below (Tables 2.2 – 2.4). 
 
Table 2.1: PCR primers used to genotype CX3CR1-eGFP-ki and NE KO mice. 
Gene 
(reference) 
Primer 
type 
Primer 
name 
Melting 
temp. 
Sequence 5'→ 3' 
Amplicon 
size (bp) 
NE Common 
forward 
oIMR7065 60.2°C TGC ACA GAG 
AAG GTC TGT CG 
- 
 WT 
reverse 
oIMR7064 59.8°C GGA ACT TCG 
TCA TGT CAG CA 
230 
(Mouse 
Mutant 
Resource, 
2012)   
KO 
reverse 
oIMR8162 65.4°C TGG ATG TGG 
AAT GTG TGC 
GAG  
310 
CX3CR1 Common 
forward 
CX3CR1GF
P_KL001 
60.1°C CAA CAG GGT 
TCC AAG CAA G 
- 
 WT 
reverse 
CX3CR1GF
P_KL002 
59.9°C GGA CAG GAA 
GAT GGT TCC AA 
438 
(Jung et al., 
2000) 
KO 
reverse 
CX3CR1GF
P_KL003 
59.8°C TGG TGC AGA 
TGA ACT TCA GG 
569 
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Table 2.3: PCR reaction mixture used to genotype CX3CR1-eGFP-ki mice. 
Reagents (units) Stock conc. Final Conc. Volume (n = 1,  µl) 
dH2O - - 18.15 
CX3CR1GFP_KL001 
(pmol/µl)  100 0.5 0.125 
CX3CR1GFP_KL002 
(pmol/µl) 100 0.5 0.125 
CX3CR1GFP_KL003 
(pmol/µl)  100 1 0.25 
dNTPs (mM) 10 0.3 0.75 
MgCl2 (mM) 50 2 1 
NH4 buffer (×) 10 1 2.5 
Taq (U/µl) 5 0.5 0.1 
Total Volume   23 
Total vol. (with 2µl DNA)     25 
 
Table 2.4: PCR cycling conditions used for genotyping. 
Step Temperature Time Cycles 
Initial denaturation 94°C 5 minutes 1 
Denaturation 94°C 30 seconds 30 (NE) 
 
35 (CX3CR1) 
Annealing 60°C 30 seconds 
Extension 72°C 30 seconds 
Final extension 72°C 5 minutes 1 
Storage 4°C hold - 
Table 2.2: PCR reaction mixture used to genotype NE KO mice. 
Reagents (units) Stock conc. Final conc. Volume (n = 1,  µl) 
dH2O - - 17.9 
oIMR7064 (pmol/µl) 100  1 0.25 
oIMR7065 (pmol/µl) 100  1 0.25 
oIMR8162 (pmol/µl) 100 1 0.25 
dNTPs (mM) 10  0.2 0.5 
MgCl2 (mM) 50   2.5  1.25 
NH4 buffer (×) 10 1 2.5 
Taq (U/µl) 5 0.5 0.1 
Total Volume   23 
Total vol. (with 2µl DNA)     25 
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Following PCR amplification, 3 µl ×10 DNA loading buffer (15% Ficoll/0.24% 
bromophenol blue/0.24% xylene cyanol FF) was added to the PCR reaction mixture and 
mixed well prior to loading 18 µl into a 1% agarose/1× Tris-acetate-EDTA (TAE) gel 
containing GelRed™ Nucleic Acid Stain. The gel was run on a Mupid®-One 
ADVANCE electrophoresis unit (Eurogentec, Southampton, UK) in 1× TAE buffer at 
100 volts for 40 minutes and visualised using a BioDoc-It Imaging System (UVP, 
Upland, USA).  
 
2.3 Cell sorting of leukocyte subsets  
a) Harvesting primary leukocytes: 
Leukocytes were harvested from the bone marrow (BM) and spleens of mice. BM was 
extracted from both femur and tibia bones. The bones were dissected and rubbed with 
tissue paper to remove the surrounding muscle tissue. Both ends of the bones were cut 
off with scissors and the marrow flushed into a petri dish with 5-10 ml of cold PBS 
using a syringe with a 30 gauge needle. The marrow was gently homogenised with the 
plunger of a 5-ml syringe, passed through a cell strainer (40-μm-pore size) and collected 
in a 50 ml Falcon tube. Whole spleens were removed from mice and directly 
homogenised, as above. The resulting cell suspensions were pelleted by centrifugation 
at 1200 RCF at 8°C for 5 minutes. The supernatant was discarded and the pellet 
resuspended in 2 ml Ammonium-Chloride-Potassium (ACK) lysis buffer (150 mM 
NH4Cl, 1 mM KHCO3, 0.1 mM EDTA, pH 7.3) for 5 minutes at RT to lyse any 
erythrocytes. The remaining leukocytes were washed twice in PBS and stored at 4°C in 
the dark.  
 
b) FACS-sorting leukocyte subsets: 
Fluorescence activated cell sorting (FACS) was used to purify leukocyte subsets from 
spleens harvested from naïve CX3CR1-eGFP-ki mice. Freshly prepared splenocytes 
were resuspended in 4 ml PBS and immunostained with 0.4 µg anti-GR1 monoclonal 
antibody conjugated to PE for 20 minutes on ice in the dark. The cell density was 
determined using a haemocytometer (see section 2.5b) and adjusted accordingly to 
1.5×10
7
 cells per ml in PBS + 2% foetal calf serum (FCS). The live/dead marker DAPI 
was added at a final concentration of 80 ng/ml prior to sorting the splenocytes on a 
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FACSAria II cell sorter. Classical monocytes, non-classical monocytes, neutrophils and 
lymphocytes were distinguished based on GR1 and CX3CR1-eGFP expression patterns. 
The cell subsets were sorted into pre-cooled polypropylene collection tubes coated with 
1 ml pure sterile heat inactivated (HI) FCS and counted on a haemocytometer. Cell 
numbers were standardised (between 5-10×10
5
 cells) and pelleted by centrifugation at 
1300 RCF at 4°C for 20 minutes. The supernatants were discarded and the cells were 
either promptly used or snap frozen in liquid nitrogen and stored at -80°C.  
 
c) MACS-sorting classical monocytes: 
Monocytes were also purified from the spleen and BM of naïve CX3CR1-eGFP-ki mice 
by MACS (magnetic-activated cell sorting)-separation using the Monocyte Isolation 
Kit, as per the manufacturer’s instructions. Following cell preparation, up to 108 
leukocytes were passed through an LS column, placed in the magnetic field of a 
MidiMACS™ Separator. The magnetically labelled non-target cells are depleted by 
being retained within the MACS column, whilst the unlabelled monocytes pass through 
the column for collection. For increased purity, the cells were passed sequentially 
through two columns. The labelled non-monocytes were subsequently eluted by 
pipetting 5 ml MACS-buffer (PBS, 0.5% BSA, 2 mM EDTA) onto the column and 
firmly applying the provided plunger. Upon collection, cell numbers were determined 
using a haemocytometer (see section 2.5b). 5×10
4
 cells from each fraction were 
prepared for analysis by flow cytometry to ascertain the purity of the MACS-sort (see 
section 2.5c). The remaining cells were kept on ice and used promptly for 
transmigration and gene expression assays.  
 
2.4 NE expression analysis  
a) RT-qPCR: 
NE transcript expression was assayed by reverse transcription quantitative PCR (RT-
qPCR). Frozen pellets of FACS-sorted leukocytes were thawed and total RNA extracted 
using an RNeasy® Micro Kit as per the manufacturer’s instructions. The concentration 
of isolated RNA was determined by measuring its absorbance at 260 nm using a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Labtech 
International Ltd., Ringmer, UK). 150 ng RNA was converted into cDNA in a 20 μl 
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volume using the iScript cDNA Synthesis Kit as per the manufacturer's instructions. 
qPCR reactions were subsequently performed on a 96-well StepOne real-time PCR 
System (Applied Biosystems, Foster City, USA). Details regarding the primers used to 
measure the expression of NE, as well as the housekeeping genes GAPDH and 
cyclophilin, are shown below, along with details of the qPCR reaction mixtures and 
cycling parameters, which remained constant (with the exception of the primers) for all 
genes analysed (Tables 2.5 – 2.7). 
 
Table 2.5: qPCR primers used for mRNA quantification.  
Gene 
(reference) 
Primer 
type 
Primer 
name 
Melting 
temp. 
Sequence 5'→ 3' 
Amplicon 
size (bp) 
NE Forward 5’NE 57.3°C CAC  TGT GTG 
AAC GGC CTA 
AA 
171 
(Access. No.   
NM_015779.2) 
Reverse 3’NE 56.7°C GGA GCC ATT 
GAG CTG GAT A 
 
GAPDH Forward 5’GAPDH 67.8°C TCG TGG ATC 
TGA CGT GCC 
GCC TG 
251 
 
(Access. No. 
M32599) 
Reverse 3’GAPDH 66.3°C CAC CAC CCT 
GTT GCT GTA 
GCC GTA T 
 
Cyclophilin Forward 5’Cyclo 57.9°C CCA CCG TGT 
TCT TCG ACA T 
114 
 
(Access. No.  
M60456.1) 
Reverse 3’Cyclo 57.5°C CAG TGC TCA 
GAG CTC GAA 
AG 
 
Table 2.6: qPCR cycling conditions used for transcript quantification. 
Step Temperature Time Cycles 
Initial denaturation 95°C 15 minutes 1 
Denaturation 95°C 15 seconds  
40 Annealing/Extension 60°C 1 minute 
 
DNA dissociation 
95°C 15 seconds 1 
60°C 15 seconds 1 
95°C 15 seconds 1 
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b) Western blot: 
Cellular NE protein expression was assayed by Western blotting. Pellets of pre-sorted or 
whole leukocytes (1-10×10
5
 total cells) were lysed with 25 µl sodium dodecyl sulphate 
(SDS) loading buffer (250 mM Tris pH6.8, 6% SDS, 10% glycerol, 0.05% 
Bromophenol blue) supplemented with 10 µl/ml beta-mercaptoethanol (β-ME). Lysates 
were sonicated for 10 minutes and passed through a 0.3 ml insulin syringe (31G needle) 
several times to shear genomic DNA and reduce viscosity. After 10 minutes of boiling 
at 100°C, 20 µl of each lysate and 5 µl of SeeBlue® Plus2 Pre-stained Protein Standard 
was loaded onto a Mini-Protean® TGX™ precast polyacrylamide gel and proteins 
separated by SDS-polyacrylamide gel electrophoresis (PAGE) for 70 minutes at 120 
volts on a Power Pac HC (Bio-Rad, Hemel Hempstead, UK) Upon completion, the gel 
was equilibrated in cathode buffer (25 mM Tris base, 192 mM glycine, 10% methanol) 
for 15 minutes and proteins transferred to a methanol-activated hydrophobic PVDF 
membrane equilibrated in anode buffer (25 mM Tris base, 10% methanol) by 
electroblotting at 0.25A for 1.5 hours. The membrane was subsequently blocked in 5% 
milk (in PBS) for 1 hour and incubated with a primary rabbit anti-NE polyclonal 
antibody (1 μg/ml) on a rocker overnight at 4°C. After washing with PBS containing 
0.05% Tween (PBST) four times for 5-10 minutes, the membrane was incubated with a 
secondary goat anti-rabbit IgG polyclonal antibody conjugated to horseradish peroxidise 
(HRP) (0.2 μg/ml) on a rocker for 2 hours at RT. The membrane was washed as before, 
incubated with 1-2 ml SuperSignal® West Pico Chemiluminescent Substrate and 
developed on a SRX-101A Medical Film Processor (Konica-Minolta, Ramsey, USA). 
To provide a protein loading control, the membrane was washed once more, re-probed 
sequentially with a primary mouse anti-β-actin monoclonal antibody (1 μg/ml, 2 hours 
Table 2.7: qPCR reaction mixtures used for transcript quantification. 
Reagents (units) Stock conc. Final conc. Volume (n = 1,  µl) 
dH2O - - 8.2 
SYBR green mix (×) 2 1 10 
Forward primer (µM) 5 1×10-4 0.4 
Reverse primer (µM) 5 1×10-4 0.4 
cDNA (×) 20 1 1 
Total Volume   20 
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at RT) and secondary rabbit anti-mouse IgG polyclonal antibody (0.2 μg/ml, 1 hour at 
RT), and processed and developed, as before. 
 
c) Slot blot: 
To determine levels of secreted NE protein, 250 µl leukocyte-conditioned media (see 
section 2.8a) was loaded into the centre of the wells of a PR 648 slot blot apparatus 
(Hoefer Scientific Instruments, San Francisco, USA) overlaying a methanol-activated 
hydrophobic PVDF membrane equilibrated in PBS. Suction was applied to draw the 
liquid through the membrane, adsorbing any proteins onto its surface. This process was 
repeated with 1 ml PBS to clean the membrane. As with Western blot analysis, the 
membrane was subsequently blocked, probed sequentially with an anti-NE primary and 
anti-rabbit secondary antibody, incubated with chemiluminescent substrate and 
developed on a SRX-101A Film Processor.  
 
d) Immunoprecipitation:  
To determine if immunoprecipitation could be implemented to measure levels of 
secreted NE, 10 ng recombinant mouse NE in 500 µl RPMI-1640 SF media was initially 
incubated with 50 µl EZview™ Red Protein G Affinity Gel beads for 1 hour at RT on a 
rotating wheel. The beads were pelleted by centrifugation at 4000 RCF at RT for 2 
minutes. The supernatant was subsequently incubated with a further 50 µl beads 
supplemented with 1 µg polyclonal rabbit anti-NE antibody overnight at 4°C on a 
rotating wheel. The beads were pelleted as before and the supernatant discarded. To 
elute the adsorbed proteins, the beads were either boiled for 10 minutes in 25 µl SDS 
loading buffer or incubated twice in 15 µl 0.2 M glycine buffer (pH 2.5) for 10 minutes. 
The beads were pelleted once more and the supernatants analysed by Western blot, as 
before.  
 
e) ELISA: 
To determine if secreted NE could be quantified by an enzyme-linked immunosorbent 
assay (ELISA), pellets of whole bone marrow leukocytes (10
6
 total cells) harvested 
from NE
+/+
 and NE
-/-
 mice were lysed in RIPA buffer and adjusted to a volume of 200 
µl with PBS. The lysates were serially diluted 2-fold in PBS (9 final dilutions, total 
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volume of 100 µl per well) across a 96 well plate and incubated overnight at 4°C. The 
lysates were subsequently poured off, washed twice with 200 µl PBS and blocked with 
1% BSA (100 µl, in PBS) for 1 hour at RT. The wells were washed three times, as 
before, and incubated with a primary rabbit anti-NE polyclonal antibody (50 μl, 1 
μg/ml) for 1 hour at RT. The wells were washed three more time and incubated with a 
secondary goat anti-rabbit IgG polyclonal antibody conjugated to HRP (50 μl, 0.2 
μg/ml) for 1 hour at RT. After a final round of washing, the wells were incubated 
sequentially with 50 μl TMB peroxidase substrate and 50 μl hydrochloric acid (1 M, 
after 2 minutes). NE protein expression levels were quantified by spectroscopy at 450 
nm using a Spectra MR spectrometer (Dynex technologies Ltd., West Sussex, UK). 
    
f) Immunofluorescence:  
Immunofluorescence (IF) analysis was employed to investigate the cellular localisation 
of NE protein in murine leukocytes. 2×10
5
 total or MACS-sorted leukocytes (in 80 µl 
PBS) were seeded onto coverslips and left to adhere at RT for 15 minutes. To facilitate 
cell attachment, the coverslips were initially coated with 90 µl 0.001% poly-L-lysine in 
dH2O for 30 minutes at 37°C, after which the excess liquid was removed and the 
coverslips allowed to air-dry completely (~15 minutes). Upon cell attachment, the PBS 
was removed and the cells immediately fixed either in 500 µl methanol (incubated at -
20°C for 10 minutes) or 4% PFA in PBS (incubated at RT for 20 minutes). The cells 
were subsequently washed three times with 500 µl PBS. Cells fixed in PFA were 
permeabilised with 300 µl 0.1% Triton in PBS for 1 minute at RT, before being washed 
again, as before. The cells were next incubated in blocking solution (PBS, 10% goat 
serum, 1 μg/ml mouse BD Fc Block) overnight at 4°C and immunolabelled with a 
polyclonal rabbit anti-NE antibody (1 μg/ml), in conjunction with fluorophore-
conjugated antibodies raised against different cell markers, including CD45 (general 
leukocyte marker), Ly6G (a neutrophil marker) and CD115 (a monocyte marker). The 
antibodies were prepared in 250 μl PBS + 1% FCS, in which the cells were incubated 
for at least 5 hours, if not overnight, at 4°C in the dark. The cells were washed as before 
and incubated with a secondary goat anti-rabbit polyclonal antibody conjugated to 
Alexa Fluor-555 (0.8 μg/ml) for 1.5 hours at RT. As appropriate, the cells were also 
stained with 250 μl of the nuclear dye DRAQ5 (1 mM) for a further 10 minutes. The 
coverslips were washed as before, immersed in two pots of sterile H2O to remove 
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excess PBS, and mounted onto microscope slides, cell side down, in a small drop of 
ProLong® Gold Antifade Reagent. The slides were allowed to cure overnight at RT, 
after which they were stored at 4°C in the dark. 
NE expression and localisation was subsequently determined using a Zeiss LSM 5 
PASCAL confocal laser-scanning microscope (Carl Zeiss Ltd, Welwyn Garden City, 
UK) incorporating either a ×20 water dipping objective lens (numerical aperture 0.5) or 
a ×63 oil dipping objective lens (numerical aperture 1.4). Z-stack images (0.7 µm 
optical sections) of cells were captured using the multiple track scanning mode and 
reconstructed in silico using the image processing software IMARIS (Bitplane, Zurich, 
Switzerland). NE
-/-
 cells were included during analysis to establish levels of non-
specific fluorescence.    
 
g) Flow cytometry: 
To investigate NE protein expression in murine leukocytes ex vivo, total leukocytes 
were harvested from the blood, BM, or peritoneal cavity of CX3CR1
+/eGFP
 mice and 
prepared for flow cytometric analysis (see section 2.5c). Cell surface NE expression was 
assayed for on live cells, whilst immunostaining for intracellular NE stores required the 
cells to first undergo fixation and permeabilisation. This was initially achieved using 
methanol or a combination of PFA and Triton. 3×10
5
 cells were pelleted at 1200 RCF at 
8°C for 5 minutes, resuspended in 100 μl ice-cold methanol or 2% PFA in PBS, 
vortexed briefly, and incubated at RT for 20 minutes. Cells fixed in PFA were pelleted 
and subsequently permeabilised in 100 µl 0.1% Triton in PBS at RT for 5 minutes. 
Unfortunately, neither fixation method enabled successful immunostaining. As such 
cells were subsequently fixed/permeabilised using the Leucoperm kit (AbD Serotec, 
UK) as per the manufacturer's instructions, prior to undergoing receptor blocking, 
immunostaining, and flow cytometric analysis (see section 2.5c). To label NE, the cells 
were initially incubated with a primary rabbit anti-NE polyclonal antibody (1 mg/ml; 
1:100, 1:500 and 1:1000 dilutions were all tested) at RT for 20 minutes. The cells were 
washed twice in 500 µl PBS and incubated with a secondary goat anti-rabbit polyclonal 
antibody conjugated to Alexa Fluor-555 (2 mg/ml; 1:500, 1:1000 and 1:2500 dilutions 
were all tested) at RT for a further 20 minutes.  
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2.5 Mouse peritonitis model of inflammation  
a) Induction of inflammation: 
Peritonitis was elicited in mice by intraperitoneal (i.p.) injection of a given 
inflammatory mediator prepared in 1 ml sterile PBS. Control mice were injected with 
PBS only. Upon completion of the stimulation period, the mice were anaesthetised by 
intramuscular (i.m.) injection of 1 ml/kg ketamine (40 mg) and xylazine (2 mg) 
prepared in saline solution and sacrificed by cervical dislocation. The heart was made 
accessible by thoracotomy and whole blood was collected by cardiac puncture into a 1-
ml syringe pre-coated with 0.5 M EDTA and transferred into a 15 ml Falcon tube on ice 
containing 5 ml PBS. The peritoneal cavity of the mouse was next exposed and injected 
with 6 ml ice-cold lavage buffer (PBS, 0.25% BSA, 2 mM EDTA). The abdomen of the 
mouse was shaken for 30 seconds to dislodge adherent cells and the lavage was 
retrieved and transferred to a 15 ml Falcon tube on ice.  
 
b) Peritoneal lavage counts: 
The total number of leukocytes present in the peritoneal lavage was calculated using a 
haemocytometer (Neubauer, Wertheim, Germany). 10 µl of retrieved lavage buffer was 
mixed with 10 μl 0.4% trypan blue solution and transferred to a chamber on the 
haemocytometer. The number of viable cells (trypan blue negative) was counted under 
an Axiovert 40 CFL light microscope (Zeiss) using ×20 magnification and the cell 
concentration and total cell number was extrapolated using the manufacturer’s 
instructions. 
 
c) Flow cytometric analysis of leukocyte recruitment:  
Following their collection, the leukocytes present in the blood and peritoneal lavage 
were analysed by flow cytometry. The cells in the samples were initially pelleted by 
centrifugation at 1200 RCF at 8°C for 5 minutes. The supernatant was discarded and the 
pellet resuspended either in itself (blood) or 500 µl PBS containing 1% heat inactivated 
normal goat serum (NGS) (lavage). 50 µl of cell-suspension was transferred to a 96 well 
FACS plate containing 5 μg/ml mouse Fc BlockTM and incubated on ice for 20 minutes. 
The cells were subsequently immunostained for various cell surface markers of interest. 
Fluorophore-conjugated antibodies raised against these markers were prepared in 50 μl 
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PBS/NGS, added to the appropriate wells and incubated on ice in the dark for 20 
minutes. The cells were next washed in 200 μl PBS/NGS and pelleted by centrifugation, 
as before. The supernatant was discarded and the pellet resuspended in 300 μl ACK 
lysis buffer at RT for 5 minutes to lyse the erythrocytes. The cells were washed twice in 
PBS/NGS, resuspended in 200 μl PBS/NGS and transferred to FACS tubes. 10 μl of the 
cell viability stain 7-AAD (25 μg/ml) in PBS was added and vortexed prior to acquiring 
sample data using a FACScalibur flow cytometer and CellQuest acquisition software 
(both from BD Biosciences, Mountain View, USA). The data was subsequently 
analysed using FlowJo7.6.4 software (Tree Star Inc., Ashland, USA). Leukocyte protein 
expression levels were represented as relative fluorescence intensity (RFI), measured as 
the ratio of the median fluorescence intensity (MFI) of the specific markers to the MFI 
of isotype controls. 
 
2.6 Mouse cremaster muscle model of inflammation 
a) Induction of inflammation 
To elicit inflammation in the mouse cremaster muscle, male mice were anaesthetised by 
an i.m. injection as before and administered an intrascrotal (i.s.) injection of a given 
inflammatory mediator prepared in 400 µl sterile PBS. 4 µg anti-PECAM monoclonal 
antibody conjugated to Alexa Fluor-555 was included for real-time intravital 
experiments. Control mice were injected with PBS only. In some experiments, mice 
were pre-treated with the NE-inhibitor GW311616A (2 mg/kg) or a vehicle control 
(H2O) by gavage in 0.5 ml H2O 24 hours prior to i.s. stimulation.  
 
b) Confocal analysis of leukocyte recruitment: 
Upon completion of the stimulation period, the mice were sacrificed by cervical 
dislocation and the cremaster muscles surgically removed – a midline incision was 
made in the scrotum and the testicles gently drawn out, before the cremaster muscle was 
separated from the underlying connective tissue, opened via a longitudinal incision, and 
subsequently fully removed from the testis. The cremasters were next fixed by being 
pinned flat on a piece of dental wax and immersed in 4% PFA at 4°C for 1 hour. After 
two rounds of washing in PBS, the tissues were incubated in blocking/permeabilisation 
solution (PBS, 12.5% FCS, 12.5% GS, 0.5% Triton X-100) for 3 hours at RT on a 
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rotating wheel and immunostained for α-smooth muscle actin (SMA) (a pericyte 
marker) and either MRP-14 (a neutrophil marker) or VE-cadherin (an EC marker). 
Fluorophore-conjugated antibodies raised against these markers were prepared in 200 μl 
PBS + 10% FCS, in which the tissues were incubated at least overnight at 4°C in the 
dark. The tissues were washed three times in PBS, each for 30 minutes, at RT on a 
rotating wheel and stored in PBS at 4°C in the dark. 
Leukocyte recruitment to the inflamed cremaster muscle was subsequently determined 
using a Leica TCS SP5 confocal microscope (Leica Microsystems, Milton Keynes, 
UK), incorporating a ×20 water dipping objective lens (numerical aperture 1). Z-stack 
images (0.7 µm optical sections) were captured of post-capillary venules (700 µm 
segments) with a diameter of 20-50 μm at a scanning frequency of 600 Hz and 
reconstructed in silico using the image processing software IMARIS (Bitplane, Zurich, 
Switzerland). Total numbers of monocytes and neutrophils within/attached to the vessel 
of interest or within 300 µm of the surrounding tissue were counted. 5-6 venules were 
analysed per cremaster and a mean average was calculated. 
 
c) Confocal intravital microscopy: 
Intravital microscopy (IVM) was conducted on the cremaster muscle of male 
CX3CR1
+/eGFP
 mice to study the mechanisms of monocyte migration in real time. The 
mice were anaesthetised and stimulated as before. Upon completion of the stimulation 
period, the mice were re-anaesthetised by i.p. injection of ketamine (100 mg/kg) and 
xylazine (10 mg/kg) prepared in saline solution. The mice were maintained at 37°C 
throughout the procedure by being placed on a custom-built heated microscope stage. 
Once in a deep sleep (after ~40 minutes) one of the testicles was exteriorised and the 
cremaster muscle opened, as before. The cremaster was carefully separated from the 
epididymis and, with the aid of pins, spread radially over the viewing window of the 
stage. A flow of warm Tyrodes buffered solution was continuously applied to the 
exteriorised cremaster muscle to preserve its moistness, while simultaneously 
accommodating the ×20 water dipping objective lens of the Leica TCS SP5 confocal 
microscope. As necessary, the Tyrodes solution was supplemented with a given 
inflammatory mediator to perpetuate the inflammatory response.  
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Straight post-capillary venules, 20-50 μm in diameter and exhibiting good blood flow 
were selected for analysis of monocyte extravasation. Z-stack images (1 μm optical 
sections) of half vessels were captured using a resonance scanner at 8,000 Hz at 
intervals of 1 min for a total of 60-90 minutes. The images were reconstructed using 
IMARIS, yielding high-resolution four-dimensional videos of monocytes interacting 
with the vasculature. This enabled the mode and duration of monocyte extravasation to 
be studied in response to different inflammatory stimuli.      
 
2.7 Mouse ear model of inflammation 
a) Induction of inflammation: 
To elicit inflammation in the mouse ear, CX3CR1
+/eGFP
 mice were anaesthetised i.m. as 
before and injected intradermally (i.d.) into the dorsal side of the ear pinnae (typically of 
the left ear) with a given inflammatory mediator prepared in 30 µl sterile PBS. 2.5 µg 
anti-PECAM-1 monoclonal antibody conjugated to Alexa Fluor-555 was also included 
to label the vasculature in situ. Control mice were injected with PBS only. 
 
b) Confocal analysis of leukocyte recruitment: 
Upon completion of the stimulation period, the mice were sacrificed by cervical 
dislocation, the stimulated ear(s) removed whole with scissors and fixed in 4% PFA at 
4°C for 30 minutes. Following a brief wash in PBS, the ventral skin and cartilage of the 
ear were gently separated from the dorsal skin using forceps. The dorsal skin was 
subsequently pinned flat on a piece of dental wax and reimmersed in 4% PFA for a 
further 10 minutes. Each tissue was washed several times in PBS and stored at 4°C in 
the dark.   
As with the cremaster muscle model, leukocyte recruitment to the inflamed ear was 
determined using a Leica TCS SP5 confocal microscope incorporating a ×20 water 
dipping objective lens. Z-stack images (0.7 µm optical sections) were captured of post-
capillary venules (700 µm segments) with a diameter of 20-60 μm at a scanning 
frequency of 800 Hz and reconstructed in silico using the image processing software 
IMARIS. Total numbers of monocytes within/attached to the vessel of interest or within 
300 µm of the surrounding tissue were counted. 6-7 venules were analysed per ear and a 
mean average was calculated.  
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c) Confocal analysis of NE activity and expression: 
NE activity was assessed in the ear and cremaster muscle of CX3CR1
+/eGFP
 mice by 
administering the fluorescent imaging agent Neutrophil Elastase 680 FAST™ 
intravenously (i.v.) (2 nmols in 200 µl PBS) immediately prior to inducing local 
inflammation. After 4 hours, the tissues were harvested, processed and imaged, as 
before. NE activity was correlated to the fluorescence intensity measured at 640-700 nm 
following excitation at 633 nm. NE protein expression was also evaluated in stimulated 
ears. Following PFA-fixation and protein blocking (as before), tissues were 
immunostained with a primary rabbit anti-NE polyclonal antibody (10 μg/ml) overnight 
at 4°C. After washing with PBS three times for 30 minutes, the tissues was incubated 
with a secondary goat anti-rabbit IgG polyclonal antibody conjugated to Alexa Fluor-
647 (0.8 μg/ml) for 1.5 hours at RT. Markers for MRP-14 and VE-cadherin were 
concurrently immunostained, as before (see section 2.6b). Using the surface function on 
IMARIS, the intensity of NE staining was measured in individual monocytes and 
neutrophils, following normalisation to NE
-/- 
samples. 
 
2.8 Cell culture 
a) Stimulating leukocytes in vitro:  
In order to study NE expression in monocytes upon stimulation, 2-10×10
5 
sorted 
monocytes were initially resuspended in 500 µl RPMI-1640 media supplemented with 
10% heat-inactivated foetal bovine serum (HI-FBS), 2 mM L-glutamine, and 1% 
Penicillin (10,000 U/ml)/Streptomycin (10 mg/ml). The cells were either maintained in 
suspension in 1.5 ml Eppendorf tubes or adhered to a 12-well plate. Stimulation was 
performed in a humidified incubator adjusted to 37°C and 5% CO2 using different 
combinations of cytokines (or appropriate vehicle controls) for varying durations 
(detailed in depth in the results chapters). The cells were pelleted by centrifugation at 
1300 RCF at 4°C for 20 minutes. Secreted NE was assayed for in the recovered 
supernatant via slot blot analysis or immunoprecipitation (see sections 2.4c-d), while 
cellular NE was analysed either by Western blotting (see section 2.4b) or 
immunofluorescence (see section 2.4f). NE activity was also evaluated in cells fixed 
with PFA (opposed to methanol) by incubating the coverslips in 250 µl PBS containing 
Neutrophil Elastase 680 FAST™ (1 µM) for 2 hours at 4°C.  
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b) Murine leukocyte transmigration assay: 
Murine skin endothelial cells (sENDs) were routinely cultured in Dulbecco's modified 
Eagle's medium (DMEM), supplemented with 10% HI-FBS, 2 mM L-glutamine, 1% 
non-essential amino acids, 1 mM sodium pyruvate and 5 µM β-ME (all Invitrogen, 
UK). Transmigration assays were readied in 24-well plates by seeding 5×10
4
 sEND 
cells onto Transwell filters (3 or 8 µm pore size) (VWR, Soulbury, UK) pre-coated with 
150 µl gelatin (0.5%). The cells were placed in a humidified incubator (37°C, 5% CO2) 
and allowed to reach confluency for two days. 1-5×10
5
 total or sorted murine leukocytes 
suspended in 150 µl RPMI-1640 media supplemented with 0.5% HI-FBS, 2 mM L-
glutamine, and 1% Penicillin (10,000 U/ml)/Streptomycin (10 mg/ml) were then added 
to the upper chamber of the Transwells. 1 ml of media was added to the lower chamber 
and supplemented either with FBS (total of 10%) or murine CCL2 (10 nM) to induce 
cell migration. Numbers of transmigrated cells were quantified after 4-16 hours by 
counting and combining the number of cells in the lower chamber in three separate and 
randomised fields of view using an Olympus IX81 inverted microscope (Olympus 
Medical, Southend-on-Sea, UK) (4× objective). Assays were run in triplicate.  
 
c) Human leukocyte transmigration assay: 
Human umbilical vein endothelial cells (HUVECs) were routinely cultured in a 50:50 
mix of DMEM and Hams F12 media supplemented with 10% HI-FBS, 25 µg/ml 
endothelial mitogen (AbD Serotec, UK), 1 µg/ml heparin (Sigma-Aldrich, USA) and 
1% Penicillin (10,000 U/ml)/Streptomycin (10 mg/ml). The human monocyte-like U937 
cell line was routinely cultured in RPMI-1640 media supplemented with 10% HI-FBS, 
2 mM L-glutamine and 1% Penicillin (10,000 U/ml)/Streptomycin (10 mg/ml). 
Transmigration assays were readied in 24-well plates by seeding 5×10
5
 HUVEC cells 
onto Transwell filters (8 µm pore size) pre-coated with 150 µl gelatin (0.5%). The cells 
were placed in a humidified incubator (37°C, 5% CO2) and allowed to reach confluency 
for two days. 5×10
5
 U937 cells suspended in 150 µl supplemented RPMI-1640 media 
(containing a reduced 0.5% HI-FBS) containing either the NE-inhibitor ONO-5046 (50 
µM) or PBS (vehicle control) were then added to the upper chamber of the Transwells. 
1 ml of media supplemented with human CCL2 (10 nM) was added to the lower 
chamber to induce cell migration. Numbers of transmigrated cells were quantified after 
4 hours as before. Assays were run in triplicate. 
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2.9 Statistical analysis 
Data analysis was performed using GraphPad Prism, version 6. Graphs are presented as 
a mean value ± standard deviation (SD) or standard error of the mean (SEM), as 
appropriate. An unpaired two-tailed T-test was used to compare data from two groups. 
A one sample T-test was used to compare a sample mean to a known value. P-values < 
0.05 were considered to be statistically significant.    
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CHAPTER 3: Establishing a mouse model to facilitate the 
concurrent study of NE and monocyte biology. 
 
3.1 Introduction 
Particularly useful in dissecting complex signalling pathways and intricate molecular 
mechanisms, the implementation of in vitro techniques has contributed immensely to 
our current understanding of leukocyte transendothelial migration. That being said, 
there are major caveats to extrapolating in vitro data to in vivo physiology. Even the 
most elaborate in vitro models struggle to replicate the complex structure of vessel walls 
or take fully into account the contribution of environmental factors, such as the 
haemodynamic forces of the circulation or local cytokine production. Accordingly, and 
owing to the advent of established animal models, the mechanisms of leukocyte 
migration are now being increasingly studied directly in vivo. 
Several strategies have been developed to study monocyte trafficking in vivo. 
Monocytes have been labelled with fluorescent beads or radioactive isotopes and 
adoptively transferred into recipient mice. Increasingly, transgenic mouse models 
expressing the enhanced green fluorescent protein (eGFP) reporter gene are being 
employed. Lysozyme-M eGFP-knock-in mice express eGFP specifically in 
myelomonocytic cells including neutrophils and monocytes, while the c-fms-eGFP 
transgene is expressed throughout the mononuclear phagocyte system (Sasmono et al., 
2003). Probably the most commonly used transgenic model to study monocytes is the 
CX3CR1 knockout mouse. CX3CR1 constitutes a specific seven transmembrane G 
protein-coupled receptor for the chemokine CX3CL1. CX3CR1 is expressed by 
monocytes, subsets of natural killer (NK) and dendritic cells and the brain microglia 
(Imai et al., 1997). In order to disrupt the CX3CR1 gene, the second exon was replaced 
by the eGFP gene (Jung et al., 2000). This approach not only created a mutant CX3CR1 
locus, but also fluorescently labelled all CX3CR1-bearing cells. As such, CX3CR1-
eGFP-knock-in mice have been routinely used to identify and track monocytes and their 
derivatives in vivo.        
CX3CR1 is expressed by all murine monocytes, though to varying extents with classical 
and non-classical monocytes displaying intermediate and high levels of CX3CR1 on 
their surfaces, respectively. CX3CR1 has been implicated in the adhesion and migration 
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of both monocyte subsets through the endothelium, a potent source of CX3CL1, though 
predictably appears to play a more dominant role in the trafficking of non-classical 
monocytes. Interestingly, the recognition of CX3CL1 by CX3CR1 on monocytes also 
confers an essential anti-apoptotic survival signal (Gautier et al., 2009). Accordingly, 
heterozygous CX3CR1
+/eGFP
 mice are most commonly used during intravital studies as 
they are devoid of any defects in monocyte migration and/or survival, while retaining 
sufficient fluorescence intensity. Monocyte trafficking has been monitored in these mice 
under physiological and inflammatory conditions both ex vivo, for example by 
analysing infiltrated cells in the peritoneal cavity, and in vivo in the mouse cremaster 
muscle (Soehnlein et al., 2008), kidney (Li et al., 2008), and spleen (Swirski et al., 
2009a).  
We aimed to similarly exploit CX3CR1-eGFP-ki mice to investigate monocyte 
migration in vivo in this study. In particular, we were interested in how the protease 
neutrophil elastase may regulate this process. Through its ability to induce endothelial 
injury and cleave virtually every type of extracellular matrix protein, NE has been 
implicated as a potent mediator of vascular and tissue injury. This has led to the 
generation of numerous recombinant endogenous or synthetic NE-specific inhibitors, 
which, while ultimately intended as possible therapeutics for NE-mediated pathologies, 
have also been routinely used in research labs to better understand NE biology. Applied 
principally in vitro, the physiological roles of NE in vivo have however been most 
commonly and rigorously investigated in NE knock-out (NE
-/-
) mice (Belaaouaj et al., 
1998). While numerous studies conducted on these mice have identified NE as a 
regulator of neutrophil extravasation, the involvement of NE in the trafficking of 
monocytes has received almost no attention. To address this issue, NE KO mice were 
crossed, for the first time, with CX3CR1-eGFP-ki mice. CX3CR1
+/eGFP
 mice carrying 
either mutant or wild-type copies of the NE gene were subsequently compared to 
investigate the expression and function of NE in monocyte migration in vivo.  
For this study to be successful, it was imperative to initially establish a robust set of 
protocols for the effective application of all tools, reagents, and mouse models. 
Furthermore, though NE KO mice are reportedly normal in the absence of inflammatory 
stress, we felt it necessary to characterise the leukocyte profiles of naïve NE
-/-
 and NE
+/+
 
mice to confirm there were no underlying differences that may influence their responses 
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during inflammation. We sought to achieve these general aims in this opening results 
chapter by addressing the following specific objectives: 
 Optimise imaging techniques to reliably identify and track CX3CR1-eGFP
+
 
monocytes both ex vivo in suspension and in situ at sites of inflammation. 
 Develop gene expression assays specific for NE. 
 Develop genotyping assays to distinguish mutant and wild-type alleles of 
CX3CR1 and NE.  
 Determine the number, proportion and distribution of leukocyte subsets in NE-/- 
and NE
+/+
 mice under naïve conditions. 
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3.2 Results 
a) Blood monocytes and neutrophils from CX3CR1-eGFP-ki mice can be reliably 
identified by flow cytometry. 
Flow cytometry is a commonly used technique to identify discrete leukocyte 
populations within a heterogeneous sample of cells based on their physical and 
biochemical characteristics. It uses laser light to gauge the size and granularity of cells 
and to detect fluorescently-labelled antigens expressed specifically or distinctly by a cell 
type of interest. In this manner, mouse blood monocytes are traditionally classified as 
CD115
+
, CD11b
+
, F4/80
int 
(Sunderkötter et al., 2004). They can also be crudely 
distinguished from other blood leukocytes by their relatively large size and moderately 
granular cytoplasm, reflected respectively in their forward and side scatter profiles 
(FSC
int
, SSC
int
). The two major monocyte subsets can be subsequently divided 
according to CD62L, Ly6C, and CCR2 expression. 
The generation of CX3CR1-eGFP-ki mice has provided a new approach to classify 
monocytes by flow cytometry. Not only are all monocytes in these mice intrinsically 
fluorescent, the two subsets can be distinguished by eGFP intensity. As fewer 
monocyte-specific markers are required, there is also a greater scope to simultaneously 
stain for other markers of interest. While monocytes have been identified in CX3CR1-
eGFP-ki mice by flow cytometry in other studies, we have yet to optimise a gating 
strategy in our group. Using blood harvested from CX3CR1
+/eGFP
 mice, we sought to 
gate both monocyte subsets, as well as neutrophils, according to CX3CR1 and GR-1 
expression. GR-1 is a GPI-anchored protein of unknown function consisting of two 
epitopes, Ly6G and Ly6C. Ly6G represents a specific marker of neutrophils, while 
Ly6C is expressed by classical monocytes (as well as neutrophils) but not non-classical 
monocytes.  
Cell analysis was performed on a BD FACSCalibur. This particular flow cytometer is 
capable of detecting up to four colours at the same time. Three of the colour detectors 
(FL-1, FL-2, and FL-3), in addition to the forward and side scatter detectors, are 
excitated with a 488 nm blue laser, while the fourth colour detector (FL-4) is excitated 
with a 635 nm red laser. eGFP emits green light (λmax = 510 nm) when excited with the 
blue laser, which is detected in the FL1 channel. GR-1 was immunostained with an anti-
mouse monoclonal antibody (clone RB6-8C5) conjugated to eFluor-660, detected in the 
FL4 channel. In addition, all cells were stained for the platelet-marker CD41 and the 
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viability stain 7-AAD, which intercalates DNA of dying or dead cells only. Platelets 
often stick to leukocytes, influencing their light scattering properties, while dead cells 
tend to bind antibodies non-specifically, giving rise to false positive results. Only cells 
negative for CD41-PE-Cy7 and 7-AAD, both of which are detected by the FL3 channel, 
were gated for analysis. All other cell markers were conjugated with fluorophores 
detected in the FL2 channel (Appendix 3.1).     
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In running blood samples from CX3CR1
+/eGFP
 mice through the flow cytometer, total 
leukocytes were initially separated from erythrocytes and cellular debris by their FSC 
and SSC profiles, as verified by expression of the general leukocyte marker CD45. 
Dead cells and platelet complexes were subsequently excluded and the remaining cells 
plotted according to CX3CR1 and GR-1 expression. This revealed four distinct 
populations of cells (Figure 3.1). The two CX3CR1
+
 populations were also positive for 
CD11b, CD115 and F4/80, and displayed an intermediate FSC/SSC profile, confirming 
them as monocytes. The CX3CR1
med
 but not CX3CR1
hi
 cells also expressed GR-1 and 
CD62L, signifying these cells correspond to classical and non-classical monocytes, 
respectively. Those cells negative for CX3CR1 but positive for GR-1 were also highly 
granular (SSC
hi
), positive for CD11b and Ly6G, but negative for F4/80 and CD115, all 
indicative of neutrophils. The remaining CX3CR1
–
, GR-1
–
 double-negative population 
represents all other leukocytes, including CD38
+
 lymphocytes and NK1.1
+
 NK cells.  
 
b) Monocytes in CX3CR1-eGFP-ki mice can be visualised undergoing TEM in the 
cremaster muscle and ear dermis. 
Having established a rigorous approach to identify and quantify both monocyte subsets 
ex vivo in the blood of CX3CR1
+/eGFP
 mice, we next sought to directly study monocyte 
trafficking in situ at sites of inflammation. Using a combination of immunofluorescence 
Figure 3.1: Flow cytometric gating strategy for discerning leukocytes in CX3CR1-eGFP-ki 
mice. Blood harvested from CX3CR1
+/eGFP
 mice was lysed, immunostained and analysed by 
flow cytometry. CD45
+
 leukocytes were separated from residual erythrocytes by their FSC/SSC 
profile. Upon the exclusion of dead cells and platelet complexes, classical monocytes (green), 
non-classical monocytes (pink) and neutrophils (blue) were distinguished according to GR-1 
and CX3CR1 expression (A), as confirmed by their SSC properties and relative fluorescence 
intensities (RFI) of CD11b, CD115, F4/80, CD62L, Ly6G, NK1.1 and CD38 (B). Data are 
represented as the mean ± SEM (n = 2 mice, average of 2-3 FACS readings per mouse). 
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and confocal microscopy, our group has previously imaged CX3CR1-eGFP
+
 monocytes 
migrating out of stimulated post-capillary venules in the cremaster muscle (Voisin et al., 
2009). Found only in males, the cremaster muscle envelops the testis and helps regulate 
its movement. Due to its thin, transparent, and highly vascularised nature, the mouse 
cremaster muscle is often exploited to record high resolution images of the 
microcirculation during inflammation. This enables leukocyte extravasation to be 
directly visualised and its underlying mechanisms characterised, including how and 
where the leukocytes interact with the vasculature and each other. We sought to use the 
cremaster muscle of CX3CR1
+/eGFP 
mice, as before, to analyse monocyte 
transendothelial migration in this study. Furthermore, we applied the same imaging 
protocols to the thin dorsal skin of the mouse ear, another preparation commonly used 
to study leukocyte trafficking.  
We initially stimulated both the cremaster muscles and ears of CX3CR1
+/eGFP 
mice with 
LPS, a reaction previously shown to induce both monocyte and neutrophil infiltration 
(Voisin et al., 2009). After 4 hours the tissues were harvested, immunostained, and 
analysed by three-colour confocal microscopy. Vascular endothelial cells were 
identified by immunostaining for the junctional molecules VE-cadherin or PECAM-1. 
Arterioles, venules and capillaries were distinguished according to the distinct 
morphology of their endothelium or associated layer of pericytes, as identified by α-
SMA staining (Appendix 3.2). In order to identify neutrophils, we stained for MRP-14, a 
cytoplasmic calcium binding protein highly expressed by neutrophils (Newton and 
Hogg, 1998). Using this approach, monocytes and neutrophils could be clearly 
visualised and counted, both in the cremaster muscle and ear, as they emigrated out of 
post-capillary venules (Figure 3.2).  
 
c) NE transcript can be accurately detected in murine samples by PCR. 
As part of this study we intended to characterise NE expression in murine monocytes by 
measuring levels of both NE transcript and protein. This was principally achieved in 
vitro by qRT-PCR and Western blotting, respectively. Both of these techniques, though 
commonly employed by our group, had to be re-optimised specifically for NE. Ideal as 
negative controls, samples from NE KO mice were included in all analyses to ensure 
NE was reliably detected in WT mice.  
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Quantitative reverse transcription PCR (qRT-PCR) is the most common approach for 
measuring mRNA abundance. In this method, total RNA is first transcribed into 
complementary DNA (cDNA), which is subsequently used as a template for qPCR. 
Incorporating DNA-binding fluorescent dyes, during qPCR the amount of PCR product 
is assessed throughout the reaction. By establishing the critical threshold (CT) cycle, i.e. 
A 
B 
Figure 3.2: Confocal imaging of monocyte and neutrophil transendothelial migration in 
vivo in CX3CR1-eGFP-ki mice. Representative reconstructed confocal images of post-capillary 
venules in the cremaster muscle (A) and ear (B) of CX3CR1
+/eGFP
 mice stimulated with LPS for 
4 hours. Upon culling the mice, tissues were harvested, fixed in PFA and immunostained for 
neutrophils (MRP-14, blue) and either VE-cadherin (cremaster, red) or α-SMA (ear, red). 
CX3CR1-eGFP
+
 monocytes are shown in green. Scale bar, 30 μm. 
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the first PCR cycle in which a tangible fluorescent signal can be detected, the amount of 
starting RNA material can be derived. Sequence-specific primers are essential in qPCR 
to ensure only the target transcript is amplified and detected. In order to measure 
transcript levels of NE, we were first required to design an appropriate pair of primers. 
To reduce amplification from contaminating genomic DNA, we targeted sequences that 
span exon-exon boundaries. Specifically, the chosen forward and reverse primers 
corresponded to the boundaries of exons II/III and exons III/IV of the NE transcript, 
respectively (Table 2.5 and Appendix 3.3). In keeping with the recommended guidelines 
for qPCR, the primers were also 18-25 nucleotides long (19 and 20), exhibited similar 
melting temperatures (56 and 54°C), contained a GC content between 50 and 60% (50 
and 53%), and yielded an amplicon between 100 and 300 bp (171 bp).   
To confirm the chosen primers generated PCR products specific to NE, conventional 
PCR was performed on cDNA obtained from NE
+/+
 and NE
-/-
 mice. As NE is 
transcribed predominantly in developing myeloid cells, RNA was originally isolated 
from whole bone marrow leukocytes. Upon resolving the PCR products on a gel, a 
single band of appropriate size could be seen in the NE
+/+
 lane only (Figure 3.3A). A 
specific and uniform PCR product is imperative during qPCR to achieve accurate 
template quantification. This was achieved specifically by employing the comparative 
CT method of relative quantification, in which levels of a target gene (in this case NE) 
are normalised to an endogenous housekeeping gene (GAPDH). For this to be valid, the 
PCR efficiencies, i.e. the rate at which a PCR amplicon is generated, have to be equal 
for both genes at approximately 100%. Under such circumstances, levels of PCR 
products double every cycle during the exponential phase of amplification. When 
represented as a semi-log regression line plot of CT value vs. log of input cDNA, a 
100% efficient reaction is indicated by a standard curve slope of -3.32. With PCR 
efficiencies for NE and GAPDH measuring at -3.15 (107%) and -3.27 (102%), 
respectively, we can be confident that these same primers enabled cellular NE 
expression to be reliably assessed, as described later on in the study (Figure 3.3B).  
 
d) NE protein can be accurately detected in murine samples by Western blotting. 
Western blotting is the most commonly used technique to analyse relative levels of 
individual proteins. Whole protein samples are initially separated according to size by 
gel electrophoresis and transferred to a membrane, where they are subsequently probed 
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with primary antibodies specific to the target protein. Enzyme-conjugated secondary 
antibodies are most commonly used as a means of generating a detectable signal. The 
intensity of this signal is proportional to the quantity of protein present on the blot. A 
successful Western blot is reliant on a primary antibody that is not only specific to the 
protein of interest, but also offers a high signal-to-noise ratio that can be detected with 
minimal background. 
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In the specific context of murine NE, it appears from the literature that most groups 
conduct Western blots with their own self-raised antibodies, presumably due to the lack 
of a suitable commercially available antibody. Our group too has recently raised an anti-
murine NE antibody, achieved by immunising rabbits with a synthetic peptide 
analogous to residues 84-98 of the mouse NE protein (Appendix 3.4). This sequence 
was chosen as it not only localises to the protein surface, but is also unique to murine 
NE. This was desirable as, despite sharing an identity of 73%, most anti-human NE Abs 
do not cross-react well with murine NE. Total antibodies were purified from the final 
immunised serum, effectively yielding a rabbit anti-mouse NE polyclonal antibody, 
termed SY0049.      
We initially trialled SY0049, as well as two newly available anti-human NE antibodies, 
to determine which, if any, were suitable for quantifying mouse NE via Western 
blotting. Starting with SY0049, while recombinant mouse NE could be detected (runs at 
~34 kDa under reducing conditions), it failed to detect native mouse NE (29-33 kDa) in 
the lysates of NE
+/+
 leukocytes (Figure 3.4). While the mouse anti-human NE mAb 
(from Sigma) did manage to detect a band at ~30 kDa, this band was similarly observed 
for NE
-/-
 leukocytes suggesting it was unspecific to NE. In contrast, the rabbit anti-
human NE pAb (from Abcam), in addition to recognising recombinant NE, generated 
bands in the NE
+/+
 lane only, running at ~22, 24 and 32 kDa. As all three of these bands 
are seemingly NE-specific, we propose that only the top band represents the full-length 
protein, with the two subsequent bands corresponding to lower molecular weight 
protein fragments. This is in keeping with a previous study on human neutrophils, in 
which NE is shown to generate several autolysis peptides during SDS gel 
electrophoresis (Liau et al., 1993). Due to its ability to react specifically with murine 
NE, only the rabbit anti-human NE pAb was used in future Western blot analyses.   
 
Figure 3.3: Validation of qPCR primers for NE transcript quantification. Total cellular 
RNA was extracted from whole BM leukocytes from NE
-/-
 and NE
+/+ 
mice and converted into 
cDNA. Conventional PCR was initially performed with primers specific for NE and the 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). PCR products were 
resolved on a 1.5% agarose gel (A). qRT-PCR was subsequently performed across a serial 
dilution of cDNA to determine PCR amplification efficiencies (B). 
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e) CX3CR1-eGFP-ki mice were successfully crossed with NE KO mice.  
The advent of NE KO mice has provided an elegant and robust tool to study the 
biological properties of NE in vivo. In order to characterise NE specifically in the 
context of monocytes, NE KO mice were crossed with CX3CR1-eGFP-ki mice. This 
was conducted with the assistance of Dr. Martina Beyrau. We ultimately sought to 
generate, and then compare, CX3CR1
+/eGFP
 mice carrying either double mutant (NE
-/-
) or 
wild-type (NE
+/+
) copies of the NE gene. For this to be achieved, we were initially 
required to establish genotyping assays for CX3CR1 and NE. In multiplex PCR, several 
DNA target sequences are amplified in a single PCR reaction. This technique has been 
commonly used to detect different alleles of an individual gene and was similarly 
applied here for CX3CR1 and NE. For each, PCR was conducted using a common 
forward primer and separate reverse primers specific for the WT and transgenic allele 
(Table 2.1). Importantly, the primers were designed to produce PCR products of unique 
sizes that could be distinguished when run on a gel (Figure 3.5). This enables the 
Figure 3.4: Characterisation of anti-NE antibodies by Western blot analysis. Protein lysates 
of 10
6
 whole BM leukocytes from NE
-/-
 and NE
+/+ 
mice were separated by gel electrophoresis 
along with 50 ng recombinant murine NE, transferred to a PVDF membrane and immunoprobed 
with three separate anti-NE primary Abs. All blots were subsequently and sequentially 
developed using an appropriate HRP-conjugated secondary Ab (0.2 μg/ml) and 
chemiluminescence detection reagents.  
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specific genotypes of individual mice to be deduced, ensuring the correct mice are 
utilised, both for breeding and experimental purposes. 
 
 
 
 
 
 
f) NE
-/-
 and NE
+/+
 mice display comparable leukocyte profiles under naïve conditions. 
NE
-/-
 mice have been reported to record normal counts of circulating neutrophils, 
monocytes and lymphocytes under naïve conditions (Hirche et al., 2004). As mice from 
different institutions do sometimes exhibit contrasting phenotypes, and considering we 
crossed NE KO mice with CX3CR1-eGFP-ki mice, we sought to re-establish the 
number, proportion and distribution of leukocyte subsets in naïve NE
-/-
 and NE
+/+
 mice, 
not only in the blood but in the bone marrow, spleen, and peritoneal cavity. The spleen 
and bone marrow comprise extensive leukocyte reservoirs that can be deployed into the 
circulation, as necessary, while the peritoneal cavity, to be used later as a model of 
inflammation, also contains a large resident population of leukocytes. It is imperative to 
characterise the resting leukocyte profiles of these mice and identify any significant 
differences as these may influence how the mice respond in subsequent models of 
Figure 3.5: PCR genotyping of CX3CR1-eGFP-ki and NE KO mice. Separate multiplex 
PCR reactions were employed to assay for WT and KO alleles of CX3CR1-eGFP-ki and NE KO 
mice. PCR was performed on genomic DNA isolated from ear notches using a common forward 
primer (1) and separate reverse primers specific to the WT (2) and KO (3) alleles (A). 
Importantly, each of the reactions generated a PCR product of unique size that could be 
distinguished when resolved on a 1.5% agarose gel. Representative homozygous KO, 
heterozygous and homozygous WT genotypes are shown for the CX3CR1 (B) and NE (C) genes.     
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inflammation. In this same regard, we also measured the resting expression levels of the 
key monocyte chemokine receptors CCR1, CCR2, CCR5 and CX3CR1, though only in 
the blood (Table 3.1).  
Total leukocytes were harvested from the blood, spleen, bone marrow and peritoneal 
cavity of naïve mice and counted using a haemocytometer. For each, similar numbers 
were observed for NE
-/-
 and NE
+/+
 mice (Figure 3.6A). Flow cytometry was 
subsequently employed, as before, to determine the relative proportions of neutrophils, 
classical monocytes and non-classical monocytes (Figure 3.6B). Peritoneal 
macrophages were also analysed, as identified by their high F4/80 expression (Figure 
3.6C). No statistically significant differences were observed between the two genotypes 
in each of the tissues, across all cell types. Likewise, the chemokine receptor expression 
profiles of circulating monocytes were largely identical.   
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Table 3.1:  Cell surface expression of chemokine receptors on blood leukocytes. 
 CCR1 CCR2 CCR5 CX3CR1 
Class. 
monos. 
NE
+/+
 1.63 ± 0.15 106 ± 11.9 1.11 ± 0.004 221 ± 12.4 
NE
-/-
 1.58 ± 0.27 140 ± 44.9 1.07 ± 0.058 201 ± 24.2 
Non-class. 
monos. 
NE
+/+
 1.43 ± 0.15 10.2 ± 2.20 1.09 ± 0.073 478 ± 5.46 
NE
-/-
 2.03 ± 0.45 9.79 ± 1.48 1.16 ± 0.111 437 ± 29.7 
Neutrophils NE
+/+
 1.13 ± 0.03 1.18 ± 0.02 1.06 ± 0.039 2.41 ± 0.34 
NE
-/-
 0.97 ± 0.05 1.05 ± 0.05 0.94 ± 0.049 2.12 ± 0.09 
Expression levels were assessed by flow cytometry and expressed in RFI.  Data are 
represented as the mean ± SEM (n = 3 mice, average of 2 FACS readings per mouse). 
Figure 3.6: Characterising the number and relative proportion of leukocytes in naïve NE
-/-
 
and NE
+/+
 mice. Total leukocytes were harvested from the blood, spleen, bone marrow (BM) 
and peritoneal cavity of NE
-/-
 and NE
+/+
 mice and counted using a haemocytometer (A). Flow 
cytometry was subsequently employed to assess the relative proportion of classical monocytes 
(GR-1
+
, CX3CR1
med
), non-classical monocytes (GR-1
–
, CX3CR1
hi
) and neutrophils (GR-1
+
, 
CX3CR1
–
) (B). Proportions of peritoneal macrophages (F4/80
hi
, CX3CR1
low
, GR-1
low
) were also 
assessed (C). All data are represented as the mean ± SEM (n = 3 mice, FACS-data are averaged 
across 2-3 readings per mouse). 
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3.3 Discussion 
The use of transgenic CX3CR1-eGFP-knock-in and NE knock-out mice have 
contributed immensely to our current understanding of the physiological properties of 
monocytes and NE, respectively. Exhibiting eGFP-fluorescent monocytes, 
CX3CR1
+/eGFP
 mice are routinely used to study monocyte migration and trafficking in 
vivo. The two major monocyte subsets can even be selectively monitored, as 
distinguished by eGFP intensity. Similarly, homozygous NE KO mice represent a 
valuable tool for assessing NE disruption. In order to characterise the expression and 
function of NE specifically in murine monocyte migration in this study, CX3CR1-
eGFP-ki and NE KO mice were crossed together. 
In this opening results chapter we initially sought to establish a set of protocols to 
effectively utilise and cross CX3CR1-eGFP-ki and NE KO mice. In this context, we first 
developed imaging techniques to successfully identify and track monocytes in CX3CR1-
eGFP-ki mice. Four-colour flow cytometry was used to distinguish both monocyte 
subsets from other leukocytes according to their physical and biochemical 
characteristics. Analysing the blood of CX3CR1
+/eGFP
 mice, we found the vast majority 
of eGFP-fluorescent cells were also positive for CD11b, CD115 and F4/80, and 
displayed an intermediate FSC/SSC profile, typical of monocytes. Though a subset of 
natural killer cells has been reported to express CX3CR1, all NK1.1-posititve cells (a 
pan NK marker) were eGFP-negative. The two major monocyte subsets could be further 
differentiated according to eGFP intensity and GR-1 expression: classical monocytes 
displayed intermediate levels of CX3CR1 and GR-1, while non-classical monocytes 
were CX3CR1
hi
, GR-1
–
. A third distinct population of CX3CR1
–
, GR-1
hi
 cells was also 
observed, corresponding to CD11b
+
, Ly6G
+
 neutrophils. Thus, by plotting CX3CR1 and 
GR-1 expression both monocyte subsets and neutrophils could be simultaneously and 
reliably identified. 
Using this approach relative and total numbers of monocytes and neutrophils could be 
determined, not only in blood, but in cell suspensions prepared from the bone marrow, 
spleen, and peritoneal cavity. While the samples in this instance were all isolated from 
naïve mice, we recognised that analysing corresponding samples from immune-
challenged mice would enable us to broadly monitor the mobilisation of these cells 
during inflammation. Indeed, in this manner flow cytometry was used in conjunction 
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with the mouse peritonitis model to track monocyte numbers in the blood and 
inflammatory exudate, as described further in Chapter 5. Changes in the phenotypes of 
these cells were simultaneously assessed by staining for different markers of interest. 
Moreover, through the use of fluorescence-activated cell sorting (FACS), a specialised 
type of flow cytometry, distinct populations of monocytes and other leukocytes could be 
retrieved for subsequent analysis. 
Flow cytometry represents a powerful method for quantifying, characterising and 
isolating leukocytes ex vivo in suspension. In order to directly study leukocytes in situ at 
sites of inflammation, immunofluorescent labelling and three-colour confocal 
microscopy were combined to capture leukocytes as they migrated through stimulated 
venules. In CX3CR1-eGFP-ki mice, endogenously fluorescent monocytes, as well as 
fluorescently-labelled neutrophils, could be seen infiltrating both the cremaster muscle 
and ear dermis in response to LPS. Through the use of Imaris imaging software, stacks 
of high-resolution confocal images were reconstructed into virtual 3-dimensional 
models, which could be subsequently manipulated, for example by adjusting the zoom, 
rotation or colour intensity. In this manner individual leukocytes could be analysed in 
great detail, providing information not only on their size and morphology, but on how 
they interact with the vasculature and each other. Leukocyte transmigration could also 
be quantitatively evaluated by counting the number of extravasated cells. Using this 
approach, CX3CR1-eGFP-ki mice have already been exploited by our group to study the 
mechanisms that govern monocyte migration through the vascular basement membrane 
(Voisin et al., 2009). 
In order to investigate the expression and function of NE in monocyte migration in this 
study we generated and compared CX3CR1
+/eGFP
 mice either deficient or normal for NE. 
This required the mice to be reliably genotyped, as achieved by employing the 
multiplex PCR assays developed in this chapter. Experimental mice were bred by 
mating CX3CR1
eGFP/eGFP
, NE
+/– 
males with CX3CR1
+/+
, NE
+/– 
females, thereby yielding 
CX3CR1
+/eGFP
 progeny, as required, carrying either one (NE
+/-
), two (NE
-/-
) or no 
(NE
+/+
) copies of the mutant NE allele. Using this approach, littermates could be 
directly compared, limiting genetic and environmental variables. Indeed, this was 
exploited in order to evaluate the leukocyte profiles of naïve NE
-/- 
and NE
+/+ 
mice and 
confirm there were no underlying differences that may influence their responses in 
subsequent models of inflammation. Leukocytes were analysed from the blood, spleen, 
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bone marrow and peritoneal cavity. While leukocytes ultimately mobilise to peripheral 
tissues from the blood, during inflammation the spleen and bone marrow are known to 
release their leukocyte stores into the circulation, thereby promoting their rapid and 
abundant infiltration. Monocytes are stored in particularly large quantities in the spleen 
while also being continuously produced in the bone marrow. Both tissues have been 
shown to serve as a rapid source of monocytes in murine studies for example, and 
respectively, in response to myocardial infarction (Swirski et al., 2009a) and bacterial 
infection (Serbina and Pamer, 2006).  
Importantly, and in keeping with their original description, no significant differences 
were observed in the total number or relative proportion of leukocytes across all tissues 
in NE
-/- 
mice compared to NE
+/+ 
controls. Looking specifically at monocytes, both the 
classical and non-classical subset could be detected in the blood, comprising around 7% 
and 5% of total circulating leukocytes, respectively. Relative to each other, the 
proportion of the two monocyte subsets (split roughly 60/40) is in keeping with 
previous studies. Levels of total blood monocytes are however higher than the 4% 
commonly reported, possibly due to the exclusion of all dead cells and platelet 
complexes during flow cytometric analysis. In the bone marrow, classical monocytes 
predominate supporting the theory that non-classical monocytes undergo differentiation 
principally in the blood. In contrast, slightly higher levels of non-classical monocytes 
could be seen in the spleen, consistent with a recent study (Swirski et al., 2009a). 
Surface expression levels of the major monocyte chemokine receptors CCR1, CCR2, 
CCR5 and CX3CR1 were also compared on circulating classical and non-classical 
monocytes in naïve NE
-/-
 and NE
+/+ 
mice. The engagement of such receptors by 
chemokines is involved not only in monocyte extravasation but in their mobilisation 
from the bone marrow and spleen, as well as their life span (Gautier et al., 2009). 
Importantly, as comparable expression profiles were generated for both genotypes 
across all receptors, it is likely that their respective monocytes will have the same 
capacity to respond to stimulation in future models of inflammation. In this context, 
CCR2 plays a dominant role in mediating the early migration of classical monocytes by 
binding its cognate ligand CCL2. Indeed, CCR2 expression was ~10-fold higher in 
classical monocytes compared to non-classical monocytes, in keeping with the 
literature. Moreover, negligible amounts of CCR2 were observed on the surface of 
neutrophils, presumably rendering them unresponsive to exogenously administered 
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CCL2. Monocytes typically also express CCR1 and CCR5, which bind to a variety of 
chemokines, including the shared ligands CCL3 and CCL5. These receptors could be 
scarcely detected in our hands however, on either monocyte subset, calling into doubt 
the suitability of the specific detection antibodies used during flow cytometric analysis.  
As a means of characterising NE expression later on in this study, in this chapter we 
initially designed and optimised PCR and Western blotting assays to quantify NE 
transcript and protein, respectively. For each, NE could be detected in the lysates of 
leukocytes harvested from the bone marrow of WT mice. The specificity of these 
signals was corroborated using NE
-/- 
mice. Collectively, these results confirm NE
-/- 
mice 
as full knockouts and identify BM leukocytes as a suitable positive control for 
subsequent analyses. Moreover, as immunostaining was successfully employed in 
Western blotting, we recognised that the same polyclonal rabbit anti-NE antibody might 
also be applicable to other expression assays, such as flow cytometry and confocal 
microscopy. 
In conclusion, in this chapter we have successfully crossed CX3CR1-eGFP-ki and NE 
KO mice, thereby establishing a valuable mouse model to rigorously, specifically and 
concurrently study NE and monocyte biology. In subsequent chapters, CX3CR1
+/eGFP
 
mice carrying either mutant or WT copies of the NE gene were directly compared (by 
employing the various methods we have just optimised) to investigate the expression 
and function of NE in monocyte migration in vivo. 
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CHAPTER 4: Investigating the expression of NE in murine 
monocytes. 
 
4.1 Introduction 
The most significant insights into the expression profile of neutrophil elastase have 
arisen from studies performed on human neutrophils, where this protein was first 
discovered (Janoff and Scherer, 1968). Encoded by a single-copy gene, NE is 
transcribed almost entirely during the promyelocytic stage of neutrophil development in 
the bone marrow and is switched off completely upon maturation. The translated 
protein, detected in promyelocytes and thereafter, originally constitutes an inactive pro-
enzyme. Activation requires the removal of specific peptides from the N- and C-termini, 
after which the protein is targeted to azurophil granules along with the structurally 
related proteinase 3 and cathepsin G. NE is stored in azurophil granules at millimolar 
concentrations and therefore represents a major protein component of neutrophils. 
Although the majority of NE is packaged inside the lumen of azurophil granules 
amongst a matrix of negatively charged proteoglycans, it is emerging that some NE also 
localises to a protein complex in the granule outer membrane (Metzler et al., 2014). 
For the most part NE is restricted to azurophil granules until actively released following 
neutrophil exposure to inflammatory stimuli. NE has been shown to be released in vitro 
in response to a range of mediators including formyl tripeptide (fMLP), interleukin-8 
(IL-8), and activated complement fragment C5a. Such release can be dramatically 
increased by priming the cells for example with LPS or TNF-α (Owen et al., 1997). NE 
release has also been shown to be greatly amplified by integrin-mediated cell adhesion 
(Rainger et al., 1998). Even under such optimal conditions, neutrophils only release up 
to 25% of their total NE contents into the extracellular milieu, though a considerably 
larger proportion (up to 6-fold more) does typically become sequestered on the outer 
cell membrane (Owen et al., 1997). Moreover, NE can translocate to the nucleus and be 
incorporated into neutrophil extracellular traps (NETs).  
The expression profile of NE appears to be largely conserved in mice. The gene for 
mouse NE is composed of five exons and four introns, analogous to human NE. 
Transcripts can be abundantly detected in developing granulocytes in the bone marrow 
of mice, while mature blood neutrophils display intracellular stores of the NE protein 
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(Belaaouaj et al., 1998). Originally encompassing a larger pro-enzyme, the protein 
undergoes almost identical processing steps as seen in humans prior to being packaged 
into azurophil granules. These granules can be stimulated for secretion, with the lipid 
mediator LTB4 particularly potent in inducing NE release both freely into the 
surroundings and to the neutrophil cell surface (Young et al., 2007). 
Despite its name, neutrophil elastase is not exclusively expressed by neutrophils. NE 
has also been detected in U937 cells, a human cell line with many characteristics of the 
mononuclear phagocyte lineage, as well as primary human blood monocytes and 
macrophages and endothelial cells of atherosclerotic plaques (Dollery et al., 2003). 
These cells were shown to contain not only the NE protein but the NE transcript, 
refuting the dogma that NE synthesis occurs only in the bone marrow. In culturing 
human blood monocytes, NE expression appeared to diminish as the cells differentiated 
into macrophages. Monocytes also demonstrated a greater capacity to secrete their NE 
stores in response to CD40 ligand, a member of the TNF superfamily of molecules. The 
expression of NE by human monocytes has been similarly observed in a handful of 
other studies. These collectively indicate NE synthesis is not ubiquitous. Owen et al. 
detect NE only in a distinct subset of ‘pro-inflammatory’ monocytes representing 20-
30% of the circulating monocyte pool (Owen et al., 1994). Similarly, Kargi et al. only 
found ~40% of blood monocytes to be NE-positive, though to varying extents (Kargi et 
al., 1990). In these cells, NE localised to cytoplasmic granules, akin to azurophil 
granules of neutrophils.  
Neutrophils aside, mouse NE transcript, protein, and activity have also been recorded in 
resident peritoneal macrophages and mast cells (Kolaczkowska et al., 2009). In contrast, 
in comparing the transcriptomes of mouse and human monocytes, NE could not be 
significantly detected in mouse monocytes using a microarray approach, though, 
surprisingly, nor could it be significantly detected in the corresponding human samples 
(Ingersoll et al., 2010). Considering these inconsistencies, and the lack of any 
supporting studies, we believe there is a need to rigorously and explicitly investigate the 
expression of NE in murine monocytes. We sought to achieve this goal in this chapter. 
The specific objectives we wanted to address are as follows: 
 Assess the relative levels of NE transcript in classical and non-classical 
monocytes. 
93 
 
 Assess the relative levels of NE protein in classical and non-classical 
monocytes. 
 Establish the cellular localisation of NE in monocytes. 
 Develop assays for measuring levels of secreted NE. 
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4.2 Results 
a) Murine classical monocytes express high levels of NE transcript. 
Through fluorescence-activated cell sorting (FACS), distinct sub-populations of cells 
can be retrieved upon flow cytometric analysis. Using this approach, the two monocyte 
subsets, as well as neutrophils and a crude lymphocyte population were isolated from 
total splenic leukocytes harvested from naïve CX3CR1-eGFP-ki mice. Individual cell 
types were distinguished according to CX3CR1 and GR-1 expression, as before (see 
Chapter 3.1). Spleen-derived monocytes were chosen for gene analysis as they 
outnumber their equivalents in the circulation and are more amenable to extraction 
(Swirski et al., 2009a). Yielding cell purities of more than 90% (Appendix 4.1), the 
FACS-sorted cells were subsequently screened for NE expression.     
Quantitative real-time PCR (qRT-PCR) was initially employed to evaluate NE 
expression at the transcript level. Relative levels of NE mRNA were measured in each 
leukocyte cell type, following normalisation to the housekeeping gene GAPDH or 
cyclophilin. Specifically, the comparative CT method was applied, in which the CT 
(cycle threshold) value of a target gene, in this case NE, is compared to that of the 
reference gene. The CT value corresponds to the cycle number at which the 
amplification curve crosses a uniform threshold line. For both genes, the threshold line 
was manually set to lie in the middle of the exponential phase of the amplification plot, 
as required for accurate quantification. Upon calculating ΔCT scores for each sample, 
fold-expression changes in NE were subsequently calculated using the formula 2
ΔΔCT
, 
which reflects the effective doubling of PCR product with each amplification cycle. 
Fold changes were presented relative to the neutrophil population, displaying an 
effective expression of 1 (Figure 4.1).  
NE transcripts were detected in each of the leukocyte subsets analysed, as validated by 
NE
-/-
 controls, which failed to penetrate the threshold line. While lymphocytes and non-
classical monocytes contained marginally lower levels of NE transcript compared to 
neutrophils, significantly higher levels were recorded for classical monocytes. Taken 
together our results indicate that while both subsets of murine monocytes are seemingly 
capable of expressing the NE gene, there is a striking heterogeneity as to the level of 
expression.    
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b) Classical monocytes retain NE protein after MACS- but not FACS- sorting. 
To determine if murine monocytes also express the NE protein, naïve splenic leukocytes 
were FACS-sorted as before and assayed for cellular NE protein expression by Western 
blotting. This was achieved using an anti-human NE rabbit polyclonal antibody that we 
previously confirmed to cross-react with murine NE. As expected, neutrophils were 
shown to contain an abundance of NE protein. Interestingly, no protein could be 
detected in the remaining leukocyte types including either monocyte subset (Figure 
4.2A). As NE translation may only be initiated in these cells upon stimulation, we 
incubated sorted cells with a cocktail of pro-inflammatory cytokines and chemokines 
for 24 hours in vitro prior to Western blot analysis. As before however, no protein could 
be detected in the lymphocyte or monocyte populations (Figure 4.2B).  
Speculating that the NE protein might be released by monocytes during FACS-sorting, 
we next sought to purify monocytes using MACS technology. In magnetic activated cell 
sorting, individual cell types can be isolated from a heterogeneous mixture according to 
their extracellular protein profiles. Total cells are initially incubated with magnetic 
nanoparticles coated with antibodies against distinct surface antigens. Upon passing the 
cells through a column placed in a strong magnetic field, those labelled with antibody 
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Figure 4.1: Quantifying NE transcript levels in different leukocyte subsets of NE
+/+
 mice. 
Quantitative real-time PCR was employed to determine relative levels of NE transcript in 
splenic leukocyte homogenates. Total RNA was extracted from 5×10
5
 FACS-sorted classical 
monocytes, non-classical monocytes, neutrophils and lymphocytes, converted into cDNA and 
used as a template for qRT-PCR. NE expression was specifically calculated using recorded CT 
values normalised to the housekeeping genes GAPDH and/or cyclophilin. cDNA from NE
-/-
 BM 
leukocytes was used as a negative control. Fold changes are presented (on a log scale) relative 
to neutrophils (set to 1). Data are represented as the mean ± SEM (n = 5 runs, 6 mice). Each run 
was performed in triplicate. Some runs were coordinated by Dr. Martina Beyrau. 
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are retained in the column while the remaining ‘negative fraction’ flows through 
unimpeded. In order to purify monocytes in this study, we used a specific monocyte 
isolation kit, in which unlabelled monocytes are freely collected as the remaining 
leukocytes are held in the column. Isolating monocytes in this manner via negative 
selection is preferable as the cells remain largely ‘untouched’ and hence are less likely 
to be activated.  
 
 
 
 
 
 
 
Figure 4.2: NE protein expression in FACS-sorted leukocytes. Western blot analysis was 
employed to assay for intracellular levels of NE protein in splenic leukocytes. Total protein 
lysates from 5×10
5
 FACS-sorted classical monocytes, non-classical monocytes, neutrophils and 
lymphocytes were resolved by gel electrophoresis, transferred to a PVDF membrane and 
immunoprobed for NE. Analysis was conducted either immediately after FACS-sorting (A) or 
following 24 hours stimulation with a cocktail of LPS, IFN-γ and CCL2 (each at 100 ng/ml) in 
a 24-well plate in 500 µl RPMI-1640 media (B). Mouse NE runs at 22-32 kDa. β-actin (42 kDa) 
was used as a loading control.  
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Using this isolation kit, monocytes were MACS-sorted from the mouse bone marrow, as 
recommended by the manufacturer, as well as the spleen. Cells were harvested from 
CX3CR1-eGFP-ki mice, enabling the purity of the sorted cells to be rigorously assessed 
by flow cytometry. Samples from the spleen and particularly the bone marrow were 
shown to be significantly enriched for monocytes following MACS-separation (Figure 
4.3). These monocytes were almost entirely of the classical subset, in keeping with the 
manufacturer’s description. While classical monocytes typically represent only 8-15% 
of total leukocytes in the bone marrow and 1-2% in the spleen, this was increased after 
MACS-sorting to more than 90% and 70%, respectively. Importantly, the small fraction 
of remaining cells were almost entirely depleted of neutrophils (< 0.5%). Owing to its 
greater purity, classical monocytes sorted from the bone marrow were subsequently 
subjected to Western blot analysis to examine NE protein expression. In stark contrast 
to FACS-sorted monocytes, MACS-sorted monocytes were found to contain the NE 
protein, at a level similar to whole bone marrow leukocytes (Figure 4.4). 
 
 
 
 
 
Figure 4.3: Flow cytometric analysis of leukocytes pre- and post-MACS-sorting. Flow 
cytometry was employed to determine the purity of classical monocytes (GR-1
+
, CX3CR1
med
, 
red) following their MACS-sorting from whole leukocyte samples harvested from the bone 
marrow (BM) (A) or spleen (B) of CX3CR1
+/eGFP
 mice. Relative levels of neutrophils (GR-1
+
, 
CX3CR1
–
, Ly6G
+
, orange) were also assessed. Shown are representative FACS plots from one 
round of experiments. 
Figure 4.4: NE protein expression in MACS-sorted leukocytes. Western blot analysis was 
employed to assay for intracellular levels of NE protein in bone marrow (BM)-derived 
leukocytes. Total protein lysates from 3.5×10
5
 whole BM leukocytes or MACS-sorted classical 
monocytes were resolved by gel electrophoresis, transferred to a PVDF membrane and 
immunoprobed for NE. Whole BM leukocytes from NE
-/-
 mice were used as a negative control. 
Mouse NE runs at 22-32 kDa. β-actin (42 kDa) was used as a loading control. 
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c) Monocyte NE is stored in cytoplasmic granules. 
Having established murine classical monocytes do express the NE protein, we next set 
out to elucidate its cellular localisation by immunofluorescence microscopy. For this to 
be achieved we hoped to exploit the same anti-NE antibody as used for Western 
blotting. We initially attempted to visualise NE in whole bone marrow leukocytes 
harvested from CX3CR1-eGFP-ki mice. The cells were fixed onto cover slips with PFA, 
permeabilised with Triton X-100 and subsequently stained for NE and the neutrophil 
marker Ly6G. NE
-/- 
leukocytes were used as a negative control. Though the neutrophils 
and monocytes could be clearly identified, the NE staining appeared largely non-
specific as fluorescence could be observed for NE
+/+
 and NE
-/- 
cells alike (Appendix 
4.2). As this could not be resolved by lowering the working concentration of the 
primary anti-NE antibody and/or the secondary anti-rabbit antibody (data not shown), 
we next revised our choice of fixative and permealising agent and exchanged 
PFA/Triton for methanol. Using this approach, NE staining could be seen in NE
+/+
 cells 
only (Figure 4.5). As expected, NE in neutrophils appeared to localise to intracellular 
granules, though interestingly this same expression pattern was also noted for other 
Ly6G
–
 cells. Unfortunately, as methanol causes irreversible bleaching of eGFP, the 
cellular localisation of NE specifically in monocytes could not be confirmed. 
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As a means of exploring the sub-cellular localisation of NE in monocytes, we initially 
tried to identify monocytes by incubating whole BM leukocytes with antibodies against 
the monocyte markers CD115 and eGFP (in CX3CR1
+/eGFP
 mice), however none of 
these provided specific staining (data not shown). Taking a different approach, we next 
stained for NE directly in MACS-sorted monocytes, harvested both from the bone 
marrow and the spleen (Figure 4.6A-B). Irrespective of their origin, 100% of the sorted 
monocytes displayed intracellular stores of NE, akin to those seen in neutrophils. By 
concurrently staining for the pan-leukocyte surface marker CD45 and by incorporating 
the nuclear stain DRAQ5, it appears the NE-positive granules are largely confined to the 
monocyte cytoplasm (Figure 4.6C).       
 
 
Figure 4.5: NE protein localisation in murine leukocytes. Whole bone marrow leukocytes 
were harvested from CX3CR1
+/eGFP
 mice, seeded onto cover slips, and fixed/permeabilised with 
methanol. The cells were subsequently immunostained for NE (red) and the neutrophil marker 
Ly6G (blue) and analysed by confocal microscopy. NE
-/-
 leukocytes were used as a negative 
control. Scale bar, 5 µm. 
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d) Levels of secreted NE could not be precisely measured. 
In neutrophils, while NE is constrained to azurophil granules under naïve conditions, 
upon stimulation these intracellular stores have been shown to be actively released. In 
order to rigorously investigate the potential release of NE by murine monocytes, we 
sought to establish an assay capable of accurately detecting NE in solution. We initially 
tried developing an enzyme-linked immunosorbent assay (ELISA) in which dissolved 
proteins are immobilised onto a microtitre plate. A detection antibody is subsequently 
added, forming a complex with a particular protein of interest, while an enzyme-
conjugated secondary antibody produces a signal readout proportional to the amount of 
target complex present in the sample. To determine if NE could be quantified by 
ELISA, whole cell lysates harvested from the bone marrow of NE
+/+
 and NE
-/- 
mice 
Figure 4.6: Sub-cellular localisation of NE in classical monocytes. Classical monocytes were 
MACS-sorted from the bone marrow (A) and spleen (B) of CX3CR1
+/eGFP
 mice, seeded onto 
cover slips, and fixed/permeabilised with methanol. The cells were subsequently 
immunostained for NE (red) and the pan-leukocyte surface marker CD45 (green), incubated 
with the nuclear stain DRAQ5 (blue) and analysed by confocal microscopy. Higher 
magnification images of BM monocytes reveals NE is expressed in cytoplasmic granules (C). 
Scale bar, 10 µm.  
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were immobilised onto a 96-well plate and incubated with the rabbit anti-NE antibody. 
Essentially representing a negative control, we were surprised to see a signal be 
generated at all in the NE
-/- 
mice, yet alone a signal equal in intensity to its NE
+/+
 
counterpart (Figure 4.7). Though we tried increasing the concentration of blocker and 
denaturing the lysates prior to analysis, this was not sufficient to remove the non-
specific signal from the NE
-/-
 samples (data not shown). 
 
 
 
 
 
Though only considered to produce semi-quantitative results, we next attempted to 
assay for soluble NE via slot blot analysis. In a slot blot, a dissolved protein sample is 
applied directly onto a nitrocellulose membrane. As the sample is drawn through the 
membrane via a vacuum pump the proteins become adsorbed onto the membrane 
surface while the remaining components pass freely through. This approach enables 
large sample volumes to be analysed in their entirety. As with Western blotting and 
ELISA, the expression of a single target protein can be subsequently explored by 
immunodetection. To determine if levels of soluble NE could be measured by slot blot 
analysis, 5 and 50 ng of recombinant murine NE in 1 ml of PBS were processed in 
parallel using the rabbit anti-NE antibody. Encouragingly, differences in the amount of 
total NE were reflected in the intensity of the chemiluminescent signals generated by 
Figure 4.7: Assaying for NE protein by ELISA. Whole bone marrow leukocytes from NE
+/+ 
(♦) and NE-/- (■) mice were lysed, serially diluted 2-fold across an ELISA plate, and 
immunoprobed for NE. Sample absorption at 450 nm was characterised to determine relative 
levels of NE protein expression. 
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the two samples (Figure 4.8A). To validate its application for endogenous murine NE, a 
subsequent slot blot was performed on the lysates of bone marrow leukocytes isolated 
from NE
+/+
 and NE
-/- 
mice (Figure 4.8B). Regrettably, a comparable signal was 
generated for both genotypes. Similarly observed for the ELISA, it is clear that NE is 
not the only cellular component detected by the anti-NE antibody.    
 
 
 
 
 
In contrast to an ELISA or slot blot which are unable to differentiate bona fide and 
artifactual signals, during Western blot analysis non-specific protein bands can be 
resolved by gel electrophoresis. In this light, we next attempted to extract and 
concentrate soluble NE by immunoprecipitation prior to evaluating its expression by 
Western blot analysis, as before. To gauge its feasibility, we initially attempted to 
precipitate recombinant murine NE using the anti-NE antibody in conjunction with 
protein G sepharose beads. The beads were subsequently boiled to elute the attached 
proteins (Figure 4.9A). In assaying for NE, two large non-specific bands at ~25 and 35 
kDa could be detected in each of the samples, including the appropriate negative 
controls. We initially speculated that these bands derived from the sepharose beads 
which were commonly present in all of the samples. Specifically, we theorised they 
resulted from the deterioration of the beads through boiling. Accordingly, a second 
elution protocol encompassing a low pH glycine buffer was tested instead, however the 
miscellaneous bands persisted (Figure 4.9B). Considering these bands run at a similar 
Figure 4.8: Assaying for NE protein by slot blot. Relative expression levels of recombinant 
(A) and endogenous (B) murine NE were assessed by slot blot analysis. 5 and 50 ng 
recombinant murine NE and protein lysates of 2.5×10
5
 whole bone marrow (BM) leukocytes 
from NE
-/- 
and NE
+/+ 
mice were denatured, transferred to a nitrocellulose membrane in 1 ml 
PBS, and immunoprobed for NE. 
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size to endogenous murine NE, immunoprecipitation does not constitute a viable 
method for measuring levels of secreted NE.  
 
 
 
 
 
 
 
Figure 4.9: Assaying for NE protein by immunoprecipitation. We attempted to 
immunoprecipitate 10 ng recombinant murine NE (NE+) suspended in 500 µl RPMI-1640 
media. Control samples lacking NE (NE–) were also processed. NE was sequestered onto 
Protein G beads via an anti-NE antibody (Ab+). All attached proteins were subsequently eluted 
from the beads either through boiling (A) or by using a low pH glycine buffer (B). The samples 
were subsequently resolved by gel electrophoresis, transferred to a PVDF membrane and 
immunoprobed for NE. Regrettably, both approaches ubiquitously yielded non-specific bands 
of a similar size to endogenous murine NE (22-32 kDa). 
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e) NE secretion could not be induced in monocytes in vitro. 
Rather than directly measuring secreted NE in solution, we next sought to monitor the 
depletion of NE stores from leukocytes using flow cytomtery. This approach should 
enable relative levels of NE to be quantified both within the cell body and displayed on 
the outer cell surface upon stimulation. To determine if cellular NE could indeed be 
identified by flow cytometry, leukocytes from the blood and bone marrow of naïve 
CX3CR1-eGFP mice were fixed, permeabilised and immunostained for NE. While 
neutrophils and monocytes could still be clearly defined upon fixing, neither cell type 
demonstrated positive staining for NE (Figure 4.10). Though we tried increasing the 
working concentrations of the detection antibodies and adding secondary permeabilising 
agents for a deeper penetration, no NE-staining could be observed. Likewise, no NE 
could be detected sequestered on the outer cell surface of any leukocyte subset, either in 
the circulation or following recruitment during peritonitis (Appendix 4.3). 
 
 
 
 
Figure 4.10: Assaying for intracellular NE protein by flow cytometry. Whole leukocytes 
harvested from the blood (shown) and BM of naïve CX3CR1
+/eGFP
 mice were ACK-lysed, fixed 
and permeabilised using Leucoperm reagents and immunostained for NE. NE
+/+
 (blue) and NE
-/- 
(red) leukocytes were directly compared. 
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Figure 4.11: Monocyte NE is not secreted following in vitro stimulation with CCL2 or 
LTB4. Intracellular NE expression levels were compared in naïve and stimulated leukocytes by 
Western blotting (A) and immunofluorescence (B). Regarding the former, 5×10
5
 MACS-sorted 
monocytes and whole bone marrow (BM) leukocytes from CX3CR1
+/eGFP
 mice were cultured in 
12-well plates in 500 µl RPMI-1640 media supplemented with CCL2, LTB4 (each at 100 ng/ml) 
or vehicle (PBS). After 4 hours, cellular lysates were resolved by gel electrophoresis, 
transferred to a PVDF membrane and immunoprobed for NE. β-actin was used as a loading 
control. NE expression was also assayed for in monocytes by immunofluorescence. Cells were 
stimulated with CCL2, LTB4 or PBS in plates as before (shown) or in suspension, though only 
for 45 minutes. Scale bar, 3 µm.  
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Reverting back to established techniques, we next endeavoured to evaluate NE release 
from monocytes by Western blotting. Upon MACS-sorting, monocytes were stimulated 
in vitro for 4 hours either with the monocyte-specific chemoattractant CCL2 or with 
LTB4, a lipid mediator previously shown by our group to induce extensive NE 
degranulation from purified neutrophils (Young et al., 2007). Neither however triggered 
a tangible release of cellular NE (Figure 4.11A). Theorising that NE might be mobilised 
to the outer cell surface instead of being freely released, we next analysed the 
monocytes by immunofluorescence. Recognising that cell adhesion may also influence 
NE secretion, the cells were stimulated both in suspension and following attachment to 
coverslips. Irrespective of the stimulation protocol used however, monocytic NE could 
not be triggered for release by either CCL2 or LTB4 (Figure 4.11B). Treatment with 
phorbol myristate acetate (PMA), a synthetic and general inducer of leukocyte 
degranulation also failed to reduce intracellular NE expression, though NE in 
neutrophils was shown to mobilise to the cell nucleus (Appendix 4.4). 
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Discussion: 
It is emerging that neutrophil elastase, in spite of its name, is not exclusively found in 
neutrophils but rather can be expressed by several different cell types. NE expression 
has already been demonstrated in human macrophages and monocytes, however 
equivalent studies have yet to be conducted on mice. In this light, and considering our 
interest in exploiting mouse models to explore NE as a regulator of leukocyte migration, 
we sought to rigorously evaluate the expression of NE in murine monocytes in this 
chapter. This specifically entailed analysing levels of NE transcript and protein in the 
two major monocyte subsets, harvested from both the spleen and bone marrow of 
CX3CR1-eGFP-ki mice. 
As a means of isolating pure populations of classical and non-classical monocytes, 
whole splenocytes were originally separated by fluorescence-activated cell sorting 
(FACS). Both monocyte subsets are well represented in the spleen and, importantly, 
have been shown to share an identical morphology, transcriptome and function with 
their blood counterparts. Upon sorting, monocytes, as well as neutrophils and a crude 
population of lymphocytes, were initially assayed for NE transcript by qRT-PCR. For 
neutrophils, high-level transcription of NE and several other serine proteases is known 
to be limited to the promyelocytic stage of development. Once the mature proteins are 
packaged into azurophil granules gene transcription is reportedly terminated. Refuting 
this dogma, we were able to detect NE transcripts in mature splenic neutrophils. While 
NE was also expressed, albeit in lower amounts, in lymphocytes and non-classical 
monocytes, we were intrigued to discover a multi-fold increase in the expression of NE 
transcripts in classical monocytes. This is in accordance with previous reports in which 
mature monocytes have been shown to have a preserved capacity to increase production 
of granule proteins through de novo synthesis (Dale et al., 2008). Furthermore, NE 
transcripts have been directly detected in human blood monocytes (Dollery et al., 2003). 
This study did not however differentiate between the two monocyte subsets. In this 
regard, our results suggest there is a striking heterogeneity in NE expression between 
monocyte subsets in mice, with classical monocytes containing significantly greater 
quantities of the NE transcript compared to non-classical monocytes. 
To determine if murine monocytes also expressed the NE protein, whole lysates of 
FACS-sorted classical and non-classical monocytes were analysed by Western blotting. 
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Neutrophil lysates were run in parallel and, as expected, were shown to contain a 
significant amount of NE protein. In contrast, no protein could be detected for either 
monocyte subset. Considering its potential role in monocyte transmigration, we initially 
speculated that NE was not required by monocytes under naïve conditions and only 
underwent translation upon stimulation. This did not seem to hold true however as 
incubating monocytes in vitro with a cocktail of inflammatory mediators did not elicit 
NE synthesis. Recognising the NE protein contains an N-terminal signal peptide, we 
considered that NE was synthesised and constitutively released by monocytes. 
Alternatively, it was feasible that monocytes contained NE stores but in quantities that 
lay below the detection limit of our Western blot assay. Neutrophils store NE in copious 
amounts, between 1-4 µg/10
6
 cells (Edwards, 2005). It was possible that NE is 
packaged differently in monocytes at a lower undetectable concentration.  
One final explanation we considered is that monocytes release their NE stores during 
cell purification. Following stimulation with the cytokine CD40 ligand, human 
monocytes were shown to expel almost their entire NE contents (Dollery et al., 2003). If 
our murine monocytes were similarly stimulated, albeit inadvertently, during FACS-
sorting, this may explain the apparent absence of NE during Western blotting. To 
confirm if this was occurring, we incorporated a second cell purification method using 
MACS-technology. Whole cell suspensions from the mouse bone marrow and spleen 
were applied to a specific monocyte isolation kit, resulting in a pronounced enrichment 
of monocytes, predominantly of the classical subset. The bone marrow in particular 
demonstrated a high purity of classical monocytes, more than 95%, while in the spleen a 
purity of approximately 75% was attained. Importantly, both samples were almost 
completely devoid of NE-laden neutrophils. Instead, the majority of contaminating cells 
were GR-1
Int
, Ly6G−, SSC
hi
 in keeping with a recent description of eosinophils (Rose et 
al., 2012), which, certainly in humans, do not express the NE protein (Wiedow et al., 
1996). 
Considering the abundance of NE transcripts detected in classical monocytes, we were 
particularly intrigued to re-assess their protein content by Western blotting following 
MACS-sorting. Due to their higher purity, bone-marrow derived monocytes were 
initially investigated. In stark contrast to our previous results conducted on FACS-
sorted cells, upon MACS-sorting NE could be clearly detected in monocytes and at a 
level similar to whole bone marrow leukocytes. Moreover, the presence of multiple NE 
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bands on the Western blot, presumably as a result of NE autolysis, suggests NE from 
monocytes retains its catalytic activity. Thus, though critically dependent on the method 
of isolation, murine monocytes do seemingly have the capacity to store the NE protein. 
This being established, we next employed immunofluorescence to explore the 
subcellular localisation of NE in classical monocytes MACS-sorted from the bone 
marrow, as well as the spleen. Though monocytes isolated from the spleen are 
altogether less pure, in immunofluorescence any contaminating cells can be individually 
identified and disregarded. Once seeded onto cover slips, we initially tried fixing and 
permeabilising the cells with a combination of PFA and Triton X-100. This approach 
however gave rise to false positive staining in NE
-/- 
controls, possibly due to the 
incomplete quenching of free aldehyde groups in the PFA, which thereby remain 
susceptible to interacting non-specifically with the primary/secondary detection 
antibodies (Melan, 1999). We next attempted to fix and permeabilise the cells 
simultaneously using methanol. Although this approach bleached the endogenous eGFP 
fluorescence of the monocytes, it did provide specific staining for NE. In bone marrow 
neutrophils, NE localised to numerous intracellular stores, presumably the azurophil 
granules. This same granular staining was also observed in classical monocytes isolated 
from both the bone marrow and the spleen. This result confirms that the absence of NE 
protein in FACS-sorted monocytes is due not to their original source (i.e. the spleen) but 
to the method of cell purification.  
In a study examining NE expression in human blood monocytes, approximately 60% of 
the monocytes analysed were unstained for NE, while the remainder varied greatly in 
staining intensity (Kargi et al., 1990). Within these cells, and in keeping with our 
findings, NE localised to intracellular granules demonstrating endogenous peroxidase 
activity akin to that seen in neutrophil azurophil granules. Interestingly, these granules 
were detected in monocytes in the same proportions as NE. While these results were 
attributed to different monocyte subsets, it is similarly conceivable that these cells were 
not heterogeneous in their ability to synthesise NE but rather had been incompletely 
stimulated to release their granular stores. Highly reactive, the handling and isolation of 
monocytes may be enough to trigger stimulation. Indeed, it is feasible that a 
considerable proportion of human monocytes in this study were inadvertently 
stimulated to undergo degranulation during centrifugation elutriation. Likewise, in our 
study, the process of FACS-sorting is seemingly sufficient to stimulate monocytes to 
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expel their entire NE contents. Interestingly, in both studies, neutrophils retain their NE 
stores upon isolation, implying either that they are less readily stimulated during 
handling or that NE is differently packaged and/or regulated in neutrophils and 
monocytes. 
In previous studies, levels of secreted human NE have been successfully quantified by 
ELISA, while its enzyme activity has also been routinely assayed using the fluorogenic 
substrate methoxysuccinyl-Ala-Ala-Pro-Val-7-amino-4-trifluoromethyl coumarin. 
While this substrate is highly selective for human NE, this specificity is mostly lost in 
mice, as demonstrated by our group (data not shown) and others (Wiesner et al., 2005). 
Unfortunately, in this study we were unsuccessful in establishing an equivalent assay 
specific for secreted mouse NE. While NE could be accurately detected in the lysates of 
leukocytes, the volumes of these samples were ultimately very low, concentrating the 
protein content. In contrast, NE released into the media of cultured leukocytes was 
evidently too dilute to be detected by Western blotting. To circumvent this problem we 
next attempted to establish our own ELISA, a quantitative technique that accommodates 
high volume samples. Initially convinced we were able to detect NE in the diluted 
lysates of NE
+/+
 leukocytes, in running equivalent controls from NE
-/-
 mice it became 
clear that our signal read-out was not NE-specific. Though we revealed the anti-NE 
antibody could similarly recognise a component of foetal bovine serum, its omission in 
subsequent experiments was not sufficient to remove the signal generated in the 
knockout samples. Considering this signal weakens as the lysates are serially diluted, it 
is most likely caused by a separate cellular component as opposed to being an artefact 
of the ELISA process. Indeed, a signal could also be detected in the lysates of NE
-/- 
leukocytes when processed by slot blot.  
As whole cell lysates were similarly, yet successfully analysed by conventional Western 
blotting, one can only assume that the contaminating component in NE
-/- 
leukocytes is 
removed during gel electrophoresis. As a result, we next tried to concentrate soluble NE 
by immunoprecipitation prior to conducting a Western blot, exactly as before. 
Regrettably, this process produced miscellaneous bands on the blot that could not be 
removed and, even more compounding, ran at a size similar to native NE. Interestingly, 
no bands were visible when fresh untouched sepharose beads were eluted suggesting 
they derived from the RPMI-1640 media, which was similarly used in all samples. 
Bypassing the need for immunoprecipitation, we also tried concentrating soluble NE by 
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centrifugation, however no traces of the protein could be detected upon Western 
blotting (data not shown). 
Considering our difficulties in detecting secreted NE directly in solution, as a measure 
of NE degranulation we next tried to monitor the depletion of NE stores from stimulated 
leukocytes. For this purpose we hoped to utilise flow cytometry as this approach 
enables the concurrent differentiation of classical monocytes, non-classical monocytes 
and neutrophils. Furthermore, it would enable us to directly compare both the 
intracellular and surface expression of NE in naïve leukocytes harvested from the blood 
and leukocytes collected from inflammatory exudates. In trying to establish a working 
protocol, whole leukocytes from the blood and bone marrow were immunostained for 
NE following their fixing and permeabilisation with Leucoperm reagents. While these 
reagents have been successfully used to stain for azurophil granule proteins in human T-
lymphocytes (Sadahira et al., 2001), we failed to detect NE stores in murine leukocytes. 
In researching Leucoperm, cell permeabilisation is achieved with a relatively mild set of 
detergents that might not sufficiently penetrate the membrane of NE-laden granules. 
Accordingly, we supplemented the Leucoperm kit with Triton X-100, a stronger 
detergent that dissolves more of the lipid membrane, as well as methanol, which 
previously supported NE-specific immunofluorescence, however neither provided a 
successful NE stain (data not shown).  
This result highlights the functional limitations often exhibited by detection antibodies. 
Though incompatible for flow cytometry, the same rabbit anti-NE antibody was 
successfully applied for Western blotting and immunofluorescence. Raised against a 
synthetic NE peptide, it is possible that this antibody does not recognise NE in a native, 
folded state but rather requires it to be denatured. For Western blotting all protein 
samples were completely denatured by boiling in the presence of β-mercaptoethanol. 
Likewise, immunofluorescent staining of NE in leukocytes was best achieved using 
methanol, an effective protein denaturant. Even under denaturing conditions however, 
we were unable to specifically detect NE by ELISA or slot blot analysis and regrettably 
we remain without a functioning assay for secreted NE. For this purpose, we instead 
decided to use immunofluorescence to visualise the trafficking of NE to the cell surface 
upon stimulation, however this was not observed in response to CCL2, LTB4 or PMA, 
NE instead remaining confined to intracellular granules. This conflicts with a study 
conducted on human monocyte-like U937 cells, which were shown to be almost 
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completely depleted of their intracellular stores following stimulation with PMA, albeit 
for over 20 hours, contrasting the much shorter stimulation period of 30 minutes used in 
this study (Lemansky et al., 2007). This time period was sufficient however to induce 
NE translocation from azurophil granules to the nucleus of neutrophils (and neutrophils 
only), in keeping with previous reports (Papayannopoulos et al., 2010). Furthermore, 
and again owing potentially to the specific set-up of our assays, we were surprised not 
to observe NE secretion from neutrophils stimulated with LTB4, a supposedly potent 
inducer of azurophil degranulation (Young et al., 2007).  
In conclusion, we are the first group to report NE expression in bona fide monocytes in 
mice. Classical monocytes in particular express relatively large quantities of NE 
transcript and have also been explicitly shown to store the NE protein in cytoplasmic 
granules. This staining was akin to that seen in neutrophils. Unlike neutrophils which 
display multiple types of subcellular granules, monocytes contain only one. Studies 
have shown that monocytic granules most closely resemble neutrophil azurophil 
granules: they both contain a large number of acid hydrolases and many of the same 
microbicidal proteins, including defensins, lysozyme, and of course NE. The manner in 
which NE is stored and released in these granules is however seemingly different in 
monocytes and neutrophils as FACS-sorting only triggered complete degranulation in 
monocytes. Moreover, mature classical monocytes from the spleen appear to have a 
greater ability to synthesise NE de novo. Non-classical monocytes too seem to express 
the NE gene though to a lesser extent, while its protein content has yet to be rigorously 
assessed. 
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CHAPTER 5: Investigating the functional role of NE in 
monocyte trafficking in vivo. 
 
5.1 Introduction 
While initial studies in NE deficient mice suggest the primary role of NE is in the 
intracellular killing of engulfed bacteria, it has also been implicated in numerous other 
physiological processes. An area of much research, several groups, including ours, have 
reported a functional role for NE in neutrophil transmigration, however this is a 
contentious issue. As touched on in the previous chapter, neutrophils have been shown 
to mobilise NE to the cell surface during transmigration in response to a variety of 
inflammatory mediators. In this state NE facilitates the migration of human neutrophils 
across human umbilical vein endothelial cell (HUVEC) monolayers, as treatment with 
an anti-NE monoclonal antibody reduces PAF-induced migration by 80% (Cepinskas et 
al., 1999). The use of confocal microscopy in this same study revealed migrating 
neutrophils localise their membrane-bound NE to the leading front. Due to its potent 
ability to cleave extracellular matrix proteins, it was originally postulated that surface-
bound NE on invading pseudopodia mediated neutrophil migration through the dense 
endothelial basement membrane (EBM). In support of this, while human neutrophil 
chemokinesis, chemotaxis, and degranulation were unaffected in the presence of an NE-
specific inhibitor, migration through Matrigel, a reconstituted EBM preparation 
extracted from sarcoma cells, was reduced by more than 50% (Delclaux et al., 1996). In 
contrast, although a loss of EBM integrity was observed following the migration of 
human neutrophils across a HUVEC monolayer, this was shown to be NE-independent 
(Huber and Weiss, 1989). Moreover, the migration of fMLP-stimulated human 
neutrophils across pulmonary endothelial cells and associated basal lamina was not 
blocked by broad-acting serine protease inhibitors (Mackarel et al., 1999). 
Considering the non-specific nature of some pharmacological inhibitors and the 
reported resistance of surface-bound NE to endogenous inhibitors, the availability of 
NE-knockout mice has provided a clean and elegant tool for studying the role of NE in 
leukocyte migration, not only in vitro but in vivo. Nevertheless, NE’s involvement in 
leukocyte transmigration remains unclear. Shapiro et al. report a significant defect in 
neutrophil infiltration in the lungs of NE
-/- 
mice exposed to cigarette smoke (Shapiro et 
al., 2003). They also however demonstrate normal chemotaxis and Matrigel invasion of 
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NE
-/-
 neutrophils in vitro and instead attribute their in vivo findings to an inability of 
NE
-/-
 neutrophils to effectively penetrate the vascular endothelium. In this manner, the 
same group also report an impairment of NE
-/- 
neutrophils to cross pulmonary vein and 
microvascular endothelium in vitro compared to WT controls (Kaynar et al., 2008). This 
defect was accompanied by reduced cleavage of the endothelial adhesion molecule 
ICAM-1. ICAM-1 has been demonstrated by other studies to be liable to NE-cleavage, 
as has the closely related VCAM-1 and the major selectin ligand PSGL-1. Shown to 
participate in leukocyte adhesion, the cleavage of these molecules by NE may regulate 
the sequence of attachment/detachment events that mediate leukocyte TEM (Pham, 
2008).  
Contradicting this notion, NE
-/-
 neutrophils do not exhibit a defect in migration across 
cultured murine cardiac endothelial cells (Allport et al., 2002). Furthermore, NE KO 
mice exhibit normal profiles of neutrophil transmigration in vivo to the lung and 
peritoneum challenged with Pseudomonas aeruginosa or its lipopolysaccharide (Hirche 
et al., 2004). Similarly, NE
-/-
 mice mostly display no defects in neutrophil 
transmigration in the cremaster muscle model, though this has been postulated to result 
from the occurrence of developmental compensation as significant reductions in 
transmigration are observed following treatment with the NE-specific small molecule 
inhibitor ONO-5046. Indeed, intravenous administration of ONO-5046 suppressed 
neutrophil migration through IL-1β- and LTB4-stimulated cremasteric venules, 
specifically at the level of the EBM (Wang and Dangerfield, 2005) (Young et al., 2007). 
This is seemingly due to the ability of NE to enlarge regions of low matrix protein 
deposition in the EBM through which neutrophils preferably migrate (Wang et al., 
2006). In keeping with this, ONO-5046 also inhibited neutrophil transmigration through 
laminin-1-coated filters, while a large percentage of transmigrated neutrophils in the 
cremaster muscle were shown to carry laminin fragments on their cell surface (Wang et 
al., 2006) (Voisin et al., 2009).  
Leukocyte firm adhesion and transmigration was also significantly suppressed by ONO-
5046 in the cremaster muscles of mice stimulated with the particulate zymosan (Young 
et al., 2004). Interestingly, this was also observed in NE
-/-
 mice. This phenotype was 
attributed not to an inability to penetrate the EBM of venules but rather to impaired 
zymosan phagocytosis and subsequent generation and/or release of pro-inflammatory 
mediators. Likewise, NE
-/-
 mice showed reduced levels of inflammatory cytokines and 
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infiltrated neutrophils in response to zymosan in an air pouch model (Adkison et al., 
2002). In this same manner, NE has been shown to enhance neutrophil migration by 
inducing the secretion of the cytokines GM-CSF and CXCL8 from primary epithelial 
cells (Bédard et al., 1993) and by generating neutrophil chemotactic fragments through 
cleavage of various matrix proteins including laminin-332 and type XVII collagen 
(Mydel et al., 2008) (Lin et al., 2012). 
As a whole, there is a large amount of evidence to suggest an involvement of NE in 
neutrophil transmigration. Indeed, in accordance with its greater potency in stimulating 
NE release/cell surface expression, LTB4 was found to be more effective in eliciting 
neutrophil transmigration through mouse cremasteric venules compared to KC 
(CXCL1) or PAF (Young et al., 2007). The mechanism by which NE mediates 
neutrophil transmigration is however seemingly heterogeneous and may depend on the 
type/dose of stimulus or model/tissue of inflammation. In addition, NE has been 
implicated in the migration of other leukocyte types, largely through its ability to 
modify the composition of the inflammatory milieu by regulating chemokine and 
cytokine bioavailability and processing protein receptors. The release of NE by 
transmigrating neutrophils for example deactivates endothelial-bound CXCL12 
attenuating subsequent T-lymphocyte migration (Rao et al., 2004). NE-cleaved matrix 
protein fragments also exhibit chemotactic activity for many leukocytes, for instance 
elastin- and fibronectin-derived peptides which have been shown to recruit monocytes 
(Senior et al., 1980).  
In contrast to neutrophils, only a select few studies have explored a direct role for NE in 
the migration of other NE-expressing leukocytes, such as monocytes. In this context, 
ONO-5046 had no effect on CCL2-induced monocyte migration through cremasteric 
venules in vivo or across laminin/collagen IV coated filters in vitro (Voisin et al., 2009). 
In a chronic model of cigarette smoke exposure however, significantly fewer 
macrophages accumulated in the lungs of NE
-/-
 mice compared to wild-type controls 
(Shapiro et al., 2003). This was attributed to a defect in the pulmonary recruitment of 
circulating monocytes as isolated NE
-/-
 blood monocytes demonstrated impaired 
Matrigel penetration in vitro. Considering the minimal and inconsistent data collected 
on this matter, and in light of our recent findings confirming substantial NE expression 
in murine monocytes, in this chapter we aspired to rigorously and specifically 
investigate the function of NE in murine monocyte migration in vivo. We sought to 
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achieve this goal by directly comparing NE
-/-
 and NE
+/+
 mice and exploiting NE-
specific inhibitors. The key objectives we wanted to address are as follows: 
 Broadly assess the involvement of NE in monocyte recruitment in a peritoneal 
model of inflammation. 
 Employ confocal microscopy to investigate the role of NE during monocyte 
transendothelial migration (TEM) in vivo. 
 Assess NE activity and expression during monocyte TEM. 
 Establish an in vitro transmigration assay to elucidate the mechanisms 
underpinning NE-mediated monocyte migration. 
 
  
118 
 
5.2 Results 
a) NE
-/-
 mice exhibit a diminished accumulation of peritoneal classical monocytes in 
a time-and stimulus-dependent manner. 
The use of animal inflammation models has been invaluable in characterising the 
immune response in vivo. One commonly used inflammation model is the peritonitis 
model, which is typically performed on mice or rats. Peritonitis is described as 
inflammation of the peritoneal cavity, the gap that exists between the wall of the 
abdomen and the organs contained within. The cavity is bound by a thin serous 
membrane called the peritoneum. This membrane is locally breached upon an 
intraperitoneal (i.p.) injection, which is used to administer an inflammatory stimulus 
into the peritoneal cavity. This prompts a local influx of leukocytes and plasma proteins, 
primarily through post-capillary venules in the milky spots of the greater omentum, and 
synthesis of inflammatory mediators, the hallmarks of inflammation (Doherty et al., 
1995). The main advantage of this model is the large volume of the peritoneal cavity, 
which accumulates a great amount of inflammatory exudate that can be easily collected 
for downstream analysis. In this context, a common use of the peritonitis model is to 
quantitate leukocyte recruitment by obtaining peritoneal lavage and determining the 
total number of infiltrated cells. Furthermore, the presence of specific cell types can be 
elucidated, often by flow cytometry. This approach also enables the phenotype of 
transmigrated leukocytes to be directly compared to their counterparts in the blood.  
Exploiting the peritonitis model in this manner, we broadly investigated the functional 
role of NE in monocyte trafficking in vivo. This was specifically achieved by comparing 
the inflammatory profiles of NE
+/+
 and NE
-/-
 mice in response to acute peritonitis. As an 
initial inciting stimulus, we injected mice i.p. with 300 ng/ml IFN-γ for 16 hours 
followed by 300 ng/ml TNF-α for a further 4 hours. This reaction was used as it has 
been previously demonstrated by our lab to elicit a strong monocyte response in the 
cremaster muscle (Appendix 5.1). In characterising this reaction in the peritoneal cavity, 
leukocyte infiltrations were first evaluated by calculating the total number of peritoneal 
cells present in the collected lavage fluid (Figure 5.1A). The peritoneal cell counts of 
NE
+/+
 and NE
-/-
 mice were largely identical, suggesting NE KO mice exhibit no 
overwhelming defect in leukocyte recruitment. Interestingly, there were also no 
differences in the number of peritoneal cells when compared to PBS controls, though 
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this did enable the proportion of leukocyte subtypes to be directly compared across all 
samples during subsequent flow cytometric analysis. Specifically, relative levels of the 
two major monocyte subsets, neutrophils and macrophages were identified and gated, as 
before (Figure 5.1B). As in the cremaster muscle, IFN-γ/TNF-α abundantly recruited 
monocytes to the peritoneal cavity, specifically those of the classical subset, their 
relative peritoneal fraction increasing from ~1.5% in control mice to more than 10% 
following treatment with IFN-γ/TNF-α. Levels of non-classical monocytes appeared to 
be slightly down-regulated but remained at 5-10%, while macrophages seemingly 
vacated the cavity (explaining the comparable cell counts in PBS controls), their 
numbers dropping from 25% to under 10%. Of note, both monocyte subsets and 
macrophages were equally represented upon stimulation in NE
+/+
 and NE
-/-
 mice. In 
contrast, levels of neutrophils, though substantially up-regulated for both genotypes, 
were significantly less abundant in the cavities of NE
-/-
 mice.  
Flow cytometry was also used to analyse the proportion of leukocyte subtypes in the 
blood, as this represents the most immediate source of leukocytes available for 
transmigration (Figure 5.1C). Discrepancies in the blood profile of NE
-/-
 mice may 
suggest a defect either in the migratory capacity of circulating leukocytes or in the 
deployment of secondary leukocyte stores, such as the bone marrow and spleen, into the 
blood. In accordance with the pronounced increase in peritoneal neutrophils, stimulation 
with IFN-γ/TNF-α also induced blood neutrophilia in both NE+/+ and NE-/- mice. Levels 
of circulating monocytes were not however significantly different to one another or PBS 
controls. Thus, following IFN-γ/TNF-α–induced peritonitis no differences were 
observed in the proportion of either monocyte subset in the peritoneal lavage or blood 
of NE
-/-
 mice compared to WT controls.   
Stimulation with IFN-γ/TNF-α elicited a strong influx of both neutrophils and 
monocytes. Considering neutrophils are known to directly stimulate the mobilisation of 
monocytes during inflammation (Soehnlein and Lindbom, 2010) we next sought to 
assess monocyte recruitment to the peritoneal cavity in response to CCL2, a monocyte 
specific chemoattractant. Classical monocytes in particular respond to CCL2 as they 
abundantly express its cognate receptor CCR2 (see Table 3.2). To more rigorously 
characterise CCL2-induced peritonitis, we analysed peritoneal lavage and blood 
samples at both 4 and 16 hours post stimulation. No significant differences were 
observed in the overall number of peritoneal cells between NE
+/+
 and NE
-/-
 mice at 
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either time point (Figure 5.2A). Analysing the individual leukocyte subtypes, 
neutrophils were not recruited in response to CCL2 (Figure 5.2B). Levels of non-
classical monocytes too were largely unchanged compared to PBS controls but the 
proportion of classical monocytes increased significantly at 4 hours in both genotypes 
from less than 1% to more than 4%. This change was however more modest in NE
-/-
 
mice and by 16 hours these mice contained significantly fewer classical monocytes in 
their cavities compared to their WT equivalents. In contrast, the proportion of peritoneal 
macrophages was significantly reduced in NE
-/-
 mice at the earlier time point of 4 hours, 
but increased after 16 hours to a level comparable to that of WT mice. Importantly, this 
change in the proportion of macrophages does not account for the concurrent change in 
monocytes, and vice versa, as the same trends are observed upon plotting total cell 
numbers (Figure 5.2D). While NE
-/-
 and NE
+/+
 mice display different monocyte and 
macrophage profiles in the peritoneal lavage, relative levels of circulating monocytes 
were largely conserved in response to CCL2 (Figure 5.2C). Classical monocytosis was 
similarly observed 4 hours post stimulation, though returned to baseline levels after 16 
hours. Surprisingly, this was also observed in PBS-treated mice. Levels of circulating 
non-classical monocytes and neutrophils remained largely stable throughout the 
reaction.  
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Figure 5.1: Characterisation of peritoneal and blood leukocytes following IFN-γ/ TNF-α-
induced peritonitis. NE
+/+
 and NE
-/-
 CX3CR1
+/eGFP
 mice were stimulated i.p. with IFN-γ (300 
ng/ml) for 16 hours and TNF-α (300 ng/ml) for a further 4 hours (total test period of 20 hours). 
Total leukocytes were subsequently harvested from the blood and peritoneal cavity. Peritoneal 
cell counts were initially calculated using a haemocytometer (A). Flow cytometry was 
subsequently employed to assess the relative proportion of classical monocytes (GR-1
+
, 
CX3CR1
med
), non-classical monocytes (GR-1
–
, CX3CR1
hi
), neutrophils (GR-1
+
, CX3CR1
–
) and 
macrophages (CX3CR1
low
, GR-1
low
, SSC
hi
) in both the peritoneal cavity (B) and blood (C).  
Control mice were injected i.p. with PBS only. All data are represented as the mean ± SEM (n = 
3-4 mice). FACS-data are averaged across 2-3 readings per mouse. Statistically significant 
differences between NE WT and KO data are indicated by asterisks (**, p < 0.01, Student’s T-
test). 
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b) NE
-/-
 classical monocytes express normal levels of CD62L and CD18. 
Looking more closely at the peritoneal counts following CCL2 stimulation, total 
numbers of classical monocytes decreased between 4 and 16 hours in both NE
-/-
 and 
NE
+/+
 mice implying they do not simply accumulate in the cavity upon recruitment. The 
fate of these cells however remains currently unclear. It is possible they undergo 
apoptosis and hence become excluded from flow cytometric analysis. Alternatively, 
they may lose their typical gating phenotype by differentiating into macrophages or 
might even emigrate from the cavity via the draining lymphatics. Irrespective of how 
these cells are depleted, there remains a significant difference in the number of bona 
fide classical monocytes in the peritoneal cavities of NE
-/-
 mice compared to WT mice 
at 16 hours post CCL2 stimulation. Though it is conceivable that classical monocytes 
are more comprehensively ‘lost’ from the peritoneum of NE-/- mice, it is equally 
plausible that fewer monocytes are actively recruited. Indeed, proteases have been 
previously implicated in influencing leukocyte dynamics during peritonitis. Upon 
thioglycollate stimulation for example, mice deficient for the protease ADAM-17 
displayed a 2-fold increase in the number of infiltrated neutrophils at 4 hours but a 
reduction at 12 hours compared to WT controls, as attributed to changes in leukocyte 
surface expression of L-selectin (Tang et al., 2011). NE itself has also been directly 
proposed to regulate phasic neutrophil recruitment in response to zymosan, though in 
the cremaster muscle (Young et al., 2004). Although the precise involvement of NE in 
this reaction was not clarified, it was proposed that early recruited neutrophils induce 
the release of endogenous inflammatory mediators in an NE-dependent manner, 
initiating a secondary phase of leukocyte migration.  
Figure 5.2: Characterisation of peritoneal and blood leukocytes following CCL2-induced 
peritonitis. NE
+/+
 and NE
-/-
 CX3CR1
+/eGFP
 mice were stimulated i.p. with CCL2 (500 ng/ml) for 
4 or 16 hours. Total leukocytes were subsequently harvested from the blood and peritoneal 
cavity. Peritoneal cell counts were initially calculated using a haemocytometer (A). Flow 
cytometry was subsequently employed to assess the relative proportion of classical monocytes 
(GR-1
+
, CX3CR1
med
), non-classical monocytes (GR-1
–
, CX3CR1
hi
), neutrophils (GR-1
+
, 
CX3CR1
–
) and macrophages (CX3CR1
low
, GR-1
low
, SSC
hi
) in both the peritoneal cavity (B) and 
blood (C). Total numbers of peritoneal classical monocytes and macrophages were also 
calculated (D). Control mice were injected i.p. with PBS only. All data are represented as the 
mean ± SEM (n = 3-4 mice). FACS-data are averaged across 2-3 readings per mouse. 
Statistically significant differences between NE WT and KO data are indicated by asterisks (*, p 
< 0.05, Student’s T-test). 
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With these two studies in mind, we compared levels of L-selectin on classical 
monocytes both in the blood and lavage of NE
-/-
 and NE
+/+
 mice. We also looked at 
levels of β2 (CD18) integrins as these have been shown to mediate leukocyte migration 
and interact directly with NE (Cai and Wright, 1996). Neither L-selectin nor CD18 
showed significantly different expression levels across the two genotypes (Figure 5.3). 
There was however a collective and well characterised decrease in CD62L levels 
following monocyte transmigration, as well as an increasing trend in CD18 expression 
over time, in keeping with previous reports (Al-Numani et al., 2003). Next, to explore 
NE as a potential stimulator of endogenous cytokine production, we injected 
catalytically active recombinant NE into the peritoneal cavity of WT mice for 4 hours. 
This did not however elicit an enhanced monocyte or leukocyte response when 
compared to PBS controls (data not shown).   
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c) NE
-/-
 mice exhibit a defect in TEM in a tissue-dependent manner. 
As a means of exploring the involvement of NE in monocyte migration in greater detail, 
immunofluorescent labelling and confocal microscopy were subsequently employed to 
study monocyte infiltration in the mouse cremaster muscle. This approach enables 
monocyte extravasation to be directly visualised and its underlying mechanisms 
characterised, including how and where the monocytes interact with the vasculature. In 
Figure 5.3: Characterisation of CD62L and CD18 expression on classical monocytes 
following CCL2-induced peritonitis. NE
+/+
 and NE
-/-
 CX3CR1
+/eGFP
 mice were stimulated i.p. 
with CCL2 (500 ng/ml) for 4 or 16 hours, after which total leukocytes were harvested from the 
blood and peritoneal cavity and subjected to ACK-lysis. Relative surface expression levels of L-
selectin (A) and CD18 (B) were subsequently assessed on classical monocytes by flow 
cytometry. Data are represented as the mean ± SEM (n = 3-4 mice, one FACS reading per 
mouse).  
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line with the previous peritonitis data, we initially stimulated the cremaster muscles of 
NE
-/-
 and NE
+/+
 mice with CCL2 for 16 hours, after which the tissues were collected, 
fixed, immunostained and imaged. At this time point however almost no eGFP+ 
monocytes could be seen either within the vasculature or interstitial space (data not 
shown). Presuming the inflammatory response had already resolved, a shorter time 
point of 4 hours was next explored. Indeed, monocytes were abundantly present in both 
NE
-/-
 and NE
+/+
 tissues and could be seen migrating predominantly through medium-
sized post-capillary venules (20-50 μm in diameter). In contrast, and akin to CCL2-
induced peritonitis, neutrophils were not actively recruited. 
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To generally characterise monocyte infiltration into the cremaster muscle, 5-6 distinct 
sections of post-capillary venules were imaged per collected tissue. Individual 
monocytes were subsequently counted and categorised as residing within the lumen of 
the vessel (luminal), attached to the outer periphery of the vessel wall (abluminal-
attached), or residing in the interstitial space surrounding the vessel (abluminal-
detached) (Figure 5.4A). After 4 hours of CCL2 stimulation, no differences were 
observed regarding the total numbers of monocytes or their localisation in the cremaster 
muscles of NE
-/-
 and NE
+/+
 mice. This is in correlation with the peritonitis data which 
also showed no significant differences at 4 hours. To investigate a later time point, the 
cremasters were stimulated with CCL2 for 8 hours. This too did not yield a reduced or 
altered monocyte response in NE
-/-
 mice (Figure 5.4B-C). The total monocyte response 
was however generally reduced compared to that at 4 hours and, considering the 
negligible response at 16 hours, suggests CCL2-stimulated monocytes are recruited to 
the cremaster in one early wave after which the response begins to resolve.    
As genetic compensation has been previously reported in the cremaster muscle of NE
-/-
 
mice, we next determined whether monocyte migration was defective in NE WT mice 
Figure 5.4: Characterisation of CCL2-induced monocyte transmigration in the cremaster 
muscle. NE
+/+
 and NE
-/-
 CX3CR1
+/eGFP
 mice were stimulated i.s. with CCL2 (500 ng) for 4 or 8 
hours, after which the cremaster muscles were harvested, fixed in PFA and immunostained for 
α-SMA (red) and MRP-14 (neutrophils (N), blue). Segments of post-capillary venules were 
subsequently analysed by confocal microscopy and reconstructed into virtual 3D models using 
Imaris software (A). Total monocytes (shown in green) were counted for each venule (B) and 
categorised as residing within the lumen of the vessel (L) or in the abluminal space, either 
attached to (AA) or detached from (AD) the venular wall (C). Data are represented as the mean 
± SEM (n = 2-6 mice, average of 5-6 venules per cremaster). Scale bar, 80 µm. 
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treated with an NE inhibitor. GW311616A is a potent and specific intracellular NE 
inhibitor that is orally administered to mice and provides long-term inhibition of NE 
activity by covalently binding to the enzyme (Macdonald et al., 2001). This inhibitor 
has been previously used by our group to inhibit NE-mediated lung damage (data not 
published). Consistent with this study, we administered NE WT mice with the inhibitor 
or a vehicle control 24 hours prior to stimulating the cremaster with CCL2 for 4 hours, 
as before. Upon analysis, no distinct phenotype was noted for the NE-inhibited mice 
(Figure 5.5). Taken together with the data collected using the NE
-/-
 mice, it appears NE 
is not required for the migration of monocytes through CCL2-stimulated cremasteric 
venules.   
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Figure 5.5: NE blockade does not influence CCL2-induced monocyte transmigration in 
the cremaster muscle. NE
+/+
 CX3CR1
+/eGFP
 mice were orally administered the NE-inhibitor 
GW311616A (2 mg/kg) or vehicle (H2O) 24 hours prior to undergoing i.s. stimulation with 
CCL2 (500 ng) for 4 hours. The cremaster muscles were subsequently harvested, fixed, 
immunostained, and analysed by confocal microscopy. Total numbers of recruited monocytes 
(A) and their localisation within the tissue (B) were directly compared between the two groups. 
Data are represented as the mean ± SEM (n = 2-3 mice, average of 5-6 venules per cremaster). 
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Figure 5.6: Characterisation of CCL2-induced monocyte transmigration in the ear 
dermis. NE
+/+
 and NE
-/-
 CX3CR1
+/eGFP
 mice were stimulated i.d. with CCL2 (1 µg, 
supplemented with Alexa Fluor 555–labelled mAb to PECAM-1) for 4 hours, after which the 
whole ears were harvested, the dorsal skin carefully separated and fixed in PFA. Segments of 
post-capillary venules were subsequently analysed by confocal microscopy and reconstructed 
into virtual 3D models using Imaris software (A). Total monocytes (shown in green) were 
counted for each venule (B) and categorised as residing within the lumen of the vessel or in the 
abluminal space, either attached to or detached from the venular wall (C). Data are represented 
as the mean ± SEM (n = 3-5 mice, average of 5-6 venules per ear). Scale bar, 40 µm. 
Statistically significant differences between NE WT and KO data are indicated by asterisks (*, p 
< 0.05, **, p < 0.01,  Student’s T-test). 
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Considering the inconsistent findings relating to the role of NE in the transmigration of 
neutrophils, specifically regarding its alleged tissue specificity, we next decided to 
assess monocyte TEM in NE
-/-
 and NE
+/+
 mice using a separate model of inflammation 
in the ear. CCL2 again was used as an inflammatory stimulus for 4 hours, the time-point 
at which we observed the greatest influx of monocytes (Appendix 5.2). As a means of 
limiting the accelerated photobleaching of eGFP observed in monocytes in the ear, a 
fluorescently-conjugated anti-PECAM-1 antibody was injected concurrently with the 
stimulus, staining the vascular endothelium in vivo. This enabled the ears to be 
immediately fixed and analysed by confocal microscopy upon harvesting. Importantly 
this clone of antibody does not affect leukocyte dynamics during TEM (Woodfin et al., 
2011). As in the cremaster muscle, monocytes were recruited to post-capillary venules 
in the ear dermis to a similar extent in NE
-/-
 and NE
+/+
 mice (Figure 5.6). In contrast to 
before however, there was a clear difference in the localisation of monocytes within the 
inflamed ear, with NE
-/-
 mice exhibiting significantly fewer abluminal monocytes, both 
attached to the outer venular wall and residing freely in the interstitial space. Instead, 
the majority of monocytes in these mice were confined to the venular lumen. These 
cells were largely spherical in morphology and appeared to have adhered to but not 
spread on the endothelium. Taken together, in the absence of NE it would appear that 
monocytes exhibit an early-stage defect in TEM through CCL2-stimulated post-
capillary venules in the ear.  
 
d) Monocytes release NE during the early steps of TEM in vivo. 
To further understand the involvement of NE in monocyte TEM, we attempted to assay 
for NE activity in vivo using Neutrophil Elastase 680 FAST™. Comprising two 
fluorochromes adjoined by an NE-selective protein sequence, NE 680 FAST is optically 
silent in its native state but generates an intense fluorescent signal upon cleavage by NE. 
Assuming the catalytic activity of NE is a decisive factor, this approach should provide 
an indication of how NE mediates monocyte TEM, including the type and location of 
cells in which NE is most active. Prior to employing NE 680 FAST in this manner in 
vivo, we initially sought to verify its ability to be activated intracellularly and in an NE-
specific fashion in vitro. This was achieved by seeding whole blood leukocytes from 
NE
-/-
 and NE
+/+
 mice onto cover slips. CX3CR1
+/eGFP
 mice were used in order to identify 
monocytes. The cells were subsequently fixed in PFA (half were also permeabilised 
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with Triton X-100) and incubated with NE 680 FAST. Upon confocal analysis, NE 
activity was detected irrespective of permeabilisation, though, regrettably, also 
irrespective of NE expression. Indeed, NE
-/-
 blood leukocytes, including monocytes, 
produced an NE signal of equal intensity compared to WT controls (Figure 5.7). 
Recognising NE 680 FAST is designed to be used primarily in vivo, we next assessed 
its specificity in both an ear and cremaster model of inflammation. NE
-/-
 and NE
+/+
 mice 
were administered NE 680 FAST intravenously prior to inducing inflammation with 
either CCL2 or LTB4, a potent stimulator of neutrophil chemotaxis and NE 
degranulation. The tissues were harvested after 4 hours, fixed in PFA and analysed by 
confocal microscopy. As before however, NE activity could be observed for NE
+/+
 and 
NE
-/-
 mice alike, both in the cremaster muscle and ear, and in response to CCL2 and 
LTB4 (Figure 5.8 and Appendix 5.3). This activity, while not NE-specific, did emanate 
from small, spherical cell-like structures. Interestingly however these cells were not 
monocytes nor were they neutrophils as confirmed by analysing NE 680 FAST activity 
in LysM-eGFP-ki mice (Appendix 5.4). 
 
 
 
 
 
Figure 5.7: Characterisation of NE 680 FAST activity in vitro. Whole blood leukocytes 
harvested from NE
-/-
 and NE
+/+
 mice were ACK-lysed, seeded onto poly-L-lysine–coated cover 
slips and fixed in PFA. The cells were subsequently incubated in 250 µl PBS containing 
Neutrophil Elastase 680 FAST (1 µM) for 2 hours at 4°C. NE activity (blue) was determined by 
measuring the fluorescence intensity between 640-700 nm following excitation at 633 nm. 
Monocytes are shown in green. Scale bar, 15 µm.  
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Rather than directly assaying for NE activity, as an indication of NE’s involvement in 
monocyte TEM we next determined whether there was a depletion of intracellular NE 
stores in monocytes during inflammation. Though we were unable to stimulate NE 
release from monocytes in vitro in the previous chapter, in recognition of the relative 
Figure 5.8: Assaying for NE activity in CX3CR1-eGFP-ki mice in situ. NE
+/+
 and NE
-/-
 
CX3CR1
+/eGFP
 mice were administered Neutrophil Elastase 680 FAST (4 nmols in 200 µl PBS) 
i.v. immediately prior to administering CCL2 (1 µg, supplemented with Alexa Fluor 555–
labelled mAb to PECAM-1, red) i.d. for 4 hours. Whole ears were subsequently harvested, the 
dorsal skin carefully separated and fixed in PFA. Segments of post-capillary venules were 
analysed by confocal microscopy and reconstructed into virtual 3D models using Imaris 
software. NE activity (blue) was determined by measuring the fluorescence intensity between 
640-700 nm following excitation at 633 nm. Monocytes are shown in green. Scale bar, 30 µm. 
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simplicity of these studies, we next endeavoured to measure NE release from monocytes 
undergoing extravasation in situ in the ear. This was achieved by immunostaining post-
stimulated tissues for NE. As a means of optimising this process we initially stained for 
NE in LTB4-stimulated ears of NE
+/+
 and NE
-/-
 mice. Using methanol as a joint 
fixative/permeabilising agent, we were unable to detect NE in WT neutrophils (data not 
shown). In contrast, and in reverse to staining for NE in vitro, the protein could be 
detected when using PFA as a fixative and Triton X-100 as a permeabilising agent. 
Indeed, intracellular NE was observed in NE
+/+
 neutrophils only, located both within the 
vasculature and in the interstitial space, corroborating previous reports that only a small 
fraction of NE is freely released by neutrophils during TEM (Figure 5.9) (Owen et al., 
1995). In contrast, the infiltrating monocytes were not strongly labelled for NE. 
Intrigued by this observation, we were keen to next evaluate NE expression in 
monocytes in response to CCL2. As an internal positive control we stained once more 
for neutrophils, which, while unresponsive to CCL2, are generally observed in small 
numbers in the lumen of post-capillary venules upon i.d. injection. As seen with LTB4, 
upon CCL2 stimulation the majority of monocytes were depleted of their NE stores. 
This was seen not only for transmigrated monocytes in the interstitial space but for 
monocytes residing within the lumen of post-capillary venules (Figure 5.10). These 
findings are in accordance with the observed accumulation of luminal monocytes in the 
ears of NE
-/-
 mice and strongly suggest NE is released and functionally required by 
monocytes early on during TEM.  
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Figure 5.9: Assaying for NE expression in CX3CR1-eGFP-ki mice in situ. Ears of NE
+/+
 and 
NE
-/-
 CX3CR1
+/eGFP
 mice were stimulated with LTB4 (300 ng) i.d. for 4 hours. Whole ears were 
subsequently harvested, the dorsal skin carefully separated and fixed in PFA and 
immunolabelled for NE (blue), α-SMA (vasculature, red) and MRP-14 (neutrophils, red). 
Monocytes are shown in green. Segments of post-capillary venules were analysed by confocal 
microscopy and reconstructed into virtual 3D models using Imaris software. Scale bar, 20 µm. 
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e) Inhibiting NE abates the transmigration of human U937 monocytes in vitro.    
Recognising that all of the preceding experiments have been conducted on constitutive 
KO mice for NE, to confirm monocyte TEM is mediated specifically by their own NE 
stores, we sought to establish an in vitro Transwell migration assay using pure 
populations of monocytes (Figure 5.11A). Specifically, we wanted to compare the 
ability of MACS-sorted NE
+/+
 and NE
-/-
 splenic monocytes to migrate across a confluent 
layer of murine skin endothelial cells (sENDs), purposely selected to more closely 
resemble the vasculature in the ear dermis. To optimise this assay, we initially 
characterised the transmigration of whole blood leukocytes towards foetal bovine serum 
(FBS), a rich and varied source of chemoattractants. Using this approach, after 4 hours, 
significant numbers of leukocytes could be seen traversing uncoated Transwell inserts 
with an 8 μm, but not a 3 μm, pore size. After growing a layer of sENDs on top of the 
membrane, transmigration was predictably delayed with significant numbers of cells 
accumulating at the bottom of the chamber after 16 hours (data not shown). This being 
established, we repeated the assay using MACS-sorted splenic classical monocytes. 
Considering the low number of cells yielded by this process, several spleen samples 
were pooled together. In keeping with our in vivo data, NE
-/-
 monocytes demonstrated a 
trend towards reduced migration compared to WT controls (Figure 5.11B).  
Though ideally wanting to replicate the Transwell assay using CCL2, as used 
throughout this study, the necessary expenditure with regards to both mice and reagents 
would have been too great. To circumvent this issue we decided to develop the 
Transwell assay not with primary cells but with a model cell line. Specifically, we 
employed the human monocyte-like U937 cell line, which is known to express NE 
(Appendix 5.5) and has been routinely studied to explore its biological properties in 
Figure 5.10: Characterisation of NE expression during CCL2-induced monocyte 
transmigration in the ear dermis. Ears of NE
+/+
 CX3CR1
+/eGFP
 mice were stimulated with 
CCL2 (1 µg, supplemented with Alexa Fluor 555–labelled mAb to PECAM-1, dashed line) i.d. 
for 4 hours. Whole ears were subsequently harvested, the dorsal skin carefully separated and 
fixed in PFA and immunolabelled for NE (blue) and MRP-14 (neutrophils, red). Segments of 
post-capillary venules were analysed by confocal microscopy and reconstructed into virtual 3D 
models using Imaris software (A). NE expression was quantified in monocytes (green) residing 
within the vessel lumen (L) or in the abluminal space, either attached to (AA) or detached from 
(AD) the venular wall, as measured relative to the average intensity of NE expression in luminal 
neutrophils (set to 100%) (B). Data are pooled from 3 separate mice. Statistically significant 
differences are indicated by asterisks (***, p < 0.0001, Student’s T-test). Scale bar, 5 µm. 
 
141 
 
vitro. For conformity, we also swapped the murine sENDs with human umbilical vein 
endothelial cells (HUVECs). No longer able to exploit the NE KO mice, in order to 
investigate the role of NE in monocyte migration we made use of the NE-specific 
inhibitor ONO-5046. U937 cells were pre-treated with ONO-5046 or a vehicle control 
before being added on top of a confluent layer of TNF-α–activated HUVECs. Using 
CCL2 as a chemoattractant, we observed a significant reduction in the number of 
infiltrating monocytes after 4 hours when NE was inhibited (Figure 5.11C). This 
strongly suggests that monocytes utilise their own NE stores during TEM. 
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Figure 5.11: Transwell cell migration assay. Monocyte migration was assessed in vitro in 24-
well plates through an endothelial cell monolayer (A). The migratory potential of 1.5×10
5
 NE
+/+
 
and NE
-/-
 MACS-sorted splenic monocytes through murine skin endothelial cells (sENDs) was 
initially compared after 16 hours in response to 10% FBS (B, blue). We subsequently compared 
the migratory potential of 5×10
5
 human U937 cells pre-treated either with the NE-inhibitor 
ONO-5046 (50 µM) or vehicle (PBS) through human umbilical vein endothelial cells 
(HUVECs) after 4 hours in response to human CCL2 (10 nM) (C, red). The total number of 
migrated cells per well was calculated as the sum of cells counted in the lower Transwell 
chamber in three random fields of view (at ×4 zoom). Data are represented as the mean ± SEM 
(n = 1-3 mice, averaged across triplicate wells). 
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5.3 Discussion  
Having established in the previous chapter that murine monocytes express neutrophil 
elastase, we were keen to next describe its functional relevance. In this regard, we were 
specifically interested in exploring a potential role for NE in monocyte transmigration. 
NE has already been strongly implicated in neutrophil trafficking and while murine NE 
has been proposed to support pulmonary monocyte recruitment during emphysema 
these findings have not since been corroborated or expanded upon (Shapiro et al., 
2003). In this chapter we endeavoured to comprehensively evaluate NE’s involvement 
in monocyte migration in vivo by stimulating, quantifying, and directly visualising 
monocyte recruitment in NE deficient and WT mice. 
A relatively simple model of inflammation, we initially characterised monocyte 
infiltration into the peritoneal cavity during peritonitis. The mice were originally 
stimulated with IFN-γ and TNF-α for a total of 20 hours, a reaction our group has 
previously used to elicit monocyte infiltration into the cremaster muscle. Indeed, the 
number of peritoneal monocytes significantly increased as compared to PBS controls in 
both NE
-/-
 and NE
+/+
 mice. Primarily classical monocytes were recruited, in keeping 
with their pro-inflammatory description. In addition, both genotypes displayed an even 
greater influx of neutrophils. Interestingly, while peritoneal monocytes were evenly 
represented, neutrophil recruitment was significantly reduced in NE
-/-
 mice, which, 
though not unexpected, has not been previously demonstrated in response to IFN-γ and 
TNF-α. Under these same conditions, while NE might simply not be functionally 
required for infiltrating monocytes, it is also possible that any defects in monocyte 
recruitment in NE
-/-
 mice are compensated for by the concurrent recruitment of 
neutrophils, albeit in an NE-independent manner and irrespective of their own reduced 
migration. Certainly, neutrophils are known to pave the way for classical monocytes 
during inflammation. The neutrophil secretion products azurocidin, LL-37, and 
cathepsin G for example directly promote monocyte extravasation by activating formyl 
peptide receptors. Moreover, neutrophil-derived cytokines promote monocyte-
endothelial interactions by inducing endothelial expression of CCL2 and VCAM-1 
(Soehnlein and Lindbom, 2010). 
In this regard, though we could have employed neutrophil-depleting antibodies, in order 
to obtain a more specific model of monocyte infiltration we induced peritonitis with the 
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potent classical monocyte chemoattractant CCL2. While CCL2 has also been shown to 
mediate the migration of dendritic cells and T-lymphocytes, it does not typically attract 
neutrophils, as verified by our results. Using this approach, we observed a decreasing 
trend in the proportion and number of peritoneal classical monocytes in NE
-/-
 mice at 4 
hours compared to WT mice, which became significantly different by 16 hours. This 
reduction might be explained in several ways. It was evident in both genotypes that 
upon being recruited, the classical monocytes were not simply accumulating in the 
cavity as their total peritoneal numbers actually fell over the course of CCL2 
stimulation. With this in mind, and considering the more marginal difference seen in 
monocyte levels at the earlier time point, it is possible that NE
-/-
 monocytes undergo 
largely normal recruitment but are then ‘lost’ from the cavity at a greater rate compared 
to their WT equivalents. This was difficult to assess however as the mechanism by 
which this might occur is unclear. Highly plastic cells, it is possible that upon 
recruitment the monocytes quickly differentiated into macrophages. Indeed, in a model 
of thioglycollate-induced peritonitis, early recruited monocytes were shown to have 
differentiated into macrophage-like cells by 24 hours (Henderson et al., 2003). Such 
differentiation has been shown to be accompanied by a loss of GR-1 expression, which 
would explain why these cells no longer befit the GR-1
int
, CX3CR1
int
 phenotype of bona 
fide classical monocytes (Martin et al., 2011). Though peritoneal macrophages also 
typically express low surface levels of CX3CR1, in a previous study using CX3CR1-
eGFP-ki mice, monocyte-derived peritoneal macrophages were shown to retain high 
eGFP-fluorescence for several days (Jung et al., 2000). Taken together, freshly 
differentiated macrophages are likely to assume a phenotype akin to non-classical 
monocytes, however no obvious differences were observed in the proportion of these 
cells between NE
-/-
 and NE
+/+
 mice.  
We also considered that the apparent depletion of monocytes from the peritoneum was 
attributable to the cells either undergoing cell death or rapidly draining from the cavity 
via the lymphatics. In recognition of the relatively low number of classical monocytes 
initially recruited to the cavity however, delineating the fate of these cells would have 
been extremely onerous. In this light, we focused instead on establishing whether the 
observed reduction in peritoneal monocytes in NE
-/-
 mice in response to CCL2 was as 
result of a defect in monocyte recruitment. As a means of more directly investigating a 
potential role for NE during monocyte transendothelial migration, we employed 
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confocal microscopy to analyse infiltrating monocytes in the cremaster muscle. The 
high resolution afforded by this approach enables the interactions of monocytes and 
endothelial cells to be clearly visualised as the different stages of TEM are undertaken. 
To complement our peritonitis data, we used CCL2 as an inflammatory stimulus and 
compared monocyte emigration from cremasteric venules in NE
-/-
 and WT mice after 4 
and 16 hours. Supporting our previous results, no significant differences were seen in 
the number or vascular localisation of monocytes after 4 hours, with the majority of 
cells appearing to have successfully completed transendothelial migration. Interestingly, 
and in contrast to CCL2-induced peritonitis, inflammation in the cremaster muscle was 
seemingly already resolved by 16 hours as the tissues were almost entirely depleted of 
monocytes. Accordingly, a shorter time point of 8 hours was explored. Whilst 
monocytes were observed in the tissue, they were less plentiful than at 4 hours 
suggesting CCL2 recruits monocytes into the cremaster muscle in a single wave. 
Moreover, no differences were seen between NE
-/-
 and WT mice at this time point.  
It is conceivable that this lack of phenotype in NE
-/-
 mice is attributed to genetic 
compensation, a phenomenon that has been previously described in the cremaster 
muscles of these mice with regards to neutrophil infiltration (Young et al., 2007). To 
explore this possibility we disrupted NE activity pharmacologically, rather than 
genetically, by administering an NE inhibitor 24 hours prior to CCL2 stimulation, 
however this too did not yield any differences in monocyte recruitment when compared 
to vehicle-treated controls. It should be noted however that in the aforementioned study 
NE activity was blocked by continuous intravenous infusion of the NE-inhibitor ONO-
5046. Our study instead employed the distinct NE-inhibitor GW311616A, which, owing 
to its greater efficacy and longer half-life in vivo, reportedly only requires a single orally 
administered bolus to rapidly inhibit circulating NE activity by more than 90% and for 
up to 4 days (Macdonald et al., 2001). Certainly, using this approach our group has been 
successful in blocking NE-mediated tissue damage in the lung (data unpublished). In 
this light, and considering the apparent normal phenotype of NE
-/-
 mice, it appears NE is 
not functionally required for the migration of monocytes through CCL2-stimulated 
cremasteric venules in vivo.   
While the basic principles of the leukocyte adhesion cascade are thought to be largely 
conserved during inflammation, it is emerging that important variations exist with 
regards to the specific mechanisms that govern this process both in different tissues and 
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in response to different inflammatory stimuli. For example, it was found that mice 
deficient for intercellular adhesion molecule (ICAM)-2 demonstrate a defect in 
neutrophil recruitment to the peritoneal cavity in response to IL-1β but not TNF-α or 
thioglycollate (Huang et al., 2006). This same study also reports that blocking ICAM-2 
in PECAM-1-deficient mice inhibits IL-1β induced neutrophil migration in the 
peritonitis model, but not in the cremaster muscle. Discrepancies in leukocyte 
transmigration into the peritoneum and cremaster muscle have been similarly observed 
elsewhere, for example in mice deficient for leukocyte-specific protein 1, which, while 
demonstrating a profound inhibition in IL-1β-induced leukocyte transmigration in the 
cremaster muscle actually accumulated an increased number of leukocytes in the 
peritoneal cavity (Liu et al., 2005).  
Tissue-specificity could also be a decisive factor in this study with NE seemingly 
mediating monocyte migration to the peritoneum but not the cremaster muscle. As a 
result, we decided to continue investigating a role for NE in monocyte TEM using a 
separate model of inflammation in the ear dermis. Using CCL2 once more as a 
monocyte chemoattractant, after 4 hours we observed a significant reduction in the 
number of transmigrated monocytes in NE
-/- 
mice. The overall number of infiltrating 
monocytes was however only marginally lower compared to NE
+/+
 mice, accounted for 
by the accumulation of NE
-/-
 monocytes inside the lumen of post-capillary venules. This 
suggests NE
-/-
 monocytes exhibit normal chemotactic potential but are compromised, 
not in their ability to arrest on the endothelium, but in their ability to commit to 
transendothelial migration. In support of this, in immunostaining for NE in WT ears, 
almost all infiltrating monocytes, including those situated within the endothelial lining, 
were shown to be depleted of their intracellular NE stores. Taken together, we 
hypothesise that during inflammation in the ear NE is released by luminal monocytes 
and is functionally required to initiate monocyte TEM.   
Collectively, our results implicate NE in the migration of monocytes in response to 
CCL2 in the peritoneum and ear but not the cremaster muscle. These discrepancies, in 
addition to highlighting the great diversity in leukocyte recruitment, may also provide 
an indication of the mechanism by which NE mediates monocyte transmigration. 
Ultimately the peritoneum, ear and cremaster represent three separate vascular beds 
with potentially characteristic protein expression patterns, signalling pathways and 
structural organization, which could for example respond uniquely to the inciting 
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injection of exogenous CCL2 or interact differently with NE and/or monocytes. Post-
capillary venules in the ear for example display a larger number of gaps between 
adjacent subendothelial pericytes and within the basement membrane compared to those 
in the cremaster muscle (Voisin et al., 2010). The nature of these gaps has already been 
shown to regulate the extravasation of neutrophils and could potentially also influence 
the migration of monocytes (Wang et al., 2012). Endothelial cells too display a marked 
heterogeneity across different tissues with regards to their structure, protein expression, 
surface phenotype and secreted molecules. Furthermore, the properties of ECs are 
known to frequently change during inflammation, with individual steps of the same 
leukocyte adhesion cascade affiliated with changes in endothelial adhesion molecules 
and chemokines (Aird, 2012). In this regard, chemokine secretion has been stipulated to 
more extensively contribute to the tissue-specific patterns of leukocyte trafficking as 
variations in chemokine secretion are more pronounced between different endothelia 
than adhesion molecules (Hillyer et al., 2003).  
Though we cannot be sure that monocyte TEM is governed in the same manner in the 
peritoneum and ear, a major difference between these two mouse models and the 
cremaster muscle is the prevalence of resident tissue macrophages. Whilst these cells 
are sparsely represented in the cremaster muscle, they constitute approximately 70% of 
all dermal leukocytes in the ears and 30% of all leukocytes in the peritoneal cavities of 
naïve mice (Dupasquier et al., 2004), (Scotland et al., 2011). Macrophages are sentinel 
immune cells that release inflammatory mediators in response to exogenous insults. 
This can lead to dramatic changes in the tissue microenvironment both directly and by 
shifting the expression of EC adhesion/stimulatory molecules (Zhang et al., 2011). This 
in turn may influence local leukocyte infiltration. In reference to our study, considering 
CCL2-induced monocyte migration was not significantly inhibited in the peritoneum of 
NE
-/-
 mice at 4 hours and was seemingly unaffected altogether in the cremaster muscle, 
one could postulate that monocytes undergo recruitment in two distinct phases: an 
initial NE-independent phase and a secondary NE- and macrophage-dependent phase. In 
this manner, we initially hypothesised that early recruited monocytes released their NE 
stores, paving the way for subsequent monocyte recruitment by stimulating resident 
macrophages to release their own endogenous mediators. Indeed, NE has been 
previously shown to enhance macrophage production of various mediators in vitro 
including CCL2 (Ishihara et al., 1999). Furthermore, NE
-/- 
macrophages are reputedly 
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impaired in their ability to generate inflammatory mediators in response to 
Pseudomonas aeruginosa infection of the lungs (Benabid et al., 2012). Injecting 
recombinant NE into the peritoneal cavities of naïve mice was not however sufficient to 
induce monocyte recruitment. The complete absence of peritoneal monocytes in this 
model cannot be ignored however, as these cells may be of key influence, for example 
by presenting NE to the macrophages or by releasing their own mediators.  
Alternatively, NE may exert an effect on macrophages in an altogether different 
manner. Intriguingly, our peritonitis data identifies significantly fewer resident 
macrophages in NE
-/- 
mice 4 hours, but not 16 hours after CCL2 stimulation when 
compared to WT mice. Such transient changes in macrophage numbers are likely to be 
attributed to the macrophage disappearance reaction (MDR). This occurs in response to 
several inflammatory stimuli, including IFN-γ/TNF-α and CCL2 as demonstrated by our 
own data, and is characterised by the inability to recover total macrophages from the 
peritoneal cavity by lavage (Barth et al., 1995). Contributing to this phenomenon is the 
observed increase in macrophage adhesion to the surrounding parietal peritoneum and 
to each other, resulting in the formation of macrophage aggregates. The reappearance of 
these cells in the cavity, as seen in NE
-/- 
mice at 16 hours, presumably involves the 
breakdown of such aggregates. If the MDR is more pronounced in NE
-/- 
mice, as 
suggested by our data, following 4 hours CCL2 stimulation, this could contribute to the 
observed reduction in classical monocytes in these mice at 16 hours. When aggregated, 
peritoneal macrophages may have a reduced capacity to become activated or secrete 
cytokines, potentially affecting subsequent monocyte recruitment. 
Whether related to or distinct from a change in endogenous mediator generation, NE
-/- 
monocytes, certainly in the ear, appear to have a reduced capacity for transendothelial 
migration and instead appear to accumulate inside the endothelial lining of post-
capillary venules. These cells are spherical in morphology and are not seen to be 
extending invasive protrusions into the endothelium, an initiating step in monocyte 
TEM, suggesting NE exerts its function earlier on during the leukocyte adhesion 
cascade. Indeed, a similar phenotype has been reported for neutrophils recruited to 
cremasteric venules in ICAM-2 deficient mice, as attributed to a defect in post-adhesion 
endothelial crawling (Halai et al., 2014). Likewise, neutrophils deficient for the 
adhesive protein JAM-A tended to remain associated with the endothelium upon cardiac 
ischemia reperfusion rather than completing TEM (Corada et al., 2005). These cells 
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were shown to adhere more efficiently to ECs than WT neutrophils and also exhibited a 
defect in cell polarization, thereby limiting their motility and subsequent diapedesis 
across the endothelium. It is possible that NE
-/-
 monocytes too exhibit increased 
adhesion and are limited in their ability to crawl along ECs and locate optimal sites of 
TEM. In this manner, NE might be required to remove existing cell-cell interactions at 
the trailing edge of crawling monocytes. In keeping with this notion, it has been 
postulated that serine proteases, including NE, are secreted by migrating monocytes to 
detach CD18 integrins from counter-receptors on the endothelium (Zhang et al., 2013). 
This however would seemingly differ from how NE and human neutrophils interact as 
elastase activity has actually been shown to enhance neutrophil adhesion to HUVECs 
(Nozawa et al., 2000). 
While the precise mechanism remains to be clarified, it does appear that monocyte-
derived NE specifically is involved in monocyte TEM. By establishing an in vitro 
Transwell migration assay, we were able to compare the migration of NE
-/-
 and NE
+/+
 
monocytes directly with all other factors and potential sources of NE (e.g. ECs) 
remaining constant. Using this approach, we were able to demonstrate a decreasing 
trend in the migration of NE
-/-
 monocytes across murine skin endothelial cells in 
response to FBS, a rich and varied source of chemoattractants. While keen to repeat 
these experiments using CCL2 as a stimulus, the costs and resources required to 
MACS-sort sufficient numbers of monocytes would have been too great. Accordingly, 
we conducted all subsequent assays with human-derived monocyte-like U937 cells. In 
evaluating their migration across human umbilical vein endothelial cells, considerably 
fewer cells (P = 0.052) accumulated in the bottom chamber in response to CCL2 when 
incubated with the NE-specific inhibitor ONO-5046. We are confident that significance 
will be reached by extending these studies.  
Concomitantly, we also plan to assess levels of intracellular NE in U937 cells pre- and 
post-migration. If a reduction is observed, it could be suggested that NE is similarly 
released and generally involved in monocyte TEM in humans and mice. U937 cell 
transmigration assays would therefore provide an appropriate, yet simple and potentially 
high-throughput model system to delineate the mechanism(s) by which NE regulates 
monocyte TEM. In this manner, we could use phase-contrast microscopy to record 
videos of monocytes as they interact with the endothelium, both in the presence and 
absence of ONO-5046. This approach might identify the specific point at which NE-
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inhibited monocytes become ‘stuck’ during TEM. Microscopy can also be used in 
combination with a cell adhesion assay to determine whether monocyte-EC adhesion is 
at all influenced when NE activity is blocked. In addition, we can monitor the 
expression levels of endothelial junctional molecules and secreted chemokines to 
determine if/how they change during normal monocyte TEM. Key molecular 
interactions can be similarly explored by incorporating other inhibitors or blocking 
antibodies, while the use of multiple chemoattractants will indicate whether NE-
mediated migration is specific to CCL2. Once a mechanism has been established in 
vitro, it can be subsequently verified in mice in vivo, using a peritonitis and ear model 
of inflammation, as before.      
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CHAPTER 6: Characterising the mode and dynamics of 
monocyte transendothelial migration in vivo. 
 
6.1 Introduction 
Whilst our initial findings have implicated NE in monocyte transendothelial migration 
in mice, identifying its specific function in this process is not likely to be easy, not least 
considering the general lack of insight regarding the migratory behaviour of monocytes 
in vivo. Indeed, the vast majority of observations relating to the mode, dynamics, and 
molecular mechanisms of monocyte TEM have been made using in vitro models, 
incorporating predominantly human monocytic and endothelial cells. Though many of 
these studies have proven to be reproducible, reliable, and predictive of monocyte-EC 
interactions in vivo (Muller and Luscinskas, 2008), a number of inherently significant 
differences do ultimately exist between in vitro and in vivo models, as outlined earlier in 
Chapter 3. In this context, we believe there is a need to characterise the various 
parameters and steps of monocyte TEM as it unfolds in vivo.  
To address this issue, our group has established a confocal intravital microscopy 
imaging platform to track leukocyte transmigration through murine cremasteric venules 
in real time. This technique offers outstanding spatial and temporal resolution, which 
has already been exploited by our lab to characterise transendothelial migration of 
neutrophils (Woodfin et al., 2011). While the initial focus of this study centred on 
comparing the profile, frequency, dynamics and stimulus specificity of neutrophils 
migrating via the paracellular and transcellular pathways, the most intriguing 
observation related to the ‘disrupted’ nature of TEM exhibited by some of the cells. 
This included hesitant TEM in which neutrophils, rather than passing normally through 
EC junctions without pause, oscillated in the junction several times before completing 
migration to the abluminal side, and reverse TEM in which post-migrated neutrophils 
moved back through EC junctions in an abluminal-to-luminal direction. These events 
were up-regulated in inflammation after ischemia-reperfusion injury, as attributed to 
reduced expression of JAM-C at EC junctions. Furthermore, and of pathophysiological 
relevance, it seemed that upon re-entering the circulation, reverse transmigrated 
neutrophils exhibited a greater propensity for ROS production, contributing to the 
dissemination of systemic inflammation and tissue damage in secondary organs. 
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The phenomenon of reverse transendothelial migration (rTEM) has also been described 
for monocytes. Using an in vitro model of a blood vessel wall consisting of human 
umbilical vein endothelial cells (HUVECs) grown on amniotic tissue, Randolph and 
Furie observed that while human monocytes incubated for 2 hours successfully 
transmigrated into the amniotic tissue, by 12 hours the majority of cells migrated back 
across the endothelium to the apical surface (Randolph and Furie, 1996). Subsequent 
studies demonstrated that reverse transmigrated monocytes were more inclined to 
differentiate into DCs as opposed to macrophages, and accordingly reverse 
transmigration was postulated to mediate the physiological trafficking of DCs from 
tissues into the lumen of lymphatic vessels (Randolph et al., 2002). A more recent study 
does however suggest that post-migrated monocytes employ reverse transmigration to 
re-enter the circulation (Bradfield et al., 2007). Though not demonstrated directly, a 
population of classical monocytes in the blood of thioglycollate-stimulated mice were 
shown to display a reverse-transmigratory phenotype, as characterised by a lack of L-
selectin surface expression. Interestingly, and in accordance with neutrophil rTEM, the 
frequency of monocytes undergoing rTEM, both in vitro and in vivo, was enhanced 
upon blocking JAM-C function.      
How exactly JAM-C promotes leukocyte rTEM is currently unclear. Recent findings 
from our group have however identified a role for the lipid mediator LTB4, certainly 
with regards to neutrophil rTEM (data unpublished). Indeed, local administration of 
LTB4, chosen initially due to its increased expression in the cremaster muscle upon 
ischemia-reperfusion injury, induced both a reduction in venular JAM-C expression and 
an increase in prevalence of neutrophil rTEM. In addressing the mechanism of JAM-C 
cleavage, as normal JAM-C expression was observed in neutrophil-depleted mice it was 
hypothesised that LTB4 elicited both neutrophil chemotaxis and degranulation, 
culminating in the degradation of endothelial JAM-C by released proteases. 
Furthermore, and of particular relevance to our own study, it appeared that JAM-C 
shedding was mediated predominately by NE, as supported by the unperturbed 
expression pattern of JAM-C in NE KO mice.  
In recognition of the exciting insights made by our group into the mechanisms and 
modes of neutrophil TEM, in this chapter we sought to similarly enhance our 
understanding of monocyte TEM by applying the same 4D intravital microscopy 
imaging platform to the cremaster muscles of CX3CR1-eGFP-ki mice. This approach 
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should enable the behaviour and dynamics of transmigrating monocytes to be rigorously 
characterised in vivo over the course of an inflammatory insult. In this regard, NE will 
no longer constitute the primary focus of our studies, however, once the principles of 
monocyte migration have been established, the involvement of NE in this process can 
be assessed using NE
-/-
 mice. The more immediate objectives of this work are as 
follows:    
 Evaluate the frequency and dynamics of monocyte para- and transcellular TEM 
in vivo. 
 Discriminate and characterise different forms of monocyte migration (e.g. 
hesitant and reverse TEM). 
 Compare the transmigration profiles of monocytes in response to different 
inflammatory stimuli. 
 Investigate the function of JAM-C during monocyte TEM. 
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6.2 Results 
a) Monocytes primarily undergo paracellular TEM in response to CCL2 in vivo. 
Four-dimensional confocal intravital microscopy of cremasteric venules has been 
previously used by our group to study the mechanisms and dynamics of neutrophil TEM 
in vivo (Woodfin et al., 2011). This was performed specifically on male LysM-eGFP-ki 
mice, exhibiting endogenously fluorescent neutrophils. In order to visualise the vascular 
endothelium, mice were injected intrascrotally (i.s.) 1-4 hours prior to analysis with an 
Alexa Fluor 555–conjugated antibody against the EC junctional molecule PECAM-1. 
Importantly, the specific clone of antibody used (clone C390) was shown to neither 
elicit nor inhibit leukocyte transmigration. Upon exteriorising and surgically preparing 
one of the cremaster muscles, image stacks of half post-capillary venules were captured 
every minute for a period of 1 hour. These images were subsequently reconstructed in 
silico, yielding high-resolution four-dimensional videos of neutrophils interacting with 
the vasculature.  
We used this same approach to characterise monocyte TEM in male CX3CR1
+/eGFP
 mice 
in this study. To elicit monocyte infiltration into the cremaster muscle we initially 
injected mice i.s. with CCL2, as used successfully in the previous chapter. Recognising 
the majority of monocytes in these studies had already completed TEM 4 hours post 
stimulation, we decided to exteriorise the cremaster muscle after 2 hours. Indeed, at this 
time point monocyte rolling and adhesion could be observed directly under the 
microscope. In order to study the more intricate interactions between monocytes and 
venular ECs, individual post-capillary venules measuring 30-50 µm in diameter were 
imaged for approximately an hour each. In analysing our initial videos, it was apparent 
that while sufficient numbers of monocytes were shown to undergo endothelial 
adhesion and crawling, almost no cells committed to TEM. Theorising that the CCL2 
was washed away upon exteriorising the cremaster muscle, we decided to supplement 
the superfusion buffer, used to bathe the tissue throughout imaging, with CCL2 at a 
concentration of 5×10
-9
 M, as used successfully previously (Voisin et al., 2009). While 
this did enhance the number of observed TEM events, we were unable to consistently 
induce the same frequency of transmigration as achieved previously for neutrophils 
(Woodfin et al., 2011). Furthermore, while small cell protrusions and subtle shape 
changes could be resolved for migrating LysM-eGFP-ki neutrophils, the relatively 
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weaker eGFP expression of CX3CR1
+/eGFP
 monocytes made such in-depth analysis 
impossible (Figure 6.1). Nonetheless, we were still able to visualise and analyse 
detailed spatiotemporal, three-dimensional dynamics of individual monocytes as they 
underwent TEM.   
 
 
 
 
Figure 6.1: Establishing a four-dimensional imaging platform to study leukocyte TEM in 
real time in vivo. Confocal intravital microscopy of cremasteric venules of LysM
+/eGFP
 (A) and 
CX3CR1
+/eGFP
 (B) mice (exhibiting green neutrophils and monocytes, respectively) administered  
LPS (300 ng, supplemented with Alexa Fluor 555–labelled mAb to PECAM-1, red) i.s. for 4 
hours. One cremaster muscle was subsequently exteriorised and surgically prepared for 4D 
confocal imaging. Representative still images are shown. Original magnification, ×40. Scale 
bar, 10 µm. 
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In response to CCL2, adherent monocytes were shown to crawl across the luminal 
surface, principally along endothelial borders. Though the majority of cells would crawl 
out of sight, several could be seen undergoing TEM. This occurred almost entirely via 
the paracellular pathway, i.e. by squeezing through pores in endothelial cell junctions 
(Figure 6.2A). Only a select few monocytes (< 5%) could be observed crossing the 
endothelium in a non-junctional transcellular manner, passing instead through the body 
of individual ECs (Figure 6.2B). Multi-cellular junctions constituted more common 
sites of paracellular TEM compared to bi-cellular junctions (ratio of ~3:1), however the 
duration of TEM was largely conserved, lasting typically between 9 and 12 minutes 
(Figure 6.3A). Following transmigration, the vast majority of monocytes remained in a 
flattened morphology at or near the site of TEM (Figure 6.3B & Video appendix 6.1A). 
While some cells were shown to engage in abluminal endothelial crawling, only a select 
few managed to detach from the endothelium and migrate into the interstitial space.  
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Figure 6.2: Modes of CCL2-induced monocyte TEM. CX3CR1
+/eGFP
 mice were administered 
CCL2 (500 ng, supplemented with Alexa Fluor 555–labelled mAb to PECAM-1, red) i.s. for 2 
hours. One cremaster muscle was subsequently exteriorised, superfused with CCL2 (5×10
-9 
M) 
and imaged for 2 hours by 4D confocal microscopy. Monocytes (green (*)) were observed 
undergoing paracellular (A) and transcellular (B) TEM, accompanied typically by a transient 
pore in PECAM-1 expression (right panel) at the cell junction or in the cell body, respectively. 
Representative time-lapse images are shown. Original magnification, ×40. Scale bar, 5 µm.  
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b) Monocytes exhibit disrupted forms of TEM in response to CCL2. 
In some instances, TEM was shown to take considerably longer than normal, with the 
cells seemingly getting stuck at the site of TEM prior to completing their passage to the 
Figure 6.3: Monocyte dynamics during CCL2-induced TEM. In analysing CCL2-stimulated 
cremasteric venules, the duration of normal TEM events was recorded for monocytes 
undergoing paracellular (at both bi- and multi-cellular junctions) and transcellular (non-
junctional) TEM (A). The duration was calculated as the time between the first frame in which a 
pore in PECAM-1 staining could be seen to the frame in which the monocyte had fully 
traversed the EC barrier. Time lapse images depict this movement of monocytes from the 
luminal (green, spherical) to abluminal (yellow, flat) space (B). TEM events were pooled from 
6 separate venules from 4 mice. Original magnification, ×40. Scale bar, 30 µm.         
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abluminal side. ‘Stuck’ cells did not however always complete transmigration. On the 
contrary, in most cases the cells remained at the site of TEM, sometimes for the 
duration of the entire 60-minute recording. While some cells could be seen extending 
protrusions into the abluminal space, either permanently or transiently, others appeared 
to simply sit atop the endothelial surface. On rare occasions, the cells would retract their 
protrusions and crawl away. Categorised collectively as an ‘incomplete’ TEM event, we 
assigned this term to any monocyte that remained stationary on the luminal surface for ≥ 
25 minutes. Furthermore, we also identified and quantified crawling monocytes 
exhibiting a ‘tailing’ phenotype, characterised by the transient formation (several 
minutes) of a greatly elongated uropod (Figure 6.4A). This seemingly resulted from the 
monocyte extending an investigative protrusion into the endothelium whilst still 
crawling. Upon detaching, the tail would retract back to the cell body, returning the 
monocyte to a normal crawling state. Tailing events were less frequently observed than 
incomplete events, which in turn were less frequently observed than normal TEM 
events, though they all occurred predominantly at multi-cellular junctions (Figure 
6.4B). Example videos of normal, incomplete and tailing migration events are shown in 
Video appendix 6.1 and 6.2. 
 
c) Monocyte TEM is not altered upon inhibiting JAM-C. 
In response to CCL2, while monocytes did exhibit incomplete and tailing phenotypes, 
neither reverse nor hesitant TEM was strictly observed, as has been previously 
described for neutrophils. These forms of disrupted neutrophil TEM were attributed to a 
reduction in JAM-C expression at EC junctions. Having confirmed JAM-C expression 
in post-capillary venules in naïve CX3CR1
+/eGFP
 mice (Figure 6.5), and considering 
CCL2 does not reportedly reduce endothelial JAM-C expression, we decided to re-
characterise monocyte TEM upon disrupting JAM-C expression. This was achieved 
both indirectly by stimulating with the lipid mediator LTB4 and directly by 
administering the JAM-C blocking antibody H33. LTB4 is thought to promote JAM-C 
cleavage by inducing neutrophil degranulation (data unpublished), while H33 disrupts 
the retention of JAM-C at endothelial junctions by blocking interactions with its binding 
partner JAM-B (Lamagna et al., 2005).   
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As LTB4 alone does not induce a strong monocyte response (Appendix 6.1), a combined 
stimulus of LTB4 and CCL2 was injected i.s. into CX3CR1
+/eGFP
 mice for 2 hours. 
CCL2 alone was used in combination with the JAM-C blocking antibody H33, which 
was administered i.v. prior to stimulation. Under these conditions, we initially evaluated 
general leukocyte recruitment, in both exteriorised and intact cremasters, as compared 
to CCL2-only controls. After 4 hours, monocyte extravasation was largely conserved 
across all mice. As expected, neutrophil extravasation was amplified in the presence of 
LTB4, a potent neutrophil chemoattractant, though interestingly only marginally in 
Figure 6.4: Disrupted forms of monocyte migration. In analysing CCL2-stimulared 
cremasteric venules, in addition to normal TEM, monocytes (*) were also observed partaking in 
‘incomplete’ and ‘tailing’ events, as depicted in the above time lapse images (A). All migration 
events occurred predominantly at multi-cellular junctions (B). TEM events were pooled from 6 
separate venules from 4 mice. Original magnification, ×40. Scale bar, 5 µm.        
 
 
Figure 6.5: JAM-C expression in cremasteric venules. Cremaster muscles were harvested 
from naïve CX3CR1
+/eGFP
 mice, fixed in PFA and immunostained for JAM-C (green) and the 
endothelial junctional marker VE-cadherin (red). ECs of post-capillary venules demonstrated 
strong JAM-C expression along endothelial junctions and faint, diffuse expression within the 
cell-body. Scale bar, 10 µm.        
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exteriorised tissues (Figure 6.6). Thus, during live imaging (exteriorised tissues) the 
profile of infiltrating monocytes and neutrophils was comparable across all 
inflammatory scenarios, enabling any potential differences in the modes and dynamics 
of monocyte TEM to be more robustly assessed. In this regard, individual venules were 
recorded as before and the average number, type and duration of migration events 
characterised (Figure 6.7). Generally, normal paracellular TEM events were most 
frequently observed. While the duration of TEM did not significantly change, the 
proportion of bi-cellular junctional events was more pronounced in the presence of H33, 
though not LTB4. This was similarly observed for incomplete migration events, which 
did exhibit a collective, albeit non-significant increase in frequency upon JAM-C 
inhibition. Importantly, monocyte reverse TEM was not observed in any of the mice 
analysed. 
 
 
 
 
 
 
Figure 6.6: Leukocyte infiltration is conserved during intravital microscopy. Numbers of 
extravasated neutrophils and monocytes were counted in both surgically prepared (external) and 
intact (internal) cremasteric venules of CX3CR1
+/eGFP
 mice stimulated with CCL2 (500 ng) i.s. 
for a total of 4 hours. JAM-C was disrupted in some mice either by administering a JAM-C 
blocking mAb (H33, 3 mg/kg) immediately prior to stimulation or by supplementing the CCL2 
stimulus with LTB4 (300 ng). Exteriorised cremasters (2 hours post stimulation) were 
superfused with CCL2 (5×10
-9 
M) during 2 subsequent hours of confocal microscopy. Data are 
represented as the mean ± SEM (n = 3 mice, average of 5-6 venules per mouse). 
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Figure 6.7: Monocyte migration is not altered upon blocking JAM-C. Total monocyte 
migration events were characterised in cremasteric venules of CX3CR1
+/eGFP
 mice stimulated 
with CCL2 (500 ng) i.s. for 2 hours. As before, JAM-C was disrupted in some mice either by 
pre-treating with the JAM-C blocking mAb H33 (3 mg/kg) or by supplementing the CCL2 
stimulus with LTB4 (300 ng). The average duration of normal monocyte TEM was conserved 
across all groups (A). The average number of normal TEM events, but also incomplete and 
tailing events was also largely comparable (B), as was the frequency of the different modes of 
migration (para- or transcellular). Data for (A) and (B) are represented as the mean ± SEM (n = 
6-8 separate venules from 3-4 mice). Total migration events were pooled for (C). 
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6.3 Discussion 
While in vitro studies have contributed tremendously to our understanding of the 
mechanisms that govern leukocyte transendothelial migration, one major caveat is the 
general lack of supporting in vivo models. Due to recent advancements in intravital 
microscopy however, this is now beginning to be addressed. In this respect, by 
employing high-resolution, four-dimensional confocal imaging our group has recently 
provided great insight into the mode, frequency, dynamics and stimulus specificity of 
neutrophil transendothelial migration through inflamed venules in the cremaster muscle 
of LysM-eGFP-ki mice (Woodfin et al., 2011). Keen to similarly characterise the in 
vivo behaviour of migrating monocytes, in this study we exploited the same confocal 
imaging platform to track the movement of endogenously fluorescent monocytes in 
CX3CR1-eGFP-ki mice. 
As has been used throughout this study, as a means of stimulating monocyte migration 
in the cremaster muscle we administered the chemokine CCL2. In response to a single 
intrascrotal injection of CCL2, while monocytes were abundantly recruited to 
cremasteric venules and were observed adhering to and crawling along the endothelium, 
almost no cells commenced diapedesis. As monocytes readily completed extravasation 
previously in this study in surgically un-compromised tissues, we theorised that in 
exteriorising and flattening the cremaster muscle, as is required for confocal analysis, 
important CCL2 gradients were dissipated, blocking TEM. To circumvent this, we 
topically applied CCL2 throughout imaging. While this did enhance the frequency of 
monocyte TEM, we were unable to consistently induce the same number of 
transmigration events as achieved previously for neutrophils. While this was to be 
expected given the relatively lower frequency of monocytes in the blood, of particular 
detriment was the technical requirement to image larger (≥ 40 µm diameter) post-
capillary venules, which, as our previous results have already demonstrated, are less 
accommodating to monocyte migration compared to their smaller (25-40 µm diameter) 
counterparts. 
Despite the various difficulties faced, we successfully managed to track monocytes as 
they underwent TEM. This occurred almost entirely via the paracellular pathway, 
predominantly at multi-cellular endothelial junctions. This is in keeping with the vast 
majority of in vitro studies, in which transcellular migration, even under the most 
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conducive circumstances, only represents the route of emigration for approximately 
10% of monocytes (Muller, 2014). What has also been reported however, and which we 
have recognised directly in this study, is that para- and transcellular migration cannot 
always be distinguished, primarily because transcellular events seem to occur most 
commonly at sites directly proximal to EC junctions. Irrespective of the specific mode 
of TEM used, prior to initiating diapedesis, monocytes were ubiquitously observed 
crawling along the endothelium, most commonly along the junctional borders. Upon 
arresting at a chosen site of transmigration, the monocytes extended a protrusion into 
the endothelium forming a pore, as visualised by a gap in PECAM-1 staining, through 
which they would subsequently squeeze their bodies. This process took on average 10 
minutes to complete, exceeding the 6 minutes recorded by our group for neutrophils. 
Relatively longer transmigration times have similarly been reported for monocytes in 
vitro (Chen et al., 2006). Upon completing TEM, rather than readily detaching from the 
venular wall and entering the interstitium, the vast majority of monocytes remained 
stationary at the site of migration in a flattened morphology. Interestingly, this was not 
routinely observed previously in intact cremaster muscles, suggesting again that 
exteriorising the cremaster muscle may influence monocyte behaviour.  
Sticking with this point, while CCL2-induced monocyte infiltration did not differ 
between intact and exteriorised tissues, the latter did demonstrate significantly greater 
levels of neutrophil extravasation. Neutrophils have been previously shown to promote 
monocyte transmigration and could possibly also influence monocyte behaviour in our 
cremaster model. In this regard, it was clear from analysing our final reconstructed 
movies that many of the migration pores apparent in the inflamed endothelium were 
attributable not to monocytes but to other cells, most likely neutrophils, though this was 
not directly confirmed as neutrophils were only labelled post acquisition. Importantly, 
there were numerous instances in which monocytes underwent TEM through recently- 
or pre-existing pores (Video appendix 6.3). This may suggest that neutrophils can 
directly guide monocytes through the endothelium, a theory we hope to explore further 
by conducting analogous experiments in neutrophil-depleted mice.  
In addition to characterising normal monocyte TEM, in this chapter we were also keen 
to determine whether monocytes exhibited any disrupted forms of migration in vivo, as 
we have previously described for neutrophils. Neutrophils specifically were shown to 
partake in hesitant TEM, in which cells oscillated in the junction prior to completing 
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TEM, and reverse TEM, consigned to post-migrated cells that crossed back into the 
endothelial lumen. With regards to CCL2-stimulated monocytes, while some 
transmigration events did take considerably longer than the collective average, these 
cells were not seen to oscillate akin to hesitant migration but rather remained stationary, 
presumably stuck in the junction. Monocytes remained in this ‘incomplete’ state for 
varying periods of time, sometimes for the duration of an entire recording. They also 
became stuck at varying stages of migration, with some cells extending considerable 
protrusions into the abluminal space, while others appeared simply to rest atop the 
junction. On rare occasions, stuck cells detached themselves entirely from the junction 
and re-engaged in luminal crawling. In addition to incomplete migration events, we also 
described a monocyte ‘tailing’ phenotype in which monocytes transiently displayed an 
elongated uropod, seemingly as a result from engaging with the endothelium in a tight 
yet localised manner whilst still crawling. As with normal monocyte TEM, both 
incomplete and tailing events occurred predominantly at EC junctions, and most likely 
reflect failed attempts to undergo transmigration at sub-optimal sites of the 
endothelium.  
In response to CCL2, on no occasion did monocytes complete TEM and reverse migrate 
back into the vascular lumen. This is in keeping with our previous peritonitis results, in 
which CCL2 stimulation did not increase the proportion of circulating classical 
monocytes with a CD62L-negative phenotype (see Figure 5.3), considered to be a 
hallmark of reverse transmigrated cells. This may not be surprising however as CCL2 
has never been implicated in reducing JAM-C expression (rather it might increase its 
expression (Keiper et al., 2005)), a phenomenon our group has already shown to 
mediate rTEM of neutrophils in vivo and others have shown to mediate rTEM of 
monocytes in vitro (Bradfield et al., 2007). To determine whether blocking junctional 
JAM-C expression in post-capillary venules can similarly induce monocyte rTEM in 
vivo, we stimulated the mouse cremaster muscle with CCL2 as before, however together 
with pre-treating the mice with the JAM-C blocking antibody H33 or supplementing the 
CCL2 with LTB4, a lipid mediator previously demonstrated by our group to induce 
JAM-C proteolysis. Neither scenario however yielded any monocyte rTEM events. The 
migration profile of monocytes more generally did not dramatically change, though the 
relative frequency of incomplete and tailing events was marginally greater. While JAM-
C expression was not directly assessed in our experiments, a reduction in junctional 
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JAM-C was confirmed in parallel studies using the same batch of reagents and 
experimental parameters (data not shown).   
In this study, we have successfully utilised high-resolution confocal imaging to 
characterise in detail the behaviour of monocytes as they undergo transendothelial 
migration in vivo for the first time. Using the mouse cremaster muscle as a model, in 
response to CCL2 stimulation monocytes were shown to engage in all steps of the 
leukocyte adhesion cascade, including rolling and arresting on the endothelial lining, 
crawling intraluminally along EC borders, and eventually committing to and completing 
TEM, most typically at multi-cellular junctions. In addition to normal TEM, monocytes 
also displayed disrupted forms of migration, in which TEM was seemingly initiated but 
not completed. At no point however was reverse TEM strictly observed, even upon 
disrupting JAM-C expression. That is not to say that monocytes do not undergo rTEM 
in vivo, as it may simply be governed in a different manner to neutrophils. With regards 
to exploring alternative monocyte-specific mechanisms, as it relates to rTEM or 
otherwise, a major limitation of the current experimental set-up is the relatively small 
number of elicited monocyte TEM events. Thus far monocyte recruitment has been 
induced almost entirely with CCL2. Previously in this study, CCL2 was also used in 
peritonitis experiments, though demonstrated a much weaker (albeit more specific) 
monocyte response as compared to a joint stimulus of IFN-γ and TNF-α. In this light, 
we believe a greater frequency of monocyte TEM may be achieved by incorporating 
different inflammatory mediators and/or optimising other experimental parameters. 
Acquiring a greater and more consistent frequency of monocyte TEM will undoubtedly 
facilitate in any subsequent comparative studies and thereby provide a more suitable 
model in which to study monocyte behaviour in vivo.   
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CHAPTER 7: General discussion 
 
7.1 Project overview 
Whilst monocytes represent key cells of the innate immune system, their inflammatory 
activities following inappropriate or excessive recruitment may cause unwanted tissue 
injury and critically contribute to the pathogenesis of a number of major diseases. Some 
anti-inflammatory therapeutics do exist for such monocyte-driven pathologies, however 
their utility is often limited by adverse side effects, often generated through non-specific 
toxicity of cells uninvolved in the disease process. As such, there is an emphasis on 
identifying novel drug targets specific to causative cell types or subsets. The classical 
subset of monocytes has been most closely associated with promoting inflammatory 
disease activity by infiltrating sites of inflammation and differentiating into pro-
inflammatory macrophages and DCs. The adhesion molecules that regulate classical 
monocyte trafficking are beginning to be described, however the potential role of 
proteases in this process remain largely unexplored. The serine protease neutrophil 
elastase has already been broadly implicated in neutrophil migration. Furthermore, NE 
is reported to play a role in the recruitment of monocytes to the lungs of mice exposed 
to cigarette smoke, as indicated by reduced numbers of pulmonary macrophages in NE
-/-
 
mice as compared to wild-type controls (Shapiro et al., 2003). We sought to build upon 
these previous findings in this study, focussing more directly on the expression patterns 
and functional properties of NE in bona fide monocytes. 
 
a) Transgenic mouse models enabled the robust and concurrent study of monocyte 
and NE biology in vivo. 
Although many of the molecular interactions that underpin monocyte migration were 
originally elucidated in vitro, the relative simplicity of these models can make 
extrapolating results to a whole, living organism unreliable. Accordingly, in this study 
we sought to investigate monocyte migration directly in vivo. Naturally as this cannot 
be easily achieved in humans we exploited mice, which possess largely homologous 
classical and non-classical monocyte subsets. More specifically, we used CX3CR1-
eGFP-knock-in mice in which the endogenous CX3CR1 gene has been replaced by the 
fluorescent reporter gene eGFP. CX3CR1 is the cognate receptor for the chemokine 
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CX3CL1 and is reputedly expressed by the brain microglia and subsets of natural killer 
and dendritic cells, as well as all monocytes (Imai et al., 1997). Flow cytometric 
analysis of the blood of CX3CR1
+/eGFP
 mice however demonstrated that only monocytes 
exhibited high eGFP fluorescence. Classical and non-classical monocytes could be 
easily sub-categorised according to GR-1 expression. Employing flow cytometry in this 
manner, monocytes were accurately identified and quantified in biological samples 
prepared from the blood, but also the spleen, bone marrow and peritoneal cavity of 
CX3CR1
+/eGFP
 mice. Furthermore, by combining confocal microscopy and computer-
assisted image processing, eGFP
+
 monocytes could be directly visualised undergoing 
transendothelial migration in situ in the cremaster muscle and ear, providing a platform 
to study in great detail interactions made between individual monocytes and endothelial 
cells. Such analyses were conducted not only on fixed, pre-collected tissue samples, but 
on live cremaster tissue in anaesthetised mice. This enabled us to track monocytes in the 
vasculature in real time and thereby gain valuable insight into the dynamics and 
mechanisms of monocyte extravasation in vivo.  
Having established selective monocyte labelling in CX3CR1-eGFP-ki mice, in order to 
rigorously, specifically and concurrently characterise the biological properties of murine 
NE, CX3CR1-eGFP-ki mice were crossed with NE knock-out mice. More specifically, 
we generated, and subsequently compared, CX3CR1
+/eGFP
 mice carrying either double 
mutant (NE
-/-
) or wild-type (NE
+/+
) copies of the NE gene. We purposely retained one 
functional copy of the CX3CR1 gene so as to avoid any significant defects in monocyte 
survival and migration, as previously reported for homozygous knock-in mice. That is 
not to say however that CX3CR1
+/eGFP
 mice display entirely representative monocyte 
behaviour. The absence of one copy of CX3CR1 for instance has been shown to 
sufficiently impair monocyte recruitment to atherosclerotic plaques (Combadière et al., 
2003). In this light and to maintain consistency, heterozygous CX3CR1-eGFP-ki mice 
were used exclusively for all comparative NE functional and expression analyses.   
 
b) Murine classical monocytes express abundant NE transcript and protein. 
To date, NE expression has been definitively demonstrated in human but not murine 
monocytes. To address this, we initially employed qRT-PCR to assay for NE transcripts 
in classical and non-classical monocytes FACS-sorted from the spleens of naïve 
CX3CR1
+/eGFP
 mice. Both monocyte subsets are well represented in the spleen and, 
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importantly, have been shown to share an identical morphology, transcriptome and 
function with their blood counterparts. Though NE transcripts were accurately detected 
in both subsets, as validated by NE
-/-
 negative controls, expression levels were 
significantly more abundant in the classical subset, exceeding even those of neutrophils. 
To determine whether NE was similarly expressed at the protein level, monocytes were 
sorted as before and analysed by Western blotting. Intriguingly, NE protein was 
expressed in neutrophils only, even upon extensive cytokine stimulation. To validate 
this result, NE expression was re-evaluated in classical monocytes purified using 
MACS- instead of FACS-technology. In marked contrast to before, these cells were 
shown to contain abundant NE protein stores. Follow-on confocal analyses revealed NE 
localised to small cytoplasmic granules, akin to the azurophil granules of neutrophils. 
This was ubiquitously observed for classical monocytes harvested from the spleen but 
also the bone marrow, suggesting NE is synthesised and packaged early on during 
monocyte development.  
As a means of characterising monocyte NE secretion, prior to being subjected to 
Western blot or confocal analysis, MACS-sorted monocytes were stimulated in vitro 
with a range of mediators, namely CCL2, a classical monocyte chemoattractant and 
activator; LTB4, a potent inducer of NE release, certainly from neutrophils; and PMA, a 
general, synthetic stimulator of cell degranulation. Monocytes did not however display 
depleted NE stores under any condition. Unexpectedly, neutrophils too were 
unresponsive to LTB4, though they were shown to mobilise NE to the cell nucleus in 
response to PMA, in keeping with previous studies (Papayannopoulos et al., 2010). This 
result demonstrates not only that the cells were generally susceptible to in vitro 
stimulation, but also that NE trafficking is distinctly regulated in monocytes and 
neutrophils.  
Interestingly, in response to CCL2 NE was shown to be depleted from monocytes 
recruited to post-capillary venules in the mouse ear in vivo. This was ubiquitously 
observed in post-migrated monocytes residing in the interstitial space but also in a high 
proportion of luminally adherent monocytes, suggesting NE is triggered for release 
prior to transmigration. By way of explaining the seemingly conflicting expression data 
generated in vitro and in vivo, it is possible that upon being administered intradermally, 
CCL2 induces the local production of other inflammatory mediators that harbour an 
independent or collective ability to stimulate NE monocyte degranulation. The TNF-like 
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molecule CD40L for example is expressed by endothelial cells under certain 
inflammatory conditions and has also been shown to trigger mass NE release from 
human monocytes in vitro (Dollery et al., 2003). Alternatively, the shear stress exerted 
by the circulating blood may be a decisive factor. Indeed, a number of processes during 
leukocyte extravasation have been shown to be shear-dependent, such as integrin 
adhesion and activation and pseudopod formation and retraction (Mitchell and King, 
2012). Furthermore, shear stress has been directly implicated in enhancing the secretory 
capacity of classical monocytes during inflammation (Evani et al., 2013). In this 
manner, NE has been explicitly postulated to be triggered for release by monocytes 
upon shear exposure as a means of regulating their passage through the microcirculation 
(Zhang et al., 2013). Certainly, if NE degranulation is sensitive to shear stress, this may 
explain the complete absence of NE protein from monocytes purified via FACS-sorting, 
a process in which cells experience strong hydrodynamic shear forces.  
 
c) NE
-/-
 mice exhibit defective monocyte transmigration.  
Under naïve conditions, NE
+/+
 and NE
-/-
 mice displayed comparable monocyte profiles, 
not only in the bone marrow where they are produced, but in the blood, spleen and 
peritoneal cavity, suggesting NE does not play a pivotal role in homeostatic monocyte 
trafficking in vivo. In order to assess its potential involvement in inflammatory 
trafficking, monocyte profiles were re-evaluated in response to several mouse models of 
acute inflammation. In this regard, we initially assessed monocyte infiltration into the 
peritoneal cavity during peritonitis. While no differences were observed between NE
+/+
 
and NE
-/-
 mice in response to IFN-γ and TNF-α, upon stimulation with CCL2 
significantly fewer classical monocytes were retrieved from the cavity of NE
-/-
 mice. To 
determine if this might be attributable to a defect in monocyte transendothelial 
migration, we next employed confocal fluorescence microscopy to directly visualise 
monocytes as they migrated through CCL2-stimulated post-capillary venules in the 
cremaster muscle and ear dermis. While the monocyte profiles of the two genotypes 
were largely conserved in the cremaster muscle, in the ear a significantly smaller 
number of post-migrated monocytes were observed in the abluminal space of NE
-/- 
mice. Total monocyte recruitment was not however reduced, rather the majority of 
monocytes were shown to orient along the venular lumen, seemingly incapable of 
breaching the endothelial wall.  
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Collectively, our results from the peritonitis and ear inflammation models strongly 
suggest a defect in CCL2-induced monocyte migration in NE
-/- 
mice in vivo. Although 
we have unequivocally demonstrated NE is expressed by monocytes, we do appreciate 
that NE
-/- 
mice are constitutive knock-outs, deficient for NE in all of their cells. As such, 
it is possible NE derived from non-monocytes could somehow contribute to monocyte 
TEM. In this regard, whilst neutrophils are reported to store NE at millimolar 
concentrations, they were scarcely recruited in response to CCL2 and moreover 
appeared to retain their NE stores intracellularly. NE might be released however by 
other cells, such as vascular endothelial cells, which have not been directly explored in 
this study but have been proposed to express NE in humans (Dollery et al., 2003). As 
monocyte- or even myeloid-specific conditional NE KO mice do not exist, in order to 
investigate the role of monocyte-derived NE more specifically, we applied monocytes to 
in vitro Transwell migration assays. Unfortunately, as primary NE
+/+
 and NE
-/-
 
monocytes could not be purified in sufficient numbers, we instead exploited the human 
monocyte-like U937 cell line, routinely used to study NE biology. Interestingly, when 
incubated with the NE-specific inhibitor ONO-5046, considerably fewer U937 cells 
successfully transmigrated across an endothelial monolayer in response to CCL2, in 
keeping with the data generated in NE
-/-
 mice. In this light, and considering NE is 
seemingly depleted from a subpopulation of luminal monocytes in NE
+/+
 mice in the 
ear, we hypothesise that following their arrest on the endothelium, NE is released by 
monocytes where after it helps to initiate TEM.  
 
7.2 Future directions 
In this study, whilst we have identified the protease neutrophil elastase as a novel 
mediator of inflammatory monocyte trafficking in vivo, its precise mode of action is 
currently unclear and will constitute the major focus of our future works. We assume its 
proteolytic activity is a central factor and that it functions at the level of the 
endothelium, however, being highly promiscuous, identifying its principal substrate(s) 
may not be straightforward. To facilitate this, we initially plan to develop the U937-
HUVEC transmigration assay as it offers simple and potentially high-throughput 
analysis. In this manner, we are keen to first determine whether migrating U937 cells 
actively release their NE stores, as observed for monocytes in the mouse ear, by 
subjecting pre- and post-migrated cells to Western blot and immunofluorescence 
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analysis. Thereafter, we can use phase-contrast microscopy to record videos of U937 
monocytes as they interact with the endothelium, both in the presence and absence of 
the NE inhibitor ONO-5046. This approach should identify the specific point at which 
NE-inhibited monocytes become ‘stuck’ during TEM and hence where NE is likely to 
exert its function. Microscopy can also be used in combination with a cell adhesion 
assay to determine whether monocyte-EC adhesion is at all influenced when NE activity 
is blocked. In addition, we can monitor the expression levels of endothelial junctional 
molecules and secreted chemokines to determine if/how they change during normal 
monocyte TEM. Key molecular interactions can also be explored by incorporating other 
inhibitors or blocking antibodies, while the use of multiple chemoattractants will 
indicate whether NE-mediated migration is CCL2-specific.  
Once a candidate substrate or mechanism has been established in vitro, its physiological 
relevance in vivo can be subsequently validated in murine models of inflammation by 
incorporating appropriate pharmacological or genetic interventions. Representing a 
more direct and potentially immediate approach, the mechanisms of NE-mediated 
monocyte migration in vivo will also be explored by performing secondary comparative 
experiments on NE
-/-
 and NE
+/+
 mice. We are particularly keen to apply a 4D imaging 
platform to the ears of these mice, as we did for the cremaster muscle. Granted 
monocyte TEM is still defective in the ears of NE
-/-
 mice under these conditions, we 
should be able to visualise, in real time, how and where migrating monocytes are being 
inhibited. Though our lab has no direct expertise in conducting live imaging in the ear, 
we have held preliminary collaborative talks with Dr. Lai Guan Ng, a principal 
investigator at the Singapore Immunology Network who routinely conducts high-
resolution intravital multiphoton imaging of immune responses in the ear skin of 
multiple transgenic mice, including CX3CR1-eGFP-ki mice (Li et al., 2012).  
To date, in this study we have only subjected mice to acute models of inflammation. 
Though such studies have provided valuable insight into the role of NE during 
monocyte migration, we are keen to determine whether our preliminary observations 
extend to murine disease models, which more closely reproduce the complex and 
integrated physiological and pathological responses of human diseases. In this regard, 
we have already initiated a collaboration with Dr. Qingzhong Xiao, also located at the 
William Harvey Research Institute and whose research centres on atherosclerosis. 
Specifically, Dr. Xiao breeds and experiments on Apolipoprotein E knockout (ApoE
-/-
) 
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mice, which spontaneously develop atherosclerotic lesions resembling those in humans 
evolving over time from initial fatty streaks. To explore the role of NE in this process 
we crossed ApoE
-/-
 mice with NE
-/-
 mice. Though the data we have collected from these 
studies is only preliminary, it would appear that ApoE
-/-
 mice develop considerably 
smaller atherosclerotic plaques in the aortic root in the absence of NE (data 
unpublished). This is consistent with a reduced accumulation of lesional monocytes, to 
be verified in subsequent histological analyses, and supports our hypothesis that NE 
facilitates monocyte transendothelial migration, certainly in response to CCL2 whose 
expression is pronounced in atherosclerotic lesions (Barlic and Murphy, 2007).  
Though we are keen to further evaluate the pathophysiology of ApoE/NE double knock-
out mice, we similarly recognise the need to conduct additional studies with 
pharmacological NE inhibitors. To date, almost all of our functional data relating to NE 
has been generated using NE KO mice, which ultimately offer limited clinical 
relevance. Furthermore, and as regularly reported in the literature, genetic and 
pharmacological means of intervention do not always yield similar results. For example, 
atherosclerotic lesions are reduced in CCL2- and CCR2-deficient mice, however are 
unaffected upon treatment with a small molecule CCR2 antagonist, despite it 
demonstrating efficacy in several models of inflammation (Aiello et al., 2010). In the 
context of NE, a number of specific inhibitors exist, some of which have already been 
experimented with in this study, though only fleetingly. Additional studies will have to 
be conducted to determine more conclusively whether these inhibitors can abate 
monocyte transmigration in mice. In this regard, we initially plan to administer an NE 
inhibitor in combination with CCL2 into the ears of WT mice. It will be interesting to 
determine if the majority of monocytes become stuck in the vasculature, as observed in 
NE KO mice. Thereafter, we may also determine whether blocking NE activity has a 
significant effect on advanced atherosclerotic lesions or the progression of fatty streaks 
in ApoE KO mice.   
 
7.3 Wider implications 
In deepening our understanding of monocyte trafficking in experimental mouse models, 
we ultimately hope to inspire innovative new ways to manipulate monocyte trafficking 
in humans. In this context, while enhancing targeted monocyte migration may be useful 
for the treatment of various cancers and infectious diseases, the ability to selectively 
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inhibit monocyte recruitment could revolutionise the treatment of monocyte-driven 
inflammatory disorders, such as chronic liver disease, rheumatoid arthritis, HIV 
encephalitis, atherosclerosis, and cardiac infarction. Monocytes, and particularly 
classical monocytes, potentiate the immunopathology of these diseases by infiltrating 
inflamed tissues and secreting pro-inflammatory cytokines, proteases and other 
mediators, culminating in tissue damage, scarring, and in some instances even death. 
Current treatment programs are largely limited to broad-acting anti-inflammatory 
agents, many of which are associated with serious side effects arising as a result of their 
non-selective nature. While several existing therapies do target classical monocytes 
more specifically, their clinical potential has been limited by safety and efficacy 
concerns (Leuschner et al., 2011). A number of antagonists and inhibitors have for 
example been designed to disrupt CCR2/CCL2 signalling, the principal axis regulating 
classical monocyte trafficking, however the clinical application of these agents has been 
hampered by compensatory monocyte recruitment mechanisms (Zhao, 2010). In this 
light, while new therapeutic targets are clearly needed, we maintain belief that targeting 
monocyte recruitment directly represents a promising therapeutic avenue, not least 
because pharmacological inhibition of leukocyte migration has been previously 
demonstrated to be highly effective under a number of clinical disease conditions 
(Mackay, 2008). Moreover, by targeting cell recruitment, sessile 
monocytes/macrophages should remain largely unaffected.  
In addition to the major monocyte-driven pathologies outlined above, targeting 
monocyte migration may also be therapeutically beneficial for those pathologies 
characterised by high NE activity. Elevated levels of secreted NE in the lungs for 
example is one of the hallmarks of chronic obstructive pulmonary disease. Naturally, 
the source of this NE has always been attributed to infiltrating neutrophils. COPD is 
however also associated with an increased pulmonary influx of monocytes, which we 
have robustly demonstrated to express the NE protein and which seemingly release it in 
great quantities during transmigration. In this light, inhibiting monocyte infiltration into 
the lungs might dramatically reduce quantities of secreted NE, which is considered to be 
one of the predominant causes of alveolar destruction in COPD (Ohbayashi, 2002).  
Whether secreted NE contributes to disease progression or not, we believe abating 
monocyte recruitment by disrupting NE activity represents an exciting and novel 
therapeutic approach for monocyte-mediated pathologies. In this context, while several 
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small molecule NE-inhibitors have been clinically developed, predominantly for 
respiratory diseases such as COPD, the majority have failed in early clinical trials 
because of poor pharmacokinetics and a low therapeutic index. Even Sivelestat (ONO-
5046), which is widely used in Japan for the treatment of acute lung injury, has never 
been convincingly demonstrated to possess high clinical efficacy (Iwata et al., 2010). 
Though we are keen to re-evalaute the effectiveness of some of these existing 
compounds directly as monocyte inhibitors, as an alternative approach we also 
recognise the potential of targeting NE at the transcript level using siRNA. Certainly, 
this may be preferable as many protein inhibitors are reportedly ineffective against NE 
sequestered on the cell surface. In addition, considering we detected significantly 
greater quantitites of NE transcript in monocytes, it is conceivable that using siRNA 
will affect these cells more specifically while leaving the anti-microbial functions of 
neutrophils, which turn off NE transcription upon maturation, largely uncompromised. 
Off-target effects could be minimised furtherstill by incorporating monocyte-optimised 
siRNA delivery technologies, which have recently been demonstrated to silence CCR2 
expression in classical monocytes in a number of mouse disease models (Leuschner et 
al., 2011).    
In theory, interrupting classical monocyte migration represents a particularly efficient 
therapeutic strategy because it removes this destructive cell population from the 
inflammatory site rather than neutralising a single causative gene product. One potential 
caveat to this approach however is that upon inhibition the monocytes would 
presumably accumulate in the vasculature. Certainly, this was observed for NE
-/-
 
monocytes in our ear inflammation model, and was similarly observed for NE
-/-
 
neutrophils in a murine model of ventilator-induced lung injury (Kaynar et al., 2008). 
Importantly, this study showed that in the absence of NE whilst significantly fewer 
neutrophils were successfully recruited to the alveolar space, rather than confering 
protection, these mice actually developed worse parameters of acute lung injury than 
WT controls. This was attributed to a prolonged interaction between neutrophils, with 
their arsenal of proteases and reactive oxygen species, and the vasscular endothelium 
leading to local endothelial injury and increased permeabilty. In this light, we are keen 
to determine whether the retention of monocytes within the vasculature also induces an 
acute injurious effect. Certainly, this would be of considerable clinical relevance for 
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atherosclerosis, in which endothelial dysfunction contributes significantly to the 
initiation and progression of disease. 
Whilst developing new potential therapeutics constitutes the overriding motivation for 
our ongoing research, considering our work on NE is still very much in its infancy we 
recognise that this is not likely to be realised soon, if at all. Currently our data are 
limited to acute models of inflammation, which have already demonstrated tissue 
specificty and have yet to be corroborated in more complex disease models. Even so, 
induced models of animal disease are usually not wholly representative of human 
patients. Atherosclerotic plaques in ApoE KO mice for example do not typically rupture 
and thus develop the thrombo-embolisms characteristic of human cardiovascular disease 
(Ohayon et al., 2012). Indeed, despite being the most commonly used animal model in 
research, many questions have been raised about the reliability of mice as models for 
human diseases, not least because of the long list of prospective drugs that worked well 
in mice but turned out to be ineffective in patient trials (Seok et al., 2013). Regarding 
this study more specifically, we firmly acknowledge that the monocyte profiles of mice 
and humans differ in several aspects. Monocytes constitute approximately 10% of total 
blood leukocytes in humans but only 4% in mice. Of these, 90% belong to the classical 
subset in humans while classical and non-classical monocytes are roughly evenly 
represented in mice. Discrepencies have also been reported in gene expression patterns 
and effector functions. For example, whereas human classical monocytes produce the 
immunoregulatory cytokine IL-10 in response to LPS in vitro, the equivalent cells from 
mice produce pro-inflammatory cytokines, including TNF-α and IL-1 (Soehnlein and 
Lindbom, 2010). Regarding monocyte behaviour in vivo, due to restrictions on 
experimentation considerably less is known for humans making it onerous to interpret, 
and ultimately translate, results from mouse or indeed other animal models. In this light, 
while we are committed to further characterising the mechanisms of monocyte 
migration in mice, we hope and urge for complementary studies to be conducted in 
patients and human tissue samples. 
 
7.4 Conclusion 
In conclusion, our study is the first to characterise NE expression in murine classical 
monocytes. Furthermore, we have implicated NE as a regulator of classical monocyte 
recruitment in response to CCL2 in peritonitis and ear models of acute inflammation. 
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More specifically, NE appears to facilitate the initiating stages of monocyte 
transendothelial migration, seemingly by being released extracellularly, though its 
precise mode of action is still to be clarified. These results, whilst requiring further 
validation in murine disease models and ultimately patient samples, implicate NE as a 
novel and inclusive therapeutic target for monocyte-driven pathologies.  
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Appendix 
 
 
CHAPTER 3: 
 
Appendix 3.1: Fluorophore selection guide for four-colour flow cytometry. 
Channel Excitation laser Filter range (nm) Fluorophores 
FL1 (green) Argon 488 515–545 GFP/eGFP 
Alexa Fluor® 488 
Fluorescein (FITC) 
FL2 (yellow) Argon 488 564–606 R-phycoerythrin (PE) 
Alexa Fluor® 546/555 
Cy3 
FL3 (red) Argon 488 ≥ 670 7-AAD 
PE-Cy5 
PE-Cy7 
FL4 (far-red) He-Ne 635 656–667 Alexa Fluor® 647 
Allophycocyanin (APC) 
 
 
 
 
 
 
 
 
Appendix 3.2: Morphological characteristics of blood vessels. Representative confocal 
images of cremasteric venules, arterioles and capillaries, illustrating morphological differences 
in their endothelial junctions (VE-cadherin) and associated pericytes (α-SMA). 
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A) Murine NE: 
ATGGCCCTTGGCAGACTATCCAGCCGGACTCTGGCTGCCATGCTACTGGCATTGTTCCTGGGTGGCCCAG 
CACTGGCCTCAGAGATTGTTGGTGGCCGGCCGGCCCGGCCCCATGCTTGGCCCTTCATGGCATCCCTGCA 
GAGGCGTGGAGGTCATTTCTGTGGTGCCACCCTCATTGCCAGGAACTTCGTCATGTCAGCAGCCCACTGT 
GTGAACGGCCTAAATTTCCGGTCAGTGCAGGTAGTGCTGGGAGCCCATGACCTGCGGCGACAGGAGCGCA 
CTCGACAGACCTTCTCTGTGCAGCGGATCTTCGAGAATGGCTTTGACCCATCACAACTGCTGAACGACAT 
TGTGATTATCCAGCTCAATGGCTCCGCTACCATTAACGCCAACGTGCAGGTGGCCCAGCTGCCTGCCCAG 
GGCCAGGGCGTGGGTGACAGAACTCCATGTCTGGCCATGGGCTGGGGCAGGTTGGGCACAAACAGACCAT 
CACCCAGTGTGCTACAAGAGCTCAATGTGACAGTGGTGACTAACATGTGCCGCCGTCGTGTGAACGTATG 
CACTCTGGTGCCACGTCGGCAGGCAGGCATCTGCTTCGGGGACTCTGGCGGACCCTTGGTCTGTAACAAC 
CTTGTCCAAGGCATTGACTCCTTCATCCGAGGAGGCTGTGGATCTGGATTGTACCCAGATGCCTTCGCCC 
CTGTGGCTGAGTTTGCAGATTGGATCAATTCCATTATCCGAAGCCATAATGACCACCTTCTTACCCATCC 
CAAAGACCGAGAGGGCAGGACCAACTAG 
 
B) Murine GAPDH: 
ATGGTGAAGGTCGGTGTGAACGGATTTGGCCGTATTGGGCGCCTGGTCACCAGGGCTGCCATTTGCAGTGGCAAAGTG
GAGATTGTTGCCATCAACGACCCCTTCATTGACCTCAACTACATGGTCTACATGTTCCAGTATGACTCCACTCACGGCAAA
TTCAACGGCACAGTCAAGGCCGAGAATGGGAAGCTTGTCATCAACGGGAAGCCCATCACCATCTTCCAGGAGCGAGACC
CCACTAACATCAAATGGGGTGAGGCCGGTGCTGAGTATGTCGTGGAGTCTACTGGTGTCTTCACCACCATGGAGAAGGC
CGGGGCCCACTTGAAGGGTGGAGCCAAAAGGGTCATCATCTCCGCCCCTTCTGCCGATGCCCCCATGTTTGTGATGGGT
GTGAACCACGAGAAATATGACAACTCACTCAAGATTGTCAGCAATGCATCCTGCACCACCAACTGCTTAGCCCCCCTGGC
CAAGGTCATCCATGACAACTTTGGCATTGTGGAAGGGCTCATGACCACAGTCCATGCCATCACTGCCACCCAGAAGACTG
TGGATGGCCCCTCTGGAAAGCTGTGGCGTGATGGCCGTGGGGCTGCCCAGAACATCATCCCTGCATCCACTGGTGCTGC
CAAGGCTGTGGGCAAGGTCATCCCAGAGCTGAACGGGAAGCTCACTGGCATGGCCTTCCGTGTTCCTACCCCCAATGTG
TCCGTCGTGGATCTGACGTGCCGCCTGGAGAAACCTGCCAAGTATGATGACATCAAGAAGGTGGTGAAGCAGGCATCTG
AGGGCCCACTGAAGGGCATCTTGGGCTACACTGAGGACCAGGTTGTCTCCTGCGACTTCAACAGCAACTCCCACTCTTCC
ACCTTCGATGCCGGGGCTGGCATTGCTCTCAATGACAACTTTGTCAAGCTCATTTCCTGGTATGACAATGAATACGGCTAC
AGCAACAGGGTGGTGGACCTCATGGCCTACATGGCCTCCAAGGAGTAA 
 
C) Murine cyclophilin: 
ATGGTCAACCCCACCGTGTTCTTCGACATCACGGCCGATGACGAGCCCTTGGGCCGCGTCTCCTTCGAGCTGTTTGCAGA
CAAAGTTCCAAAGACAGCAGAAAACTTTCGAGCTCTGAGCACTGGAGAGAAAGGATTTGGCTATAAGGGTTCCTCCTTT
CACAGAATTATTCCAGGATTCATGTGCCAGGGTGGTGACTTTACACGCCATAATGGCACTGGCGGCAGGTCCATCTACG
GAGAGAAATTTGAGGATGAGAACTTCATCCTAAAGCATACAGGTCCTGGCATCTTGTCCATGGCAAATGCTGGACCAAA
CACAAACGGTTCCCAGTTTTTTATCTGCACTGCCAAGACTGAATGGCTGGATGGCAAGCATGTGGTCTTTGGGAAGGTGA
AAGAAGGCATGAACATTGTGGAAGCCATGGAGCGTTTTGGGTCCAGGAATGGCAAGACCAGCAAGAAGATCACCATTT
CCGACTGTGGACAGCTCTAA 
 
 
 
 
 
 
 
 
Appendix 3.3: qPCR primers used for mRNA quantification. Coding sequences of 
transcripts for murine NE (access. no. NM_015779.2), GAPDH (access. no. M32599) and 
cyclophilin (access. no. M60456.1). Successive exons are differentiated by a change in text 
colour. The sequence regions used for PCR primer design are highlighted in green.     
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Appendix 3.4: Protein sequences for mouse and human NE. Comparative analysis of mouse 
and human NE, demonstrating 73% amino acid homology. Our lab has previously raised an 
anti-murine NE antibody (SY0049) by immunising rabbits with a synthetic peptide analogous to 
residues 84-98 (highlighted in green) of the mouse NE protein. Alignment was made using 
Clustal Omega. (*) indicates positions which have a single, fully conserved residue. (:) indicates 
conservation between groups of strongly similar properties. (.) indicates conservation between 
groups of weakly similar properties. 
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CHAPTER 4: 
 
 
 
 
 
 
 
 
 
 
Appendix 4.1: Enriching leukocyte populations by FACS-sorting. Populations of classical 
monocytes, non-classical monocytes, neutrophils and lymphocytes were FACS-sorted from 
whole splenocytes according to GR-1 (y-axis) and CX3CR1 (x-axis) expression. Upon 
completion, cell purities were established by re-running a small fraction of each sorted 
population through the cytometer (a representative sequence of runs is shown above). Purities 
are represented as the proportion of cells that fall within their original sort gates. 
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Appendix 4.2: Non-specific labelling of NE in PFA-fixed leukocytes. Whole BM leukocytes 
were harvested from CX3CR1
+/eGFP
 mice, seeded onto cover slips, fixed with 4% PFA and 
permeabilised with Triton X-100. The cells were subsequently immunostained for NE (red) and 
the neutrophil marker Ly6G (blue). CX3CR1-eGFP
+ 
monocytes are shown in green. NE
-/-
 
leukocytes were used as a negative control but also stained ‘positively’ for NE. Scale bar, 5 µm. 
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Appendix 4.4: NE mobilises to the nucleus of neutrophils following PMA stimulation. 
Whole bone marrow leukocytes harvested from CX3CR1
+/eGFP
 mice were stimulated in 12-well 
plates in 500 µl RPMI-1640 media supplemented with PMA (10 ng/ml) or vehicle (PBS). The 
cells were subsequently seeded onto coverslips, fixed/permeabilised with methanol, 
immunostained for NE (red) and the neutrophil marker Ly6G (blue) and analysed by confocal 
microscopy. Scale bar, 5 µm. 
 
Appendix 4.3: Assaying for NE protein expression by flow cytometry. Whole leukocytes 
were harvested from the blood and peritoneal cavity of CX3CR1
+/eGFP
 mice stimulated i.p. for 4 
hours with IFN-γ and TNF-α (300 ng/ml each). The cells were ACK-lysed, immunostained for 
NE, and analysed by flow cytometry. NE
+/+
 and NE
-/-
 leukocytes were directly compared. 
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CHAPTER 5: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 5.2: Time course of CCL2-induced monocyte transmigration in the ear dermis. 
NE
+/+
 CX3CR1
+/eGFP
 mice were stimulated i.d. with CCL2 (1 µg) for 2, 4 or 16 hours. Whole 
ears were subsequently harvested, the dorsal skin carefully separated and fixed in PFA, and 
immunostained for the EC junctional marker VE-cadherin. Segments of post-capillary venules 
were analysed by confocal microscopy and reconstructed into virtual 3D models using Imaris 
software. Total numbers of extravasated monocytes were counted for each venule. Data are 
represented as the mean ± SD (n = 6 separate venules from 1 mouse). 
  
 
Appendix 5.1: IFN-γ/TNF-α-induced monocyte transmigration in the cremaster muscle. 
CX3CR1
+/eGFP
 mice were stimulated i.s. with IFN-γ (300 ng) for 16 hours and TNF-α (300 ng) 
for a further 4 hours, after which the cremaster muscles were harvested, fixed in PFA and 
immunostained for α-SMA (red) and MRP-14 (neutrophils, blue). Segments of post-capillary 
venules were subsequently analysed by confocal microscopy and reconstructed into virtual 3D 
models using Imaris software. Monocytes are shown in green. Scale bar, 100 μm. Image 
generated by Dr. Martina Beyrau. 
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Appendix 5.3: Assaying for NE activity in the cremaster muscle of CX3CR1-eGFP-ki mice. 
NE
+/+
 and NE
-/-
 CX3CR1
+/eGFP
 mice were administered Neutrophil Elastase 680 FAST (4 nmols 
in 200 µl PBS) i.v. immediately prior to administering LTB4 (300 ng, supplemented with 2.5 µg 
Alexa Fluor 555–labelled mAb to PECAM-1, red) i.s. for 4 hours. The cremasters were 
harvested and fixed in PFA, after which segments of post-capillary venules were analysed by 
confocal microscopy and reconstructed into virtual 3D models using Imaris software. NE 
activity (blue) was determined by measuring the fluorescence intensity between 640-700 nm 
following excitation at 633 nm. Monocytes are shown in green. Scale bar, 30 µm. 
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Appendix 5.4: Assaying for NE activity in LysM-eGFP-ki mice in situ. LysM
+/eGFP
 mice 
exhibiting eGFP
+
 neutrophils (green) were administered Neutrophil Elastase 680 FAST (4 
nmols in 200 µl PBS) i.v. immediately prior to administering LTB4 (300 ng in 30 µl PBS) i.d. 
for 4 hours. Whole ears were subsequently harvested, the dorsal skin carefully separated and 
fixed in PFA. Upon immunolabelling the vasculature (VE-cadherin, red), individual venule 
segments were analysed by confocal microscopy. NE activity (blue) was determined by 
measuring the fluorescence intensity between 640-700 nm following excitation at 633 nm. Scale 
bar, 30 µm. 
 
Appendix 5.5: NE transcript is expressed in human U937 cells. Total cellular RNA was 
extracted from U937 cells (10
6
) and converted into cDNA. Conventional PCR was subsequently 
performed with primers specific for human NE (A). The same PCR cycling parameters and 
reaction mixtures were used as before for murine NE (Tables 2.2 and 2.4). PCR products were 
resolved on a 1.5% agarose gel (B). The H2O control contains no cDNA template. 
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CHAPTER 6: 
 
 
 
 
 
 
   
 
 
  
Appendix 6.1: Characterisation of LTB4-induced leukocyte transmigration in the ear 
dermis. NE
+/+
 CX3CR1
+/eGFP
 mice were stimulated i.d. with LTB4 (300 ng) for 4, 8, or 16 hours, 
after which the whole ears were harvested, the dorsal skin carefully separated and fixed in PFA. 
Upon immunolabelling the vasculature (VE-cadherin) and neutrophils (MRP-14), total 
extravasated monocytes and neutrophils were counted in individual venule segments using 
confocal microscopy. Data are represented as the mean ± SEM (n = 2 mice, average of 5-6 
venules per ear).   
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Video Appendix 
(N.B. videos are stored on accompanying USB stick) 
 
 
Video appendix 6.3: Leukocyte-assisted monocyte migration. In analysing CCL2-stimulated 
cremasteric venules, transmigration pores in the endothelium (PECAM-1, red) could be 
observed in the absence of monocytes (green). These pores, formed presumably by other 
leukocyte types, were shown in several instances to accommodate subsequent monocyte TEM. 
Original magnification, ×40. Pore of interest is denoted by a grey dot. 
 
Video appendix 6.1: Normal monocyte transendothelial migration. CX3CR1
+/eGFP
 mice were 
administered CCL2 (500 ng, supplemented with Alexa Fluor 555–labelled mAb to PECAM-1, 
red) i.s. for 2 hours. One cremaster muscle was subsequently exteriorised and superfused with 
CCL2 (5×10
-9 
M). Individual post-capillary venules were imaged for ~60 minutes by 4D 
confocal microscopy. Luminal monocytes (green, spherical) were observed crawling across the 
endothelium scanning for sites of transmigration. Once an optimal site was reached, the 
monocytes come to rest prior to squeezing their bodies through endothelial pores and into the 
abluminal space (yellow, flat) (A). TEM occurred principally by the paracellular pathway, i.e. 
by squeezing through pores in endothelial cell junctions (B). Original magnification, ×40. Cell 
of interest is denoted by a grey dot.  
 
Video appendix 6.2: Disrupted forms of monocyte migration. In analysing CCL2-stimulated 
cremasteric venules, in addition to normal TEM, some monocytes could be observed 
undergoing disrupted forms of TEM. This included ‘incomplete’ events, in which monocytes 
(green) seemingly get stuck at the site of TEM (A) and ‘tailing’ events, in which monocytes 
display an elongated uropod, seemingly as a result from engaging tightly with the endothelium 
(PECAM-1, red) whilst still crawling (B). Original magnification, ×40. Cell of interest is 
denoted by a grey dot. 
